#chr	start	end	ref	obs	genotype	quality	gene	variant_type	coding_and_splicing	1000g	ExAC	gnomAD	dbSNP	ljb2_phylop	ljb2_mt	ljb2_sift	ljb2_pp2hvar	esp6500si_ea	cosmic64	RepeatMasker	OMIM	ClinVar	ihdb_hom_80	ihdb_het_80	ihdb_wt_80	ihdb_allsys	classification	validated
chrX	2700157	2700157	G	A	hom	222	XG	nonsynonymous SNV	XG:NM_175569:exon4:c.G178A:p.D60N,XG:NM_001141919:exon4:c.G178A:p.D60N,XG:NM_001141920:exon4:c.G178A:p.D60N,	0.07	0.07	0.07	rs5939319 [];	-0.3870	0.0000	1.0000	0.0010	0.1421					0.0875	0.0125	0.9	16		
chrX	2700202	2700202	A	G	hom	222	XG			0.39	0.39	0.39	rs5939320 [];					0.3091					0.075	0.0375	0.8875	17		
chrX	2724760	2724760	T	C	hom	222	XG	nonsynonymous SNV	XG:NM_001141919:exon8:c.T392C:p.L131P,	0.97	0.97	0.2	rs111382948 [];	0.1390		0.3400	0.0000	0.9975					0.95	0	0.05	141		
chrX	2726396	2726396	A	G	hom	222	XG			0.96	0.96	0.96	rs6567645 [];										0.4375	0	0.5625	46		
chrX	2729552	2729552	-	A	hom	214	XG			0	0	0											0.3375	0.0125	0.65	41		
chrX	2732367	2732367	-	T	hom	98.5	XG			0	0	0											0.2125	0	0.7875	40		
chrX	2733109	2733109	T	G	hom	222	XG			0.72	0.72	0.72	rs5939124 [];										0.775	0.0375	0.1875	76		
chrX	2733210	2733210	G	A	hom	222	XG			0.71	0.71	0.71	rs5939125 [];										0.7875	0.0375	0.175	78		
chrX	2733276	2733276	G	A	hom	222	XG			0.91	0.91	0.91	rs5939339 [];										0.975	0	0.025	94		
chrX	2733641	2733641	A	G	hom	222	XG			0.75	0.75	0.75	rs3672 [];										0.8625	0.025	0.1125	89		
chrX	2733668	2733668	G	A	hom	222	XG			0.74	0.74	0.74	rs3671 [];										0.7625	0.0375	0.2	78		
chrX	2733864	2733864	-	ACACACACACACACCC	hom	11.8	XG			0	0	0	rs67947487 [];										0.025	0	0.975	3		
chrX	2748051	2748051	T	C	hom	58	GYG2			0.75	0.75	0.75	rs57068689 [];										0.35	0	0.65	35		
chrX	2748253	2748253	G	C	hom	222	GYG2			0.93	0.93	0.93	rs55640257 [];					0.9941					0.4375	0	0.5625	95		
chrX	2748292	2748292	C	G	hom	222	GYG2			0.67	0.67	0.67	rs6641656 [];										0.35	0.0125	0.6375	83		
chrX	2774478	2774478	A	G	hom	222	GYG2			0.98	0.98	0.98	rs5939132 [];										0.4375	0	0.5625	46		
chrX	2774761	2774764	TCTA	-	hom	214	GYG2			0	0	0	rs142907396 [];							702			0.075	0.025	0.9	14		
chrX	2800295	2800295	G	C	hom	222	GYG2			0.81	0.81	0.81	rs211660 [];										0.9125	0.0375	0.05	88		
chrX	2821978	2821978	A	C	hom	222	ARSD			0.22	0.22	0.22	rs61619902 [];										0.075	0.05	0.875	11		
chrX	2821979	2821979	G	T	hom	222	ARSD			0.18	0.18	0.18	rs4141211 [];										0.075	0.05	0.875	11		
chrX	2832742	2832742	G	C	het	10.4	ARSD			0.76	0.76	0.76	rs211648 [];	-1.5460	0.0000	0.0300	0.0000	0.6253					0.525	0.35	0.125	122		
chrX	2832771	2832771	C	T	het	225	ARSD			0.0012	0.0012	0.0012	rs78142040 [];										0	0.8	0.2	110		
chrX	2832787	2832787	A	G	het	225	ARSD			0	0	0	rs73632954 [];	-0.1320	0.0002	0.5200	0.0030						0	0.8	0.2	110		
chrX	2832860	2832860	G	A	het	225	ARSD			0	0	0	rs73632955 [];										0	0.3375	0.6625	54		
chrX	2832871	2832871	A	G	het	225	ARSD			0	0	0	rs115343387 [];										0	0.3375	0.6625	37		
chrX	2832881	2832881	-	AT	het	217	ARSD			0	0	0	rs72264262 [];										0	0.3375	0.6625	37		
chrX	2832937	2832937	A	G	het	86	ARSD			0	0	0								1640			0	0.3375	0.6625	37		
chrX	2833534	2833541	TTACGCCC	-	het	3.8	ARSD			0	0	0											0	0.05	0.95	8		
chrX	2833551	2833551	A	T	het	19.1	ARSD			0	0	0	rs114724695 [];										0	0.1125	0.8875	17		
chrX	2833552	2833552	C	G	het	12.3	ARSD			0.01	0.01	0.01	rs115030126 [];										0	0.1125	0.8875	17		
chrX	2833580	2833580	A	G	het	53	ARSD			0.0036	0.0036	0.0036	rs112594989 [];										0	0.275	0.725	46		
chrX	2835831	2835831	C	T	het	189	ARSD			0.07	0.07	0.07	rs75490251 [];										0	0.3375	0.6625	55		
chrX	2835863	2835863	G	T	het	225	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.C845A:p.A282D,	0.08	0.08	0.08	rs78034736 [];	1.3380	0.9429	0.0000	0.9930						0	0.8125	0.1875	112		
chrX	2835964	2835964	G	A	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C744T:p.F248F,	0	0	0	rs73632972 [];										0	0.825	0.175	112		
chrX	2836041	2836041	A	T	het	96	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T667A:p.F223I,	0	0	0	rs67272620 [];	-1.3810	0.0000	0.6900	0.0060						0	0.8	0.2	99		
chrX	2836047	2836047	C	T	het	73	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.G661A:p.G221S,	0.06	0.06	0.06	rs67359049 [];	0.3830	0.1782	0.1400	0.9430						0	0.8	0.2	99		
chrX	2836060	2836060	G	A	het	145	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C648T:p.A216A,	0.07	0.07	0.07	rs113318393 [];										0	0.8125	0.1875	103		
chrX	2836084	2836084	C	G	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.G624C:p.A208A,	0.07	0.07	0.07	rs73632973 [];										0	0.8125	0.1875	106		
chrX	2836138	2836138	G	A	het	225	ARSD	synonymous SNV	ARSD:NM_001669:exon5:c.C570T:p.P190P,	0.07	0.07	0.07	rs73632974 [];										0	0.8125	0.1875	105		
chrX	2836181	2836181	A	T	het	120	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T527A:p.M176K,	0.09	0.09	0.09	rs73632975 [];	1.1320	0.1479	0.0300	0.2480						0	0.8125	0.1875	117		
chrX	2836184	2836184	C	T	het	125	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.G524A:p.G175D,	0.08	0.08	0.08	rs73632976 [];	1.3940	0.9369	0.0100	0.8830						0	0.8125	0.1875	113		
chrX	2836211	2836211	A	T	het	156	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.T497A:p.L166Q [1(large_intestine)]; 	0.09	0.09	0.09	rs73632977 [];	1.1320	0.5142	0.0300	0.9300		298990 [1(large_intestine)]; 				0.0125	0.8125	0.175	110		
chrX	2836238	2836238	G	A	het	181	ARSD	nonsynonymous SNV	ARSD:NM_001669:exon5:c.C470T:p.S157F,	0.08	0.08	0.08	rs73632978 [];	0.3710	0.4682	0.0400	0.1040						0.0125	0.8125	0.175	97		
chrX	2836373	2836373	A	G	het	56	ARSD			0.02	0.02	0.02	rs113026716 [];										0	0.3375	0.6625	37		
chrX	2856155	2856155	C	T	hom	222	ARSE	nonsynonymous SNV	ARSE:NM_000047:exon9:c.G1270A:p.G424S,	0.57	0.57	0.57	rs35143646 [];	1.3550	0.0272	0.4300	0.5110	0.6707			300180 [Arylsulfatase E - Chondrodysplasia punctata, X-linked recessive, 302950 (3)];		0.725	0.025	0.25	154		
chrX	2856422	2856422	-	TC	hom	160	ARSE			0	0	0	rs72395193 [];							180	300180 [Arylsulfatase E - Chondrodysplasia punctata, X-linked recessive, 302950 (3)];		0.175	0.1625	0.6625	34		
chrX	3523054	3523063	ACACACACAC	-	hom	214	PRKX			0	0	0								432			0.2375	0.1	0.6625	33		
chrX	3524493	3524493	T	C	hom	222	PRKX			0.98	0.98	0.98	rs6420576 [];							2386			0.9125	0	0.0875	89		
chrX	3526620	3526621	AC	-	het	152	PRKX			0	0	0								438			0.0125	0.025	0.9625	4		
chrX	3592725	3592725	G	A	hom	222	PRKX	synonymous SNV	PRKX:NM_005044:exon2:c.C249T:p.P83P,	0.48	0.48	0.48	rs10871864 [];					0.5740					0.4875	0.0875	0.425	87		
chrX	3592847	3592847	C	T	hom	222	PRKX			0.95	0.95	0.95	rs7880937 [];					0.8893					0.3875	0.0125	0.6	69		
chrX	3735732	3735732	G	A	hom	222	LOC389906			0.6	0.6	0.6	rs1054501 [];										0.6	0.0625	0.3375	61		
chrX	3746558	3746558	C	T	hom	222	LOC389906			0.99	0.99	0.99	rs4826742 [];										0.9125	0.0125	0.075	85		
chrX	5808145	5808145	C	T	hom	222	NLGN4X			0	0	0									300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.0125	0	0.9875	1		
chrX	5808861	5808861	G	A	hom	222	NLGN4X			0.72	0.72	0.72	rs1882260 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.65	0.1125	0.2375	129		
chrX	5810090	5810090	A	G	hom	222	NLGN4X			0.39	0.39	0.39	rs3810685 [];							226	300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.425	0.075	0.5	87		
chrX	5810574	5810574	C	T	hom	222	NLGN4X			0.38	0.38	0.38	rs3810686 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.45	0.075	0.475	89		
chrX	6146000	6146001	GG	-	hom	51.5	NLGN4X			0	0	0	rs72413786 [];								300427 [Neuroligin 4 - {Autism susceptibility, X-linked 2}, 300495 (3); {Aspergersyndrome susceptibility, X-linked 2}, 300497 (3); Mental retardation, X-linked, 300495 (3)];		0.3125	0.0125	0.675	29		
chrX	6451626	6451629	TCCC	-	het	32.5	VCX3A			0	0	0								501			0	0	1	0		
chrX	6452356	6452356	C	G	hom	24.1	VCX3A			0	0	0	rs5978826 [];										0.0625	0	0.9375	5		
chrX	6452367	6452367	C	G	hom	32	VCX3A			0	0	0	rs1728762 [];										0.025	0	0.975	2		
chrX	6452912	6452912	C	G	hom	194	VCX3A			0	0	0	rs142644833 [];										0.3125	0.025	0.6625	37		
chrX	6967890	6967893	AAGA	-	hom	214	HDHD1			0.24	0.24	0.24	rs147213197 [];										0.1875	0.0875	0.725	26		
chrX	6968011	6968011	A	G	hom	222	HDHD1			0.6	0.6	0.6	rs10458 [];							225			0.4625	0.05	0.4875	51		
chrX	6995315	6995315	C	T	hom	222	HDHD1	synonymous SNV	HDHD1:NM_001178136:exon3:c.G327A:p.P109P,HDHD1:NM_001135565:exon4:c.G525A:p.P175P,HDHD1:NM_012080:exon3:c.G456A:p.P152P,HDHD1:NM_001178135:exon3:c.G456A:p.P152P,	0.64	0.64	0.64	rs2379206 [];					0.5927					0.4625	0.05	0.4875	84		
chrX	6995417	6995417	C	T	hom	222	HDHD1	synonymous SNV	HDHD1:NM_001178136:exon3:c.G225A:p.A75A,HDHD1:NM_001135565:exon4:c.G423A:p.A141A,HDHD1:NM_012080:exon3:c.G354A:p.A118A,HDHD1:NM_001178135:exon3:c.G354A:p.A118A,	0.25	0.25	0.25	rs2379207 [];					0.2396					0.2	0.0875	0.7125	46		
chrX	6995438	6995438	C	T	hom	222	HDHD1	synonymous SNV	HDHD1:NM_001178136:exon3:c.G204A:p.L68L,HDHD1:NM_001135565:exon4:c.G402A:p.L134L,HDHD1:NM_012080:exon3:c.G333A:p.L111L,HDHD1:NM_001178135:exon3:c.G333A:p.L111L,	0.27	0.27	0.27	rs1803675 [];					0.2590					0.2125	0.0875	0.7	50		
chrX	7023678	7023678	G	A	hom	222	HDHD1	nonsynonymous SNV	HDHD1:NM_001135565:exon3:c.C332T:p.T111M,HDHD1:NM_012080:exon2:c.C263T:p.T88M,HDHD1:NM_001178135:exon2:c.C263T:p.T88M,	0.25	0.25	0.25	rs1131197 [];	0.5500	0.9709	0.1300	0.9810	0.2402					0.1875	0.0875	0.725	45		
chrX	7066051	7066051	A	C	hom	177	HDHD1			0.67	0.67	0.67	rs1473666 [];	-0.6680				0.6212					0.4125	0.025	0.5625	62		
chrX	7108850	7108850	A	T	hom	222	HDHD1;STS		HDHD1:dist=42619;STS:dist=28622	0.63	0.63	0.63	rs802913 [];										0.2	0.05	0.75	27		
chrX	7109083	7109083	G	A	hom	222	HDHD1;STS		HDHD1:dist=42852;STS:dist=28389	0.63	0.63	0.63	rs809104 [];										0.2	0.05	0.75	27		
chrX	7810440	7810444	TTTTT	-	hom	32.6	VCX			0	0	0								2306			0.0125	0.1625	0.825	16		
chrX	7811102	7811102	G	T	hom	25	VCX			0	0	0											0.1	0.0375	0.8625	14		
chrX	7811504	7811504	G	A	hom	43	VCX			0	0	0	rs143810768 [];										0.1	0.0125	0.8875	12		
chrX	7812017	7812017	C	T	hom	211	VCX	nonsynonymous SNV	VCX:NM_013452:exon3:c.C581T:p.P194L,	0	0	0	rs78342118 [];	-1.8340	0.0040	0.3300	0.0040	0.4206					0.6625	0.1	0.2375	107		
chrX	7812052	7812052	G	A	hom	120	VCX	nonsynonymous SNV	VCX:NM_013452:exon3:c.G616A:p.V206M,	0	0	0	rs79139778 [];	0.1130	0.0001	0.0100	0.7290	0.1373					0.1	0.075	0.825	25		
chrX	7867378	7867378	T	C	hom	222	PNPLA4			0.67	0.67	0.67	rs34709717 [];										0.55	0.0625	0.3875	58		
chrX	7867435	7867435	G	A	hom	222	PNPLA4			0.72	0.72	0.72	rs12009989 [];										0.5625	0.0625	0.375	59		
chrX	7867668	7867668	G	C	het	25.8	PNPLA4			0	0	0	rs77398473 [];							486			0.125	0.0125	0.8625	17		
chrX	7867732	7867732	A	G	hom	222	PNPLA4			0.62	0.62	0.62	rs6639976 [];										0.55	0.05	0.4	56		
chrX	7890215	7890215	C	T	hom	222	PNPLA4			0.63	0.63	0.63	rs1183732 [];										0.275	0.0375	0.6875	33		
chrX	8138502	8138502	C	G	hom	50.3	VCX2			0	0	0	rs201123318 [];										0.0125	0	0.9875	1		
chrX	8138513	8138513	C	G	hom	73	VCX2			0	0	0	rs1728762 [];										0	0	1	0		
chrX	8433663	8433663	G	C	hom	73	VCX3B			0	0	0	rs1728762 [];										0.075	0	0.925	6		
chrX	8434419	8434419	G	A	hom	101	VCX3B	nonsynonymous SNV	VCX3B:NM_001001888:exon3:c.G736A:p.V246M,	0	0	0	rs201152323 [];	0.0990	0.0004	0.0000	0.3500	0.0393					0.0125	0	0.9875	6		
chrX	8434522	8434522	T	A	hom	132	VCX3B			0	0	0	rs1071701 [];										0.1875	0.025	0.7875	19		
chrX	8434596	8434599	AGGG	-	het	61.3	VCX3B			0	0	0								442			0	0	1	0		
chrX	8498979	8498979	G	A	hom	222	KAL1			0.28	0.28	0.28	rs808127 [];										0.375	0.0875	0.5375	44		
chrX	8503641	8503641	G	A	hom	222	KAL1	synonymous SNV	KAL1:NM_000216:exon12:c.C1833T:p.I611I,	0.54	0.54	0.54	rs809446 [];					0.6663					0.6125	0.0625	0.325	107		
chrX	8504773	8504773	G	T	hom	222	KAL1			0.56	0.56	0.56	rs56520561 [];					0.6717					0.25	0.05	0.7	53		
chrX	8504833	8504833	C	T	hom	222	KAL1	nonsynonymous SNV	KAL1:NM_000216:exon11:c.G1600A:p.V534I,	0.55	0.55	0.55	rs808119 [];	-1.0550	0.0033	1.0000	0.0010	0.6706					0.6	0.0625	0.3375	104		
chrX	8556133	8556133	C	T	hom	190	KAL1			0.0006	0.0006	0.0006	rs182613971 [];										0	0	1	0		
chrX	8700168	8700168	A	C	hom	124	KAL1			0.51	0.51	0.51	rs1236390 [];										0.2	0.05	0.75	22		
chrX	8766291	8766291	T	C	hom	222	FAM9A			0.43	0.43	0.43	rs2018496 [];					0.3576					0.175	0.075	0.75	36		
chrX	8997440	8997440	G	A	hom	222	FAM9B	nonsynonymous SNV	FAM9B:NM_205849:exon5:c.C301T:p.H101Y,	0.01	0.01	0.01	rs141078293 [];	-0.4260	0.0042	1.0000	0.7280	0.0125					0	0	1	1		
chrX	9379675	9379675	G	A	het	4.13	FAM9B;TBL1X		FAM9B:dist=378559;TBL1X:dist=51660	0	0	0	rs6640411 [];										0.1	0.6	0.3	65		
chrX	9651839	9651839	T	A	hom	222	TBL1X			0.92	0.92	0.92	rs2732883 [];										0.85	0.0375	0.1125	82		
chrX	9659774	9659774	-	G	hom	214	TBL1X			0.01	0.01	0.01											0.1125	0.0625	0.825	38		
chrX	9659863	9659863	G	A	hom	222	TBL1X			0.4	0.4	0.4	rs2301674 [];										0.1125	0.0625	0.825	18		
chrX	9661165	9661165	G	T	hom	222	TBL1X			0.43	0.43	0.43	rs3747430 [];					0.4318					0.1125	0.0625	0.825	48		
chrX	9661546	9661546	T	C	hom	222	TBL1X			0.36	0.36	0.36	rs56091227 [];										0.1125	0.0625	0.825	19		
chrX	9677599	9677599	G	A	hom	222	TBL1X			0.5	0.5	0.5	rs1006912 [];										0.1125	0.05	0.8375	15		
chrX	9684684	9684684	-	AA	hom	214	TBL1X			0	0	0											0.075	0.0125	0.9125	7		
chrX	9684711	9684711	T	-	hom	21.5	TBL1X			0	0	0											0.1625	0	0.8375	15		
chrX	9684738	9684738	A	G	hom	222	TBL1X			0.29	0.29	0.29	rs16985675 [];										0.2875	0.0625	0.65	31		
chrX	9685247	9685247	A	-	hom	39.5	TBL1X			0.37	0.37	0.37	rs58867285 [];										0.1375	0.0125	0.85	16		
chrX	9686187	9686187	T	C	hom	222	TBL1X			0.42	0.42	0.42	rs2106705 [];										0.5375	0.05	0.4125	55		
chrX	9686681	9686681	G	A	hom	222	TBL1X			0.11	0.11	0.11	rs7256 [];										0.0625	0	0.9375	5		
chrX	9693397	9693397	G	A	hom	222	GPR143			0.48	0.48	0.48	rs1476509 [];										0.0625	0.05	0.8875	11		
chrX	9693652	9693652	G	A	hom	222	GPR143			0.48	0.48	0.48	rs3044 [];										0.15	0.05	0.8	19		
chrX	9711595	9711595	G	C	hom	222	GPR143			0.2	0.2	0.2	rs3788938 [];					0.2237					0.0625	0.075	0.8625	30		
chrX	9728744	9728744	G	C	hom	222	GPR143			0.08	0.08	0.08	rs11095520 [];					0.0811					0.05	0.025	0.925	8		
chrX	9859098	9859098	A	G	hom	222	SHROOM2	synonymous SNV	SHROOM2:NM_001649:exon3:c.A399G:p.P133P,	0.89	0.89	0.89	rs6640543 [];					0.9395					0.8875	0.025	0.0875	142		
chrX	9859197	9859197	A	G	hom	222	SHROOM2			0.84	0.84	0.84	rs6640544 [];					0.9386					0.3875	0.025	0.5875	72		
chrX	9866420	9866420	T	C	hom	222	SHROOM2			0.46	0.46	0.46	rs2073944 [];										0.3	0.0375	0.6625	35		
chrX	9907485	9907485	G	-	hom	214	SHROOM2			0.24	0.24	0.24	rs3216890 [];										0.05	0.0125	0.9375	8		
chrX	9914667	9914667	A	G	hom	222	SHROOM2			0.43	0.43	0.43	rs2073941 [];					0.1670					0.075	0	0.925	14		
chrX	9914947	9914947	G	C	hom	222	SHROOM2	nonsynonymous SNV	SHROOM2:NM_001649:exon10:c.G4821C:p.L1607F,	0.5	0.5	0.5	rs2073942 [];	-2.8940	0.0000	0.2600	0.0040	0.2446					0.2	0.0125	0.7875	32		
chrX	9915165	9915165	C	T	hom	222	SHROOM2			0.5	0.5	0.5	rs886128 [];										0.2	0.0125	0.7875	24		
chrX	9915849	9915849	G	A	hom	222	SHROOM2			0.25	0.25	0.25	rs1858884 [];										0.1375	0.0375	0.825	19		
chrX	9915920	9915920	G	T	hom	222	SHROOM2			0.49	0.49	0.49	rs886129 [];										0.2	0.0125	0.7875	23		
chrX	10062079	10062079	T	A	hom	222	WWC3			0.26	0.26	0.26	rs5934746 [];										0.0875	0.0625	0.85	17		
chrX	10062163	10062163	G	C	hom	222	WWC3			0.25	0.25	0.25	rs5934747 [];					0.2757					0.1625	0.0875	0.75	46		
chrX	10085674	10085674	T	C	hom	222	WWC3	synonymous SNV	WWC3:NM_015691:exon11:c.T1575C:p.D525D,	0.94	0.94	0.94	rs6530368 [];					0.8671					0.825	0.0125	0.1625	93		
chrX	10174386	10174386	C	T	hom	222	CLCN4			0.14	0.14	0.14	rs5934810 [];					0.0932					0.0125	0.0375	0.95	13		
chrX	10174946	10174946	-	TGTTTTGTTTTTG	hom	105	CLCN4			0	0	0											0.0125	0.025	0.9625	4		
chrX	10180449	10180449	C	T	hom	222	CLCN4			0.1	0.1	0.1	rs1989890 [];										0.0125	0	0.9875	3		
chrX	10181681	10181681	G	A	hom	222	CLCN4			0.01	0.01	0.01	rs148721625 [];					0.0088					0	0	1	2		
chrX	10645789	10645789	G	A	hom	222	MID1			0.01	0.01	0.01	rs142823569 [];								300552 [Midline-1 - Opitz G syndrome, type I, 300000 (3)];		0.025	0	0.975	2		
chrX	11138986	11138986	G	T	hom	222	HCCS			0	0	0									300056 [Holocytochrome c synthase (cytochrome c heme-lyase) - Microphthalmia, syndromic 7, 309801 (3)];		0	0	1	0		
chrX	11156442	11156442	G	A	hom	222	ARHGAP6			0.0048	0.0048	0.0048	rs55700213 [];										0.0125	0	0.9875	4		
chrX	11313027	11313027	T	C	hom	222	AMELX;ARHGAP6			0.7	0.7	0.7	rs946252 [];					0.6934					0.275	0.05	0.675	53		
chrX	12722616	12722616	C	G	hom	222	FRMPD4			0.99	0.99	0.99	rs4469660 [];					0.9921					0.4375	0	0.5625	100		
chrX	12738587	12738587	T	C	hom	186	FRMPD4			0.15	0.15	0.15	rs12557959 [];					0.1861					0.0625	0.025	0.9125	13		
chrX	12837558	12837558	C	T	hom	222	PRPS2			0.83	0.83	0.83	rs5935399 [];										0.35	0.0375	0.6125	41		
chrX	12838934	12838934	A	G	hom	222	PRPS2			0.52	0.52	0.52	rs917580 [];					0.6350					0.25	0.0375	0.7125	50		
chrX	12841452	12841452	-	TTT	het	60.5	PRPS2			0	0	0											0.0125	0.0875	0.9	13		
chrX	12903659	12903659	A	T	hom	222	TLR7	nonsynonymous SNV	TLR7:NM_016562:exon3:c.A32T:p.Q11L,	0.15	0.15	0.15	rs179008 [];	-0.6370	0.0372	0.1900	0.0000	0.2124					0.2	0.0375	0.7625	38		
chrX	12937804	12937804	C	T	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.C645T:p.H215H [1(stomach)]; 	0.63	0.63	0.63	rs5744080 [];					0.3924	150765 [1(stomach)]; 				0.375	0.05	0.575	58		
chrX	12939112	12939112	G	C	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.G1953C:p.L651L,	0.66	0.66	0.66	rs2407992 [];					0.3946					0.3625	0.05	0.5875	58		
chrX	12939412	12939412	C	A	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.C2253A:p.I751I [1(stomach)]; 	0.51	0.51	0.51	rs3747414 [];					0.3448	150766 [1(stomach)]; 				0.3125	0.0625	0.625	52		
chrX	12939928	12939928	T	C	hom	222	TLR8	synonymous SNV	TLR8:NM_138636:exon2:c.T2769C:p.D923D,	1	1	1	rs2109135 [];					0.9967					0.9875	0	0.0125	146		
chrX	12994886	12994886	-	T	het	25.5	TMSB4X			0	0	0											0	0.0375	0.9625	3		
chrX	13056654	13056654	T	C	hom	222	FAM9C			0.5	0.5	0.5	rs4830483 [];					0.4856					0.1375	0.05	0.8125	37		
chrX	13062722	13062722	C	T	hom	211	FAM9C			0.54	0.54	0.54	rs11095602 [];										0.4	0.1	0.5	51		
chrX	13730787	13730787	G	C	hom	222	TRAPPC2			0.74	0.74	0.74	rs7716 [];										0.65	0	0.35	59		
chrX	13734539	13734539	T	C	hom	222	TRAPPC2			0.59	0.59	0.59	rs2285633 [];										0.225	0.0125	0.7625	25		
chrX	13734920	13734920	-	TTTG	hom	214	TRAPPC2			0	0	0											0.225	0.0125	0.7625	24		
chrX	13752895	13752895	G	T	hom	222	OFD1			0.33	0.33	0.33	rs2285635 [];								300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.25	0.0375	0.7125	51		
chrX	13754425	13754425	A	-	hom	214	OFD1			0	0	0									300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.2625	0.05	0.6875	28		
chrX	13758375	13758375	G	A	hom	206	OFD1			0.42	0.42	0.42	rs2238908 [];							774	300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.1125	0.025	0.8625	14		
chrX	13767718	13767718	A	G	hom	222	OFD1			0.75	0.75	0.75	rs7878592 [];								300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.2375	0	0.7625	24		
chrX	13771576	13771576	A	G	hom	222	OFD1			0.34	0.34	0.34	rs3815049 [];					0.2229			300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.1125	0.025	0.8625	45		
chrX	13779124	13779124	G	A	hom	222	OFD1			0.42	0.42	0.42	rs55716120 [];								300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0.1	0.025	0.875	13		
chrX	13779422	13779422	-	TT	het	217	OFD1			0	0	0									300170 [OFD1 protein - Oral-facial-digital syndrome 1, 311200 (3); Simpson-Golabi-Behmelsyndrome, type 2, 300209 (3); Joubert syndrome 10, 300804 (3)];		0	0	1	0		
chrX	13789349	13789349	T	G	hom	222	GPM6B			0.32	0.32	0.32	rs13793 [];										0.225	0.025	0.75	23		
chrX	13790333	13790333	G	A	hom	222	GPM6B			0.3	0.3	0.3	rs11095627 [];										0.125	0.0375	0.8375	14		
chrX	13803960	13803960	C	T	hom	222	GPM6B			0.59	0.59	0.59	rs5978663 [];					0.5681					0.1875	0.0125	0.8	34		
chrX	13835096	13835096	T	C	hom	222	GPM6B			0.21	0.21	0.21	rs3747420 [];										0.2125	0.1	0.6875	28		
chrX	14599572	14599572	A	G	hom	222	GLRA2			0.54	0.54	0.54	rs2074211 [];					0.5854					0.175	0.05	0.775	45		
chrX	14625415	14625415	-	TT	het	197	GLRA2			0	0	0											0.0625	0.0375	0.9	12		
chrX	14708912	14708912	G	A	hom	222	GLRA2	synonymous SNV	GLRA2:NM_001171942:exon10:c.G744A:p.A248A,GLRA2:NM_002063:exon8:c.G1011A:p.A337A,GLRA2:NM_001118886:exon8:c.G1011A:p.A337A,GLRA2:NM_001118885:exon9:c.G1011A:p.A337A,	0.0024	0.0024	0.0024	rs139404975 [];					0.0007					0	0	1	0		
chrX	14749035	14749035	-	GCTATA	het	75.5	GLRA2			0	0	0								531			0	0	1	0		
chrX	14749053	14749072	CACACACACACACACACACA	-	hom	214	GLRA2			0	0	0								531			0	0	1	0		
chrX	14749341	14749341	T	C	hom	222	GLRA2			0.37	0.37	0.37	rs11795712 [];										0.425	0.0875	0.4875	55		
chrX	14868806	14868806	A	G	hom	222	FANCB			0.45	0.45	0.45	rs2905223 [];					0.5893			300515 [Fanconi anemia-associated polypeptide, 95kD - Fanconi anemia, complementation group B, 300514 (3)];		0.4375	0.075	0.4875	95		
chrX	14887147	14887147	C	G	hom	222	FANCB			0.53	0.53	0.53	rs2188383 [];								300515 [Fanconi anemia-associated polypeptide, 95kD - Fanconi anemia, complementation group B, 300514 (3)];		0.4625	0.075	0.4625	98		
chrX	14891258	14891258	G	T	hom	138	FANCB;MOSPD2			0.54	0.54	0.54	rs2285490 [];										0.2	0.0625	0.7375	29		
chrX	14930363	14930363	-	T	hom	197	MOSPD2			0	0	0											0.2875	0.0625	0.65	52		
chrX	15262372	15262372	T	A	hom	222	ASB9			0.9	0.9	0.9	rs9560 [];										0.7	0.0375	0.2625	75		
chrX	15262432	15262432	A	C	hom	222	ASB9			0.9	0.9	0.9	rs14252 [];										0.725	0.0375	0.2375	79		
chrX	15262814	15262814	-	G	hom	72.5	ASB9			0	0	0											0.075	0	0.925	12		
chrX	15262826	15262826	-	A	hom	214	ASB9			0	0	0											0.05	0.0375	0.9125	11		
chrX	15288230	15288233	ACAC	-	het	9.93	ASB9			0	0	0								270			0	0.025	0.975	2		
chrX	15332469	15332469	-	T	het	3.25	ASB11			0	0	0											0	0.0625	0.9375	5		
chrX	15333842	15333842	T	A	hom	204	ASB11			1	1	1	rs4830529 [];										0.4375	0	0.5625	46		
chrX	15756576	15756576	T	A	hom	168	CA5B			0.003	0.003	0.003	rs145113629 [];										0.0125	0	0.9875	1		
chrX	15792527	15792527	T	A	hom	222	CA5B			0.64	0.64	0.64	rs4364812 [];						150768 [1(stomach)]; 				0.6875	0.025	0.2875	79		
chrX	15794764	15794764	G	A	hom	177	CA5B			0.62	0.62	0.62	rs5980183 [];										0.275	0.075	0.65	34		
chrX	15794815	15794815	G	A	hom	222	CA5B			1	1	1	rs5936050 [];					0.9906					0.4375	0	0.5625	74		
chrX	15801330	15801330	A	C	hom	222	CA5B			0.23	0.23	0.23	rs12841514 [];							346			0.3375	0.0625	0.6	40		
chrX	15801643	15801643	A	G	hom	185	CA5B			0.66	0.66	0.66	rs28707735 [];							2264			0.7	0.025	0.275	73		
chrX	15803997	15803997	-	T	hom	201	INE2			0	0	0								2471			0.2125	0	0.7875	20		
chrX	15804387	15804387	-	A	hom	214	INE2			0	0	0	rs67895333 [];										0.3375	0.0625	0.6	37		
chrX	15804984	15804984	G	A	hom	222	INE2			0.23	0.23	0.23	rs10521650 [];										0.325	0.0625	0.6125	36		
chrX	15805571	15805571	G	A	hom	222	INE2			1	1	1	rs5936053 [];										0.9375	0	0.0625	87		
chrX	15805791	15805791	A	G	hom	195	INE2;CA5B			0.23	0.23	0.23	rs5021752 [];										0.125	0.0625	0.8125	20		
chrX	15808795	15808795	T	C	hom	222	ZRSR2			1	1	1	rs4830994 [];										0.4375	0	0.5625	46		
chrX	15808903	15808903	T	C	hom	222	ZRSR2			0	0	0											0	0	1	0		
chrX	15817963	15817963	A	G	hom	222	ZRSR2			0.88	0.88	0.88	rs5980192 [];					0.7116					0.325	0.025	0.65	62		
chrX	15818115	15818115	T	-	hom	214	ZRSR2			0.56	0.56	0.56	rs62985661 [];					0.4751					0.2	0.0875	0.7125	51		
chrX	15822013	15822013	C	T	hom	196	ZRSR2			0.3	0.3	0.3	rs5936060 [];							690			0.1875	0.075	0.7375	29		
chrX	15822022	15822022	C	T	hom	167	ZRSR2			0.56	0.56	0.56	rs5934280 [];							690			0.2	0.0875	0.7125	34		
chrX	15827524	15827524	T	G	hom	222	ZRSR2			0.88	0.88	0.88	rs5980193 [];										0.325	0.025	0.65	39		
chrX	15836648	15836648	T	G	hom	199	ZRSR2			0.56	0.56	0.56	rs5936062 [];					0.4889					0.2	0.0875	0.7125	53		
chrX	15838366	15838366	C	T	hom	222	ZRSR2	synonymous SNV	ZRSR2:NM_005089:exon10:c.C864T:p.N288N,	0.55	0.55	0.55	rs2301724 [];					0.4872					0.4625	0.1	0.4375	91		
chrX	15844915	15844915	-	A	het	186	AP1S2			0	0	0									300629 [Adaptor-related protein complex 1, sigma-2 subunit - Mental retardation, X-linked 59, 300630 (3)];		0	0.1875	0.8125	27		
chrX	15863953	15863953	A	T	hom	220	AP1S2			1	1	1	rs798169 [];								300629 [Adaptor-related protein complex 1, sigma-2 subunit - Mental retardation, X-linked 59, 300630 (3)];		0.4375	0	0.5625	46		
chrX	16168467	16168467	T	C	hom	222	GRPR	synonymous SNV	GRPR:NM_005314:exon2:c.T453C:p.S151S,	0.27	0.27	0.27	rs4986945 [];					0.3450					0.2625	0.0375	0.7	46		
chrX	16168677	16168677	T	C	hom	222	GRPR	synonymous SNV	GRPR:NM_005314:exon2:c.T663C:p.I221I,	0.35	0.35	0.35	rs4986946 [];					0.3482					0.2625	0.05	0.6875	47		
chrX	16171077	16171077	T	A	hom	222	GRPR			0.21	0.21	0.21	rs3747411 [];										0.2375	0.05	0.7125	26		
chrX	16171340	16171340	G	A	hom	222	GRPR			0.18	0.18	0.18	rs10521655 [];										0.25	0.05	0.7	29		
chrX	16171381	16171381	T	A	hom	222	GRPR			0.59	0.59	0.59	rs6632770 [];										0.5125	0.05	0.4375	53		
chrX	16171382	16171382	T	A	hom	222	GRPR			0.66	0.66	0.66	rs6632771 [];										0.4875	0.05	0.4625	51		
chrX	16171595	16171595	A	-	hom	89.5	GRPR			0.63	0.63	0.63	rs11340309 [];										0.5	0.0375	0.4625	50		
chrX	16709626	16709626	G	A	hom	222	CTPS2			0.56	0.56	0.56	rs5980322 [];					0.4270					0.2	0.075	0.725	37		
chrX	16717353	16717353	G	A	hom	214	CTPS2			0.55	0.55	0.55	rs5980324 [];										0.175	0.0875	0.7375	26		
chrX	16721129	16721129	T	C	hom	222	CTPS2			0.56	0.56	0.56	rs4831053 [];										0.175	0.0875	0.7375	26		
chrX	16871725	16871725	-	A	hom	70.5	RBBP7			0	0	0											0.0125	0	0.9875	1		
chrX	17166219	17166219	C	T	hom	222	REPS2			1	1	1	rs1426797 [];										0.925	0	0.075	91		
chrX	17705851	17705851	-	T	hom	214	NHS			0	0	0	rs11408157 [];								300457 [NHS gene - Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,302200 (3)];		1	0	0	156		
chrX	17753436	17753436	A	T	hom	222	NHS			1	1	1	rs5909331 [];								300457 [NHS gene - Nance-Horan syndrome, 302350 (3); Cataract, congenital, X-linked,302200 (3)];		0.9625	0	0.0375	155		
chrX	17819377	17819377	T	C	hom	222	RAI2	nonsynonymous SNV	RAI2:NM_021785:exon2:c.A754G:p.M252V,RAI2:NM_001172732:exon3:c.A604G:p.M202V,RAI2:NM_001172743:exon3:c.A754G:p.M252V,RAI2:NM_001172739:exon3:c.A754G:p.M252V,	1	1	1	rs6527818 [];	1.2330	0.0000	1.0000	0.0000	0.9993					0.95	0	0.05	141		
chrX	18182261	18182261	G	A	hom	158	BEND2			0.25	0.25	0.25	rs41309597 [];							2303			0.4125	0.075	0.5125	44		
chrX	18183113	18183113	-	A	het	6.55	BEND2			0	0	0											0	0.15	0.85	14		
chrX	18276121	18276132	AGGGGGAAGGGA	-	het	139	SCML2			0	0	0								534			0	0	1	0		
chrX	18278199	18278199	T	C	hom	203	SCML2			0.27	0.27	0.27	rs5909435 [];										0.0625	0.0125	0.925	10		
chrX	18284005	18284005	C	T	hom	210	SCML2			0.27	0.27	0.27	rs3795187 [];										0.075	0.0125	0.9125	11		
chrX	18342034	18342034	G	A	hom	222	SCML2	synonymous SNV	SCML2:NM_006089:exon5:c.C342T:p.D114D,	0.22	0.22	0.22	rs3213544 [];					0.2244					0.225	0.0375	0.7375	41		
chrX	18372664	18372664	C	G	hom	201	SCML2			1	1	1	rs12689111 [];										0.4375	0	0.5625	45		
chrX	18372668	18372668	C	G	hom	200	SCML2			1	1	1	rs12689113 [];										0.4375	0	0.5625	45		
chrX	18631235	18631235	G	A	het	28	CDKL5			0	0	0								1158	300203 [Cyclin-dependent kinase-like 5 - Epileptic encephalopathy, early infantile, 2, 300672 (3);Angelman syndrome-like, 105830 (3)];		0	0.225	0.775	26		
chrX	18671795	18671795	A	G	hom	202	RS1			0.44	0.44	0.44	rs56396491 [];										0.325	0.0375	0.6375	61		
chrX	18671796	18671796	T	A	hom	198	RS1			0.51	0.51	0.51	rs76265569 [];										0.325	0.0375	0.6375	61		
chrX	18767881	18767881	A	C	het	5.46	PPEF1			0	0	0	rs199592750 [];							189			0	0.0875	0.9125	7		
chrX	18824490	18824490	C	T	hom	222	PPEF1			0.04	0.04	0.04	rs140334279 [];					0.0870					0.025	0	0.975	13		
chrX	18937113	18937113	C	T	hom	222	PHKA2			0.01	0.01	0.01	rs73191588 [];										0	0.0125	0.9875	1		
chrX	19018130	19018130	-	T	het	11.8	GPR64			0	0	0								2554			0	0.0125	0.9875	1		
chrX	19041592	19041592	C	T	hom	222	GPR64			0.66	0.66	0.66	rs5909263 [];					0.6976					0.2375	0.075	0.6875	56		
chrX	19373652	19373652	-	CAGGCC	het	217	PDHA1			0	0	0									300502 [Pyruvate dehydrogenase, E1-alpha polypeptide-1 - Pyruvate dehydrogenase deficiency, 312170 (3); Leigh syndrome,X-linked, 308930 (3)];		0	0	1	0		
chrX	19373665	19373665	-	CGGCCA	het	217	PDHA1			0	0	0									300502 [Pyruvate dehydrogenase, E1-alpha polypeptide-1 - Pyruvate dehydrogenase deficiency, 312170 (3); Leigh syndrome,X-linked, 308930 (3)];		0	0	1	0		
chrX	19478294	19478294	T	A	hom	222	MAP3K15			0.91	0.91	0.91	rs5909118 [];					0.9036					0.4	0.025	0.575	62		
chrX	19478337	19478337	-	A	hom	214	MAP3K15			0	0	0	rs61014139 [];										0.4	0.025	0.575	44		
chrX	19482476	19482476	C	T	hom	222	MAP3K15	nonsynonymous SNV	MAP3K15:NM_001001671:exon4:c.G574A:p.A192T,	0.72	0.72	0.72	rs5909299 [];	0.5730		0.1000		0.8867					0.875	0.0375	0.0875	133		
chrX	20026284	20026284	A	G	hom	222	MAP7D2			0.03	0.03	0.03	rs41305209 [];										0.025	0	0.975	4		
chrX	20071046	20071046	T	C	hom	222	MAP7D2	nonsynonymous SNV	MAP7D2:NM_001168467:exon5:c.A413G:p.N138S,MAP7D2:NM_001168465:exon5:c.A545G:p.N182S,MAP7D2:NM_152780:exon5:c.A545G:p.N182S,	0.35	0.35	0.35	rs34519770 [];	-0.0330	0.0000	1.0000	0.0070	0.2684					0.175	0.0375	0.7875	37		
chrX	20144116	20144116	C	T	het	140	EIF1AX			0	0	0	rs199880393 [];										0	0.4625	0.5375	49		
chrX	20146157	20146157	-	TT	hom	53.5	EIF1AX			0	0	0											0.0125	0.0625	0.925	9		
chrX	20205856	20205856	A	C	hom	204	RPS6KA3			0.24	0.24	0.24	rs7882807 [];								300075 [Ribosomal protein S6 kinase, 90kD, polypeptide 3 - Coffin-Lowry syndrome, 303600 (3); Mental retardation, X-linked19, 300844 (3)];		0.05	0.025	0.925	10		
chrX	21534510	21534510	-	C	hom	174	CNKSR2			0	0	0	rs3838943 [];										0.0375	0.0125	0.95	5		
chrX	21619554	21619554	-	AAACAAATAT	het	22.5	CNKSR2			0	0	0											0	0	1	0		
chrX	21673605	21673608	TTTT	-	het	4.42	CNKSR2;KLHL34			0	0	0								198			0	0.0375	0.9625	4		
chrX	21985543	21985543	C	A	hom	222	SMS			0.11	0.11	0.11	rs3747277 [];								300105 [Spermine synthase - Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)];		0.025	0.0125	0.9625	4		
chrX	22003230	22003230	T	C	hom	222	SMS			0.11	0.11	0.11	rs2071136 [];					0.1183			300105 [Spermine synthase - Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)];		0.025	0.0125	0.9625	12		
chrX	22012723	22012723	-	C	hom	214	SMS			0	0	0									300105 [Spermine synthase - Mental retardation, X-linked, Snyder-Robinson type, 309583 (3)];		0.0375	0.0125	0.95	6		
chrX	23723261	23723261	T	C	hom	222	ACOT9			0.52	0.52	0.52	rs2270142 [];										0.275	0.0625	0.6625	34		
chrX	23723384	23723384	A	G	hom	222	ACOT9			0.33	0.33	0.33	rs5970777 [];										0.1875	0.0875	0.725	29		
chrX	23801593	23801593	A	G	hom	197	SAT1			0.66	0.66	0.66	rs3764885 [];					0.7859					0.3375	0.0125	0.65	62		
chrX	23801702	23801702	G	C	hom	200	SAT1			0.61	0.61	0.61	rs3764884 [];					0.7839					0.3125	0.025	0.6625	58		
chrX	23928489	23928489	C	T	hom	222	CXorf58	nonsynonymous SNV	CXorf58:NM_152761:exon2:c.C70T:p.R24C [1(prostate)]; CXorf58:NM_001169574:exon2:c.C70T:p.R24C [1(prostate)]; 	0.47	0.47	0.47	rs2707164 [];	-0.2740	0.0113	0.1900	0.5500	0.7053	1179846 [1(prostate)]; 				0.55	0.075	0.375	87		
chrX	23934052	23934052	G	A	hom	222	CXorf58			0.51	0.51	0.51	rs2520231 [];										0.2375	0.0875	0.675	33		
chrX	23934202	23934202	A	G	hom	222	CXorf58			0.42	0.42	0.42	rs2520230 [];										0.2625	0.0625	0.675	33		
chrX	24004223	24004223	-	T	hom	214	KLHL15			0	0	0											0.1375	0.025	0.8375	31		
chrX	24073761	24073761	C	T	hom	222	EIF2S3	synonymous SNV	EIF2S3:NM_001415:exon2:c.C99T:p.H33H,	0.48	0.48	0.48	rs36018672 [];	-0.7490				0.6748					0.625	0.0375	0.3375	145		
chrX	24084254	24084254	-	T	hom	214	EIF2S3			0	0	0											0.2625	0.0625	0.675	44		
chrX	24231817	24231817	-	A	het	21.5	ZFX			0	0	0											0.1625	0.125	0.7125	28		
chrX	24577591	24577591	T	A	hom	222	PCYT1B			0.77	0.77	0.77	rs2178608 [];							654			0.6375	0.0375	0.325	63		
chrX	24578306	24578306	G	A	hom	222	PCYT1B			0.66	0.66	0.66	rs3761611 [];										0.7	0.0375	0.2625	73		
chrX	24578551	24578551	T	A	hom	222	PCYT1B			0.71	0.71	0.71	rs3761610 [];										0.75	0.025	0.225	80		
chrX	24578803	24578803	C	T	hom	222	PCYT1B			0.69	0.69	0.69	rs10156959 [];										0.7	0.0375	0.2625	75		
chrX	24593464	24593464	A	-	hom	75.5	PCYT1B			0	0	0											0.3	0.0125	0.6875	41		
chrX	24593513	24593513	T	G	hom	222	PCYT1B			0.6	0.6	0.6	rs3747401 [];										0.3	0.0375	0.6625	38		
chrX	24665388	24665388	-	C	hom	214	PCYT1B			0.02	0.02	0.02											0.25	0.0625	0.6875	36		
chrX	24751958	24751958	T	C	hom	222	POLA1			1	1	1	rs75310488 [];										0.9875	0	0.0125	140		
chrX	24766651	24766651	G	A	hom	222	POLA1			0.54	0.54	0.54	rs3764770 [];										0.2875	0.025	0.6875	35		
chrX	27283839	27283839	-	TAGTTTTTCT	het	33.5	VENTXP1;SMEK3P		VENTXP1:dist=704670;SMEK3P:dist=194489	0	0	0								358			0	0	1	0		
chrX	27839572	27839572	T	C	hom	222	MAGEB10	nonsynonymous SNV	MAGEB10:NM_182506:exon3:c.T149C:p.F50S,	0.36	0.36	0.36	rs1368769 [];	0.0020	0.0000	1.0000	0.0000	0.5321					0.425	0.1125	0.4625	82		
chrX	27839617	27839617	G	A	hom	222	MAGEB10	nonsynonymous SNV	MAGEB10:NM_182506:exon3:c.G194A:p.R65Q [1(prostate)]; 	0.25	0.25	0.25	rs12557898 [];	-1.5850	0.0000	1.0000	0.0040	0.5019	1179847 [1(prostate)]; 				0.4	0.0875	0.5125	77		
chrX	28605878	28605878	-	ACTCCTG	het	12.7	IL1RAPL1			0	0	0								233	300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0	0	1	0		
chrX	28606322	28606322	T	-	hom	19.5	IL1RAPL1			0	0	0									300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0	0	1	0		
chrX	28807442	28807442	G	A	hom	222	IL1RAPL1			0.71	0.71	0.71	rs6526806 [];					0.4920	COSN414057 [2(urinary_tract)]; COSN414056 [2(urinary_tract)]; 		300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0.5125	0.0625	0.425	135		
chrX	29417510	29417510	C	A	hom	222	IL1RAPL1			1	1	1	rs4829347 [];								300206 [Il-1 receptor accessory protein-like 1 - Mental retardation, X-linked, 21/34, 300143 (3)];		0.4375	0	0.5625	46		
chrX	30236878	30236878	G	A	hom	222	MAGEB2	nonsynonymous SNV	MAGEB2:NM_002364:exon2:c.G181A:p.E61K [1(stomach)]; 	0.84	0.84	0.84	rs2529541 [];	-0.8280	0.0000	0.8900	0.0040	0.9485	150775 [1(stomach)]; 				0.8875	0	0.1125	135		
chrX	30269887	30269887	T	A	hom	222	MAGEB1			1	1	1	rs2529569 [];										0.925	0	0.075	90		
chrX	30327367	30327367	G	A	hom	222	NR0B1	synonymous SNV	NR0B1:NM_000475:exon1:c.C114T:p.C38C,	0.12	0.12	0.12	rs6150 [];					0.2001			300473 [DSS-AHC critical region on the X chromosome, gene 1 - Adrenal hypoplasia, congenital, with hypogonadotropic hypogonadism,300200 (3); Dosage-sensitive sex reversal, 300018 (3)];		0.15	0.0625	0.7875	46		
chrX	30709444	30709444	G	A	hom	191	GK			0.31	0.31	0.31	rs55895067 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.1	0.05	0.85	15		
chrX	30712796	30712796	G	C	hom	208	GK			0.81	0.81	0.81	rs5927587 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.3	0.0125	0.6875	34		
chrX	30715827	30715827	C	T	hom	222	GK			0.77	0.77	0.77	rs2035432 [];					0.7519			300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.2875	0.0125	0.7	108		
chrX	30718881	30718881	-	AAAT	hom	214	GK			0	0	0									300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.3	0.0125	0.6875	33		
chrX	30747058	30747058	G	-	het	10.8	GK			0	0	0									300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0	0.0625	0.9375	5		
chrX	30747888	30747888	G	T	het	86	GK			0	0	0	rs201500166 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0	0.275	0.725	35		
chrX	30748284	30748284	T	C	hom	222	GK			0.7	0.7	0.7	rs5926945 [];								300474 [Glycerol kinase - Glycerol kinase deficiency, 307030 (3)];		0.6	0.025	0.375	111		
chrX	30849042	30849042	-	C	het	129	TAB3			0	0	0											0.0125	0.0375	0.95	4		
chrX	30849176	30849176	G	A	hom	222	TAB3			0.58	0.58	0.58	rs5972240 [];										0.5375	0.0375	0.425	58		
chrX	30872602	30872602	A	G	hom	222	TAB3	nonsynonymous SNV	TAB3:NM_152787:exon6:c.T1180C:p.W394R,	1	1	1	rs5927629 [];	0.4700	0.0000	1.0000	0.0000	0.9997					0.9875	0	0.0125	147		
chrX	30889857	30889857	A	G	hom	222	TAB3			0.87	0.87	0.87	rs5927633 [];										0.825	0.0125	0.1625	81		
chrX	30993254	30993254	T	-	hom	202	TAB3;FTHL17		TAB3:dist=85743;FTHL17:dist=96104	0.26	0.26	0.26	rs5901965 [];										0.05	0.025	0.925	7		
chrX	31144938	31144941	AAAA	-	hom	18.8	DMD			0	0	0								219	300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.05	0.0625	0.8875	10		
chrX	31152384	31152384	-	TTATTTG	het	53.5	DMD			0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	31165675	31165678	GAAA	-	hom	214	DMD			0	0	0								279	300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0.0125	0.9875	1		
chrX	31191589	31191589	C	T	hom	197	DMD			0.87	0.87	0.87	rs2404496 [];					0.8476			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.325	0.0625	0.6125	64		
chrX	31200843	31200843	-	T	hom	214	DMD			0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.2	0	0.8	23		
chrX	31224684	31224684	A	G	hom	222	DMD			0.82	0.82	0.82	rs2293668 [];					0.8793			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.35	0.0125	0.6375	116		
chrX	31224881	31224881	G	A	hom	222	DMD			0.82	0.82	0.82	rs2293667 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.35	0	0.65	39		
chrX	31496350	31496350	C	T	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon59:c.G8798A:p.R2933Q,DMD:NM_004014:exon5:c.G623A:p.R208Q,DMD:NM_004011:exon31:c.G4787A:p.R1596Q,DMD:NM_004010:exon59:c.G8441A:p.R2814Q,DMD:NM_004022:exon16:c.G1430A:p.R477Q,DMD:NM_004006:exon59:c.G8810A:p.R2937Q,DMD:NM_004013:exon16:c.G1430A:p.R477Q,DMD:NM_004007:exon58:c.G8441A:p.R2814Q,DMD:NM_004020:exon16:c.G1430A:p.R477Q,DMD:NM_004023:exon16:c.G1430A:p.R477Q,DMD:NM_004012:exon31:c.G4778A:p.R1593Q,DMD:NM_004021:exon16:c.G1430A:p.R477Q,DMD:NM_000109:exon59:c.G8786A:p.R2929Q,	0.94	0.94	0.94	rs1800280 [];	0.7890	0.0000	0.8200	0.0010	0.9392			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.8875	0	0.1125	199		
chrX	31676096	31676096	G	A	hom	222	DMD			0.32	0.32	0.32	rs2270672 [];					0.3511			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.15	0.0375	0.8125	41		
chrX	31697764	31697764	A	T	hom	222	DMD			0.01	0.01	0.01	rs72466582 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	31854782	31854782	G	C	hom	184	DMD			0.5	0.5	0.5	rs1379871 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.1125	0.1	0.7875	20		
chrX	31986430	31986430	C	A	hom	222	DMD			0.33	0.33	0.33	rs3761604 [];					0.3123			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.1375	0.05	0.8125	37		
chrX	32360147	32360148	TT	-	hom	48.5	DMD			0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.1125	0.0125	0.875	11		
chrX	32363965	32363965	-	AG	hom	205	DMD			0	0	0	rs34160829 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.2875	0.05	0.6625	36		
chrX	32408140	32408140	-	GACTA	het	12.7	DMD			0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	32459216	32459216	-	AGGAAGTT	het	15.6	DMD			0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	32472777	32472777	-	T	het	72.5	DMD		DMD:NM_004006:exon27:c.3603+2->A,NM_004010:exon27:c.3234+2->A,NM_000109:exon27:c.3579+2->A,NM_004007:exon26:c.3234+2->A,NM_004009:exon27:c.3591+2->A	0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.05	0.1625	0.7875	36		
chrX	32481863	32481863	T	C	hom	184	DMD			0.68	0.68	0.68	rs170608 [];								300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.3125	0.025	0.6625	37		
chrX	32503194	32503194	T	C	hom	222	DMD	nonsynonymous SNV	DMD:NM_004009:exon21:c.A2633G:p.D878G,DMD:NM_004010:exon21:c.A2276G:p.D759G,DMD:NM_004006:exon21:c.A2645G:p.D882G,DMD:NM_004007:exon20:c.A2276G:p.D759G,DMD:NM_000109:exon21:c.A2621G:p.D874G,	0.73	0.73	0.73	rs228406 [];	0.0880	0.0000	0.5900	0.0130	0.6629			300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0.6	0.025	0.375	154		
chrX	33038422	33038422	-	TTTTG	het	44.5	DMD			0	0	0									300377 [Dystrophin - Duchenne muscular dystrophy, 310200 (3); Becker muscular dystrophy,300376 (3); Cardiomyopathy, dilated, 3B, 302045 (3)];		0	0	1	0		
chrX	34150506	34150506	C	T	hom	222	FAM47A			0.56	0.56	0.56	rs2939997 [];										0.2875	0.0125	0.7	30		
chrX	37698488	37698488	T	C	hom	222	DYNLT3			0.02	0.02	0.02	rs45560738 [];										0.0375	0	0.9625	5		
chrX	37700014	37700014	C	A	het	63	DYNLT3			0	0	0	rs112187044 [];							585			0.1875	0.05	0.7625	26		
chrX	38008727	38008727	G	C	hom	222	SRPX			0.91	0.91	0.91	rs9934 [];										0.8375	0.0375	0.125	83		
chrX	38037479	38037479	A	T	hom	222	SRPX			0.24	0.24	0.24	rs5918489 [];					0.4115					0.175	0.075	0.75	31		
chrX	38663104	38663104	T	C	hom	222	MID1IP1			0.66	0.66	0.66	rs198783 [];										0.675	0.0375	0.2875	69		
chrX	38663740	38663740	-	GTG	hom	214	MID1IP1			0	0	0											0.3	0.0375	0.6625	35		
chrX	39922359	39922359	A	G	hom	180	BCOR			0.6	0.6	0.6	rs3810694 [];					0.3265			300485 [BCL6 corepressor - Microphthalmia, syndromic 2, 300166 (3)];		0.1125	0.025	0.8625	33		
chrX	39933339	39933339	A	G	hom	222	BCOR	synonymous SNV	BCOR:NM_001123383:exon4:c.T1260C:p.D420D,BCOR:NM_001123385:exon4:c.T1260C:p.D420D,BCOR:NM_001123384:exon4:c.T1260C:p.D420D,BCOR:NM_017745:exon4:c.T1260C:p.D420D,	0.93	0.93	0.93	rs5917933 [];					0.8792			300485 [BCL6 corepressor - Microphthalmia, syndromic 2, 300166 (3)];		0.8375	0.0125	0.15	184		
chrX	40460197	40460197	-	AAA	hom	170	ATP6AP2			0	0	0									300556 [ATPase, H+ transporting, lysosomal, accessory protein 2 - Mental retardation, X-linked, with epilepsy, 300423 (3)];		0.125	0.0375	0.8375	23		
chrX	40506697	40506697	A	G	hom	222	CXorf38	synonymous SNV	CXorf38:NM_144970:exon1:c.T76C:p.L26L [1(prostate)]; 	0.97	0.97	0.97	rs6610447 [];					0.9436	1132306 [1(prostate)]; 				0.8875	0.0125	0.1	135		
chrX	40510773	40510773	A	G	hom	222	MED14			0.16	0.16	0.16	rs1128513 [];										0.175	0.075	0.75	23		
chrX	40514322	40514322	G	A	hom	222	MED14			0.59	0.59	0.59	rs11266293 [];					0.8092					0.7125	0.025	0.2625	120		
chrX	41002844	41002844	T	C	hom	220	USP9X			0.47	0.47	0.47	rs5918122 [];										0.225	0.0625	0.7125	31		
chrX	41012487	41012488	AA	-	hom	214	USP9X			0.46	0.46	0.46	rs55649554 [];										0.225	0.0625	0.7125	31		
chrX	41031320	41031320	T	G	het	89	USP9X			0	0	0	rs200304284 [];							1165			0	0.425	0.575	45		
chrX	41043944	41043944	T	C	hom	222	USP9X			0.21	0.21	0.21	rs5918130 [];					0.3986					0.15	0.0625	0.7875	29		
chrX	41070013	41070013	-	A	hom	214	USP9X			0	0	0	rs35642556 [];										0.15	0.0625	0.7875	24		
chrX	41093413	41093413	A	T	hom	222	USP9X			0.43	0.43	0.43	rs4827256 [];										0.45	0.0875	0.4625	56		
chrX	41197542	41197542	A	C	hom	222	DDX3X			0.66	0.66	0.66	rs953114 [];										0.3875	0.0625	0.55	41		
chrX	41198456	41198456	T	C	hom	222	DDX3X			0.28	0.28	0.28	rs2275943 [];										0.1	0.025	0.875	13		
chrX	41202273	41202273	A	G	hom	222	DDX3X			0.28	0.28	0.28	rs6610546 [];										0.1125	0.0125	0.875	13		
chrX	41203119	41203119	G	A	hom	222	DDX3X			0.66	0.66	0.66	rs2275944 [];					0.4334					0.1875	0.0375	0.775	37		
chrX	41208310	41208310	A	C	hom	222	DDX3X			0.28	0.28	0.28	rs5963957 [];										0.2375	0.025	0.7375	25		
chrX	41217084	41217084	A	T	hom	222	DDX3X;NYX		DDX3X:dist=7560;NYX:dist=89629	0.5	0.5	0.5	rs6520743 [];										0.2875	0.0375	0.675	31		
chrX	41524789	41524804	ATCCAAATAAAAAGTT	-	hom	214	CASK			0	0	0	rs200400188 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.0375	0.05	0.9125	9		
chrX	41548943	41548943	T	C	hom	192	CASK;GPR34			0.95	0.95	0.95	rs5918226 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.3875	0.025	0.5875	42		
chrX	41554814	41554814	T	C	hom	222	GPR34			0.84	0.84	0.84	rs913602 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.725	0.0625	0.2125	74		
chrX	41556195	41556195	A	T	hom	222	GPR34			0.86	0.86	0.86	rs9594 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.6875	0.0625	0.25	71		
chrX	41587218	41587218	T	C	hom	222	GPR82	synonymous SNV	GPR82:NM_080817:exon3:c.T939C:p.D313D,	0.84	0.84	0.84	rs1023065 [];					0.7713			300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.7125	0.0625	0.225	103		
chrX	41587569	41587569	C	G	hom	222	GPR82			0.85	0.85	0.85	rs1028913 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.725	0.0625	0.2125	71		
chrX	41588169	41588169	T	C	hom	222	GPR82			0.84	0.84	0.84	rs5917445 [];								300172 [Calcium/calmodulin-dependent serine protein kinase - Mental retardation and microcephaly with pontine and cerebellarhypoplasia, 300749 (3); FG syndrome 4, 300422 (3)];		0.7	0.0625	0.2375	69		
chrX	43084766	43084766	T	G	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=447280;MAOA:dist=429389	0.58	0.58	0.58	rs2205920 [];							368			0.5375	0.05	0.4125	55		
chrX	43085367	43085367	G	T	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=447881;MAOA:dist=428788	0.95	0.95	0.95	rs2410927 [];							2354			0.925	0.0125	0.0625	85		
chrX	43085373	43085373	C	T	hom	222	PPP1R2P9;MAOA		PPP1R2P9:dist=447887;MAOA:dist=428782	0.58	0.58	0.58	rs2410926 [];							2354			0.55	0.05	0.4	56		
chrX	43591036	43591036	G	T	hom	222	MAOA	synonymous SNV	MAOA:NM_000240:exon8:c.G891T:p.R297R,MAOA:NM_001270458:exon9:c.G492T:p.R164R,	0.67	0.67	0.67	rs6323 [];					0.7045					0.65	0.0625	0.2875	155		
chrX	43595428	43595428	A	G	hom	222	MAOA			0.67	0.67	0.67	rs2235186 [];					0.7048					0.275	0.05	0.675	79		
chrX	43601142	43601142	C	T	hom	209	MAOA			0.67	0.67	0.67	rs979606 [];										0.275	0.05	0.675	33		
chrX	43601363	43601363	A	G	hom	222	MAOA			0.61	0.61	0.61	rs979605 [];										0.275	0.05	0.675	33		
chrX	43603391	43603391	T	C	hom	222	MAOA	synonymous SNV	MAOA:NM_000240:exon14:c.T1410C:p.D470D,MAOA:NM_001270458:exon15:c.T1011C:p.D337D,	0.6	0.6	0.6	rs1137070 [];					0.7035					0.6375	0.0625	0.3	154		
chrX	43604841	43604841	A	G	hom	222	MAOA			0.6	0.6	0.6	rs3027407 [];										0.6125	0.0625	0.325	111		
chrX	43627999	43627999	T	C	hom	222	MAOB			0.43	0.43	0.43	rs1799836 [];					0.4596					0.1875	0.0625	0.75	45		
chrX	43741616	43741616	G	C	hom	126	MAOB			1	1	1	rs1181251 [];							221			0.875	0	0.125	107		
chrX	44202891	44202891	-	C	hom	165	EFHC2			0	0	0	rs33946300 [];										0.7625	0	0.2375	95		
chrX	44935936	44935937	TT	-	hom	45.5	KDM6A			0	0	0											0.35	0.2625	0.3875	84		
chrX	45709592	45709593	GT	-	hom	102	MIR222;KRBOX4		MIR222:dist=103062;KRBOX4:dist=597031	0	0	0								369			0.075	0.05	0.875	13		
chrX	46321382	46321382	T	-	hom	174	KRBOX4			0.22	0.22	0.22	rs34426496 [];										0.15	0.0125	0.8375	14		
chrX	46457786	46457786	G	A	hom	222	CHST7			0.7	0.7	0.7	rs735716 [];										0.4625	0.1	0.4375	53		
chrX	46466760	46466760	C	T	hom	222	SLC9A7			0.42	0.42	0.42	rs2072840 [];										0.1	0.0125	0.8875	10		
chrX	46472826	46472826	G	A	hom	222	SLC9A7	synonymous SNV	SLC9A7:NM_032591:exon16:c.C1824T:p.Y608Y,SLC9A7:NM_001257291:exon16:c.C1827T:p.Y609Y,	0.68	0.68	0.68	rs3208940 [];					0.4958					0.475	0.075	0.45	80		
chrX	46618321	46618321	C	G	hom	222	SLC9A7	synonymous SNV	SLC9A7:NM_032591:exon1:c.G144C:p.A48A,SLC9A7:NM_001257291:exon1:c.G144C:p.A48A,	0.7	0.7	0.7	rs1056846 [];					0.4458					0.4	0.075	0.525	67		
chrX	46737139	46737139	-	GTGTGT	hom	170	RP2			0	0	0								270			0.3625	0	0.6375	38		
chrX	46740032	46740032	G	A	hom	222	RP2			0.99	0.99	0.99	rs4239962 [];										0.9625	0	0.0375	93		
chrX	46893249	46893249	G	A	hom	222	PHF16			0.98	0.98	0.98	rs5906311 [];										0.3875	0.0375	0.575	45		
chrX	46918917	46918917	-	A	hom	214	PHF16			0	0	0	rs66617346 [];										0.9625	0	0.0375	93		
chrX	46918975	46918975	-	A	hom	214	PHF16			0	0	0	rs59370972 [];										0.9625	0	0.0375	93		
chrX	46919657	46919657	A	-	hom	131	PHF16			0	0	0											0.925	0	0.075	90		
chrX	46920599	46920599	C	A	hom	222	PHF16			0.68	0.68	0.68	rs6725 [];										0.475	0.0625	0.4625	49		
chrX	46938006	46938006	C	T	hom	222	RGN			0.14	0.14	0.14	rs5906321 [];										0.0875	0.025	0.8875	11		
chrX	46949403	46949403	C	T	hom	222	RGN			0.58	0.58	0.58	rs6611330 [];					0.6063	COSN168733 [1(large_intestine)]; 				0.2625	0.0625	0.675	65		
chrX	46951004	46951004	G	T	hom	222	RGN			0.6	0.6	0.6	rs5906327 [];										0.3	0.05	0.65	37		
chrX	46952219	46952219	A	G	hom	220	RGN			0.6	0.6	0.6	rs4480242 [];										0.3	0.05	0.65	37		
chrX	46992041	46992041	C	A	hom	182	RGN;NDUFB11		RGN:dist=39329;NDUFB11:dist=9574	0.56	0.56	0.56	rs6611336 [];										0.625	0.0625	0.3125	66		
chrX	47061018	47061018	C	G	hom	222	UBA1			0.98	0.98	0.98	rs4239964 [];					0.9841			314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0.9375	0	0.0625	202		
chrX	47063164	47063164	-	T	het	67.5	UBA1			0	0	0								2386	314370 [Ubiquitin-activating enzyme E1 (teA1S9) - Spinal muscular atrophy, X-linked 2, infantile, 301830 (3)];		0	0.175	0.825	17		
chrX	47086347	47086347	G	A	hom	222	CDK16			0.67	0.67	0.67	rs6417923 [];					0.6770					0.2875	0.05	0.6625	78		
chrX	47088740	47088740	C	G	het	6.2	CDK16			0	0	0											0	0.3875	0.6125	44		
chrX	47107367	47107367	-	A	het	76.5	USP11			0	0	0											0	0.2375	0.7625	21		
chrX	47229909	47229909	G	A	hom	178	ZNF157			0.37	0.37	0.37	rs3810666 [];										0.0875	0.025	0.8875	12		
chrX	47229935	47229935	T	C	hom	222	ZNF157			0.37	0.37	0.37	rs3810665 [];										0.0875	0.025	0.8875	12		
chrX	47230204	47230204	T	C	hom	222	ZNF157			0.25	0.25	0.25	rs6608713 [];					0.3089		1884			0.0875	0.025	0.8875	12		
chrX	47306422	47306422	T	C	hom	222	ZNF41			0.4	0.4	0.4	rs3810664 [];										0.1625	0.0375	0.8	20		
chrX	47308579	47308579	T	C	hom	222	ZNF41	nonsynonymous SNV	ZNF41:NM_007130:exon5:c.A590G:p.K197R,ZNF41:NM_153380:exon5:c.A590G:p.K197R,	0.003	0.003	0.003	rs148585367 [];	-0.3570	0.0014	0.4800	0.8190	0.0045					0.0125	0	0.9875	3		
chrX	47327111	47327111	T	C	hom	222	ZNF41			0.78	0.78	0.78	rs5905607 [];										0.45	0.0875	0.4625	49		
chrX	47341780	47341780	T	C	hom	222	ZNF41			0.97	0.97	0.97	rs5905609 [];										0.4375	0	0.5625	45		
chrX	47341821	47341821	A	G	hom	222	ZNF41			0.3	0.3	0.3	rs2071780 [];										0.075	0.025	0.9	11		
chrX	47430612	47430613	GT	-	het	15.6	ARAF			0	0	0	rs66672755 [];							324			0.0125	0.05	0.9375	6		
chrX	47444879	47444879	G	C	hom	222	SYN1;TIMP1			0.45	0.45	0.45	rs5953060 [];	-0.0050	0.2709	0.0000	0.0000				313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.2125	0.025	0.7625	22		
chrX	47444985	47444985	T	C	hom	222	TIMP1	synonymous SNV	TIMP1:NM_003254:exon5:c.T372C:p.F124F,	0.45	0.45	0.45	rs4898 [];	-0.3520	0.2772			0.4575			313440 [Synapsin I - Epilepsy, X-linked, with variable learning disabilities andbehavior disorders, 300491 (3)];		0.4625	0.0375	0.5	67		
chrX	47485245	47485245	G	A	hom	222	CFP			0.84	0.84	0.84	rs8177079 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.7625	0.0375	0.2	75		
chrX	47487913	47487913	-	G	hom	214	CFP			0	0	0	rs11453568 [];								300383 [Properdin P factor, complement - Properdin deficiency, X-linked, 312060 (3)];		0.9625	0	0.0375	89		
chrX	47834929	47834929	-	T	het	50.5	ZNF182			0	0	0								1578			0.0125	0.0625	0.925	7		
chrX	47863552	47863552	-	C	hom	214	SPACA5;ZNF182			0	0	0	rs36101191 [];										0.4375	0	0.5625	46		
chrX	47919624	47919625	AC	-	het	30.5	ZNF630			0	0	0	rs68131977 [];							387			0.1375	0.075	0.7875	23		
chrX	47920356	47920356	A	G	hom	222	ZNF630			1	1	1	rs727079 [];					0.9945					0.4375	0	0.5625	74		
chrX	48045802	48045803	GT	-	hom	214	SSX5			0	0	0								351			0.55	0.075	0.375	61		
chrX	48046032	48046032	T	C	hom	222	SSX5			0.96	0.96	0.96	rs2314191 [];										0.9875	0	0.0125	100		
chrX	48046428	48046428	T	A	hom	222	SSX5			0.42	0.42	0.42	rs12842603 [];										0.1875	0.05	0.7625	23		
chrX	48049666	48049666	C	T	hom	222	SSX5	synonymous SNV	SSX5:NM_021015:exon7:c.G492A:p.S164S,SSX5:NM_175723:exon6:c.G369A:p.S123S,	0.93	0.93	0.93	rs5906557 [];					0.9991					0.9875	0	0.0125	145		
chrX	48053521	48053521	T	C	hom	222	SSX5			0.88	0.88	0.88	rs4239967 [];					0.9967					0.4375	0	0.5625	74		
chrX	48054740	48054740	C	G	hom	222	SSX5	nonsynonymous SNV	SSX5:NM_021015:exon2:c.G55C:p.E19Q,SSX5:NM_175723:exon2:c.G55C:p.E19Q,	0.88	0.88	0.88	rs4824675 [];	0.0950	0.0010	0.1400	0.7210	0.9969					0.975	0	0.025	147		
chrX	48056189	48056189	C	G	hom	222	SSX5			0.96	0.96	0.96	rs4824676 [];										0.975	0	0.025	97		
chrX	48116786	48116786	C	G	hom	222	SSX1			0.35	0.35	0.35	rs7886344 [];					0.4497					0.15	0.0625	0.7875	38		
chrX	48123139	48123139	G	A	hom	222	SSX1			0.38	0.38	0.38	rs56131009 [];							379			0.15	0.0625	0.7875	21		
chrX	48125798	48125798	T	C	hom	222	SSX1	synonymous SNV	SSX1:NM_005635:exon7:c.T543C:p.S181S [1(prostate)]; 	0.44	0.44	0.44	rs5952493 [];					0.4760	1178527 [1(prostate)]; 				0.475	0.0875	0.4375	54		
chrX	48126418	48126418	-	A	hom	214	SSX1			0	0	0											0.4375	0.0375	0.525	46		
chrX	48126602	48126602	C	G	hom	222	SSX1			0.38	0.38	0.38	rs55639036 [];										0.4375	0.0875	0.475	52		
chrX	48126717	48126717	-	GAGAGAGACA	het	217	SSX1			0	0	0								303			0	0	1	0		
chrX	48154841	48154841	G	A	hom	200	SSX1;SSX9		SSX1:dist=27962;SSX9:dist=6144	0.38	0.38	0.38	rs7882625 [];							336			0.225	0.0625	0.7125	27		
chrX	48155037	48155037	-	GT	hom	214	SSX1;SSX9		SSX1:dist=28158;SSX9:dist=5948	0	0	0								312			0.0625	0.0375	0.9	9		
chrX	48155079	48155079	-	GTGT	hom	214	SSX1;SSX9		SSX1:dist=28200;SSX9:dist=5906	0	0	0											0.05	0.025	0.925	7		
chrX	48155136	48155136	G	C	hom	222	SSX1;SSX9		SSX1:dist=28257;SSX9:dist=5849	1	1	1	rs4824689 [];										0.9875	0	0.0125	99		
chrX	48155262	48155262	A	G	hom	222	SSX1;SSX9		SSX1:dist=28383;SSX9:dist=5723	0.35	0.35	0.35	rs57719120 [];										0.5625	0.075	0.3625	60		
chrX	48155263	48155263	T	C	hom	222	SSX1;SSX9		SSX1:dist=28384;SSX9:dist=5722	0.35	0.35	0.35	rs7061422 [];										0.5625	0.075	0.3625	60		
chrX	48155343	48155343	A	C	hom	222	SSX1;SSX9		SSX1:dist=28464;SSX9:dist=5642	0.38	0.38	0.38	rs7060383 [];										0.5625	0.0875	0.35	63		
chrX	48156217	48156217	A	G	hom	222	SSX1;SSX9		SSX1:dist=29338;SSX9:dist=4768	0.38	0.38	0.38	rs34091831 [];					0.5108	COSN168737 [1(large_intestine)]; 				0.225	0.0625	0.7125	44		
chrX	48156458	48156458	T	C	het	113	SSX1;SSX9		SSX1:dist=29579;SSX9:dist=4527	0.4	0.4	0.4	rs12849330 [];										0.2	0	0.8	20		
chrX	48161114	48161114	G	A	hom	222	SSX9			0.41	0.41	0.41	rs6609701 [];					0.5647					0.2375	0.075	0.6875	57		
chrX	48161189	48161189	A	G	hom	222	SSX9			0.4	0.4	0.4	rs6609702 [];	-0.9340	0.0002	1.0000	0.0000	0.5641					0.575	0.1	0.325	89		
chrX	48161281	48161281	C	G	hom	222	SSX9			0.95	0.95	0.95	rs4571855 [];										0.4375	0	0.5625	46		
chrX	48163105	48163105	A	G	hom	222	SSX9			0.4	0.4	0.4	rs4598385 [];	-2.9810	0.0004	0.7600	0.0000	0.5644	1132296 [1(prostate)]; 				0.5625	0.0875	0.35	88		
chrX	48163717	48163717	C	T	hom	222	SSX9			0.38	0.38	0.38	rs3901052 [];					0.5641					0.5625	0.0875	0.35	88		
chrX	48163886	48163886	G	A	hom	222	SSX9			0.4	0.4	0.4	rs3885827 [];						COSN168739 [1(large_intestine)]; 				0.2375	0.075	0.6875	29		
chrX	48164066	48164066	T	C	hom	222	SSX9			0.37	0.37	0.37	rs6520350 [];										0.2375	0.075	0.6875	29		
chrX	48164071	48164071	C	A	hom	222	SSX9			0.37	0.37	0.37	rs6520351 [];						COSN168741 [1(large_intestine)]; 				0.2375	0.075	0.6875	29		
chrX	48164138	48164138	A	G	hom	222	SSX9			0.94	0.94	0.94	rs5906631 [];										0.4375	0	0.5625	46		
chrX	48206021	48206022	TC	-	het	118	SSX3			0.72	0.72	0.72	rs71822704 [];							340			0	0.475	0.525	45		
chrX	48206911	48206911	G	A	hom	222	SSX3			0.4	0.4	0.4	rs6609714 [];					0.5618					0.2125	0.075	0.7125	44		
chrX	48216146	48216146	A	G	hom	222	SSX3			0.8	0.8	0.8	rs5906651 [];										0.925	0.025	0.05	95		
chrX	48243015	48243015	C	T	hom	88	SSX4;SSX4B			0	0	0	rs200267124 [];										0.1875	0	0.8125	17		
chrX	48367540	48367540	C	T	hom	222	PORCN			0.43	0.43	0.43	rs12559784 [];								300651 [Porcupine, Drosophila, homolog of - Focal dermal hypoplasia, 305600 (3)];		0.0875	0.05	0.8625	13		
chrX	48367735	48367735	T	C	hom	222	PORCN			0.45	0.45	0.45	rs3810678 [];								300651 [Porcupine, Drosophila, homolog of - Focal dermal hypoplasia, 305600 (3)];		0.0875	0.05	0.8625	13		
chrX	48367741	48367741	C	T	hom	222	PORCN			0.43	0.43	0.43	rs3810679 [];								300651 [Porcupine, Drosophila, homolog of - Focal dermal hypoplasia, 305600 (3)];		0.0875	0.05	0.8625	13		
chrX	48370473	48370473	G	A	hom	222	PORCN			0.43	0.43	0.43	rs1546839 [];								300651 [Porcupine, Drosophila, homolog of - Focal dermal hypoplasia, 305600 (3)];		0.275	0.0625	0.6625	30		
chrX	48382118	48382118	-	TT	het	63.5	EBP			0	0	0											0	0.0125	0.9875	1		
chrX	48382174	48382174	G	T	hom	222	EBP	synonymous SNV	EBP:NM_006579:exon2:c.G15T:p.A5A [1(stomach),1(prostate)]; 	0.34	0.34	0.34	rs3048 [];					0.3427	150788 [1(stomach),1(prostate)]; 				0.25	0.0625	0.6875	45		
chrX	48418126	48418126	A	G	hom	222	TBC1D25	nonsynonymous SNV	TBC1D25:NM_002536:exon6:c.A830G:p.N277S,	0.54	0.54	0.54	rs2293948 [];	0.2060	0.0000	1.0000	0.0030	0.4273					0.3625	0.05	0.5875	66		
chrX	48418659	48418659	G	A	hom	222	TBC1D25	nonsynonymous SNV	TBC1D25:NM_002536:exon6:c.G1363A:p.A455T,	0.54	0.54	0.54	rs235836 [];	-2.4360	0.0000	1.0000	0.0000	0.4275					0.375	0.05	0.575	65		
chrX	48432791	48432791	T	C	hom	222	RBM3			0.92	0.92	0.92	rs2661105 [];										0.4	0.0125	0.5875	43		
chrX	48435402	48435402	T	C	hom	222	RBM3			0.31	0.31	0.31	rs926152 [];					0.0308					0.1	0.0375	0.8625	30		
chrX	48435405	48435405	C	T	hom	222	RBM3			0.34	0.34	0.34	rs926153 [];					0.0223					0.275	0.05	0.675	46		
chrX	48435928	48435928	C	T	hom	222	RBM3			0.92	0.92	0.92	rs235829 [];	0.8700	0.2820	1.0000							0.85	0.025	0.125	84		
chrX	48436507	48436507	C	G	hom	222	RBM3			0.81	0.81	0.81	rs8931 [];										0.825	0.025	0.15	78		
chrX	48456223	48456223	G	T	hom	222	WDR13			0.81	0.81	0.81	rs235824 [];										0.8375	0.025	0.1375	84		
chrX	48459102	48459102	C	G	hom	218	WDR13			0.38	0.38	0.38	rs57467079 [];										0.1	0.0375	0.8625	13		
chrX	48460314	48460314	A	G	hom	222	WDR13	nonsynonymous SNV	WDR13:NM_001166426:exon5:c.A698G:p.H233R,WDR13:NM_017883:exon6:c.A974G:p.H325R,	1	1	1	rs235842 [];	0.5070	0.0000	0.2800	0.0000	1.0000					0.975	0	0.025	147		
chrX	48460625	48460625	G	C	hom	222	WDR13			0.81	0.81	0.81	rs235841 [];					0.9078					0.4	0.0125	0.5875	69		
chrX	48462972	48462972	C	T	hom	211	WDR13			0.35	0.35	0.35	rs2272656 [];							251			0.075	0.0125	0.9125	9		
chrX	48620183	48620183	G	A	hom	222	GLOD5			0.28	0.28	0.28	rs5906707 [];					0.2091					0.1125	0.0375	0.85	26		
chrX	48649449	48649449	T	G	hom	205	GATA1			1	1	1	rs62600348 [];										0.4375	0	0.5625	46		
chrX	48649456	48649456	T	G	hom	196	GATA1			1	1	1	rs66717003 [];										0.4375	0	0.5625	46		
chrX	48672788	48672788	G	A	hom	222	HDAC6			0.21	0.21	0.21	rs2075840 [];										0.1125	0.0375	0.85	14		
chrX	48676394	48676394	C	T	hom	126	HDAC6			0.0012	0.0012	0.0012	rs143498608 [];					0.0059					0	0.025	0.975	2		
chrX	48676839	48676839	G	A	hom	222	HDAC6			0.21	0.21	0.21	rs2075837 [];					0.1913					0.0375	0.0375	0.925	13		
chrX	48690749	48690749	C	T	hom	222	PCSK1N	synonymous SNV	PCSK1N:NM_013271:exon2:c.G117A:p.E39E,	0.24	0.24	0.24	rs11538178 [];					0.0779					0.05	0.0125	0.9375	6		
chrX	48751471	48751471	A	G	hom	222	TIMM17B	synonymous SNV	TIMM17B:NM_005834:exon5:c.T228C:p.I76I,TIMM17B:NM_001167947:exon6:c.T378C:p.I126I,	0.67	0.67	0.67	rs1128363 [];					0.5357					0.4625	0.0625	0.475	85		
chrX	48759204	48759204	C	T	hom	222	PQBP1		PQBP1:NM_001167989:exon4:c.180-3C>T,NM_001032383:exon4:c.180-3C>T,NM_001032382:exon4:c.180-3C>T,NM_001032381:exon4:c.180-3C>T,NM_144495:exon4:c.180-3C>T,NM_001167990:exon4:c.156-3C>T,NM_005710:exon3:c.180-3C>T,NM_001032384:exon4:c.180-3C>T,NM_001167992:exon3:c.180-3C>T	0.61	0.61	0.61	rs741932 [];					0.5932			300463 [Polyglutamine-binding protein 1 - Renpenning syndrome, 309500 (3)];		0.525	0.05	0.425	137		
chrX	48820063	48820063	A	C	hom	222	KCND1	nonsynonymous SNV	KCND1:NM_004979:exon6:c.T1723G:p.S575A,	0.0012	0.0012	0.0012	rs142098952 [];	1.6180	0.7217	0.3100	0.0120	0.0043					0.0125	0.025	0.9625	3		
chrX	48823976	48823976	T	C	hom	222	KCND1			0.69	0.69	0.69	rs2064034 [];										0.525	0.025	0.45	49		
chrX	48891336	48891336	G	T	hom	222	TFE3			0.08	0.08	0.08	rs3027471 [];					0.1128					0.025	0.0375	0.9375	9		
chrX	48898183	48898183	C	G	hom	222	TFE3			0.99	0.99	0.99	rs7056903 [];										0.4375	0	0.5625	46		
chrX	48900900	48900900	T	G	hom	60	TFE3			1	1	1	rs4824738 [];										0.65	0	0.35	59		
chrX	48972196	48972196	G	A	hom	222	GPKOW			0.01	0.01	0.01	rs144980507 [];					0.0357					0	0.025	0.975	2		
chrX	49021052	49021052	C	T	hom	222	MAGIX	synonymous SNV	MAGIX:NM_001099682:exon3:c.C204T:p.S68S,MAGIX:NM_001099681:exon3:c.C204T:p.S68S,MAGIX:NM_001099680:exon1:c.C48T:p.S16S,MAGIX:NM_024859:exon3:c.C204T:p.S68S,	0.06	0.06	0.06	rs12843494 [];	-2.0190	0.2772			0.1042					0.0875	0.0375	0.875	18		
chrX	49021256	49021256	A	G	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099680:exon2:c.A134G:p.H45R,MAGIX:NM_024859:exon4:c.A335G:p.H112R,	1	1	1	rs5906744 [];	-0.6460	0.2709	0.6100	0.0000	0.9982					0.9875	0	0.0125	148		
chrX	49021537	49021537	G	C	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099682:exon4:c.G289C:p.V97L,MAGIX:NM_001099681:exon4:c.G289C:p.V97L,MAGIX:NM_001099680:exon3:c.G316C:p.V106L,MAGIX:NM_024859:exon5:c.G517C:p.V173L,	1	1	1	rs5905720 [];	0.8800		0.2400	0.0010	0.9983					0.975	0	0.025	146		
chrX	49022700	49022700	T	C	hom	222	MAGIX	nonsynonymous SNV	MAGIX:NM_001099682:exon5:c.T724C:p.F242L,MAGIX:NM_001099681:exon5:c.T739C:p.F247L,MAGIX:NM_001099680:exon4:c.T751C:p.F251L,MAGIX:NM_024859:exon6:c.T967C:p.F323L,	1	1	1	rs4824462 [];	-0.0500	0.0000	1.0000	0.0000						0.95	0	0.05	149		
chrX	49061742	49061742	C	T	hom	222	CACNA1F	nonsynonymous SNV	CACNA1F:NM_005183:exon48:c.G5789A:p.R1930H,CACNA1F:NM_001256789:exon48:c.G5756A:p.R1919H,CACNA1F:NM_001256790:exon48:c.G5594A:p.R1865H,	0.09	0.09	0.09	rs33910054 [];	0.0910	0.0304	0.2100	0.0000	0.0846			300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.075	0.0375	0.8875	22		
chrX	49077072	49077072	G	A	hom	222	CACNA1F			0.11	0.11	0.11	rs5906756 [];								300110 [Calcium channel, voltage-dependent, alpha-1F subunit - Night blindness, congenital stationary, X-linked, type 2A, 300071(3); Cone-rod dystrophy, X-linked, 3, 300476 (3); Aland Island eye disease, 300600 (3)];		0.0125	0.0375	0.95	7		
chrX	49093528	49093528	T	C	hom	222	CCDC22			0.67	0.67	0.67	rs2294016 [];					0.3734					0.15	0.075	0.775	40		
chrX	49104815	49104815	T	C	hom	222	CCDC22			0.46	0.46	0.46	rs2280882 [];					0.5863		189			0.1375	0.0625	0.8	35		
chrX	49105610	49105610	T	C	hom	222	CCDC22			0.46	0.46	0.46	rs2294021 [];					0.5909					0.1375	0.0625	0.8	37		
chrX	49107564	49107583	GGGGGCTGGGGCCAGGACCG	-	hom	214	FOXP3			0	0	0								210	300292 [Forkhead box P3 (scurfin) - Immunodysregulation, polyendocrinopathy, and enteropathy, X-linked,304790 (3); {Diabetes mellitus, type I, susceptibility to}, 222100 (3)];		0.0125	0	0.9875	1		
chrX	49178630	49178630	C	G	het	34	GAGE12J			0.06	0.06	0.06	rs184873368 [];										0.2875	0.0625	0.65	30		
chrX	49178683	49178683	T	C	het	19.1	GAGE12J			0	0	0											0	0	1	0		
chrX	49179719	49179719	C	G	hom	191	GAGE12J	nonsynonymous SNV	GAGE12J:NM_001098406:exon2:c.C47G:p.P16R,	0.39	0.39	0.39	rs6520418 [];	-0.5670		1.0000	0.0000	0.4106					0.425	0.075	0.5	47		
chrX	49179755	49179755	G	A	hom	166	GAGE12J	nonsynonymous SNV	GAGE12J:NM_001098406:exon2:c.G83A:p.R28Q [1(prostate),1(large_intestine)]; 	0.4	0.4	0.4	rs7064530 [];	-2.3280		0.3600	0.4670	0.4931	291717 [1(prostate),1(large_intestine)]; 				0.35	0.05	0.6	36		
chrX	49179778	49179778	C	T	hom	190	GAGE12J			0.41	0.41	0.41	rs7064266 [];					0.4993					0.1125	0.025	0.8625	16		
chrX	49189240	49189242	TAT	-	het	150	GAGE13	nonframeshift deletion	GAGE13:NM_001098412:exon2:c.25_27del:p.9_9del,	0	0	0	rs33925578 [];										0.2125	0.225	0.5625	38		
chrX	49208469	49208469	T	G	hom	222	GAGE2A;GAGE2C;GAGE2D;GAGE2E;GAGE8			0.51	0.51	0.51	rs187856088 [];										0.1375	0.125	0.7375	27		
chrX	49208480	49208480	T	C	hom	222	GAGE2A;GAGE2C;GAGE2D;GAGE2E;GAGE8			0.57	0.57	0.57	rs143433513 [];										0.1875	0.1375	0.675	33		
chrX	49208541	49208541	C	G	het	109	GAGE2A;GAGE2C;GAGE2D;GAGE2E;GAGE8			0.2	0.2	0.2	rs144763198 [];										0	0.0625	0.9375	8		
chrX	49230980	49230980	C	T	het	4.19	GAGE12F;GAGE2A;GAGE2C;GAGE2D;GAGE2E;GAGE8			0	0	0	rs75468002 [];										0.0125	0.0125	0.975	3		
chrX	49236813	49236813	G	C	hom	57.8	GAGE2A;GAGE2B;GAGE2C;GAGE2E;GAGE8			0	0	0	rs5953308 [];										0.075	0	0.925	12		
chrX	49237281	49237281	T	G	hom	52	GAGE2A;GAGE2B;GAGE2C;GAGE2E;GAGE8			0	0	0											0.0375	0	0.9625	3		
chrX	49237348	49237348	C	T	hom	29	GAGE2A;GAGE2B;GAGE2C;GAGE2E;GAGE8			0	0	0											0.075	0	0.925	6		
chrX	49369711	49369711	A	G	hom	222	GAGE1			0.41	0.41	0.41	rs3747318 [];					0.5996	COSN414072 [1(urinary_tract)]; 				0.4375	0.0875	0.475	64		
chrX	49369820	49369820	G	C	hom	222	GAGE1			0.41	0.41	0.41	rs5906841 [];										0.125	0.0625	0.8125	20		
chrX	49454180	49454200	TATATATATATATATATATAT	-	hom	133	PAGE1			0	0	0								1095			0	0	1	0		
chrX	49458669	49458669	-	ACACAC	hom	106	PAGE1			0	0	0											0	0	1	1		
chrX	49687435	49687435	-	G	hom	214	CLCN5			0	0	0	rs11440111 [];								300008 [Chloride channel-5 - Dent disease, 300009 (3); Nephrolithiasis, type I, 310468 (3);Hypophosphatemic rickets, 300554 (3); Proteinuria, low molecular weight, with hypercalciuric nephrocalcinosis, 308990 (3)];		0.4375	0	0.5625	71		
chrX	49969467	49969467	-	CT	het	180	AKAP4;CCNB3		AKAP4:dist=3803;CCNB3:dist=58073	0	0	0	rs71952635 [];							180			0.025	0.5125	0.4625	50		
chrX	50056814	50056814	A	G	hom	204	CCNB3			0.38	0.38	0.38	rs5915179 [];					0.5910					0.2375	0.05	0.7125	49		
chrX	50118957	50118957	C	T	hom	208	DGKK			0.24	0.24	0.24	rs4074321 [];										0.075	0.05	0.875	12		
chrX	50119085	50119085	C	T	hom	222	DGKK	unknown	UNKNOWN	0.17	0.17	0.17	rs4074320 [];					0.2363					0.2375	0.05	0.7125	40		
chrX	50120032	50120032	G	A	hom	222	DGKK			0.29	0.29	0.29	rs4590578 [];										0.075	0.05	0.875	12		
chrX	50121147	50121147	-	G	hom	214	DGKK	unknown	UNKNOWN	0	0	0	rs11415594 [];										0.9625	0	0.0375	167		
chrX	50122932	50122932	A	T	hom	222	DGKK			0.24	0.24	0.24	rs4489439 [];					0.2503					0.0875	0.05	0.8625	22		
chrX	50129369	50129369	A	G	hom	222	DGKK	unknown	UNKNOWN	0.3	0.3	0.3	rs5961179 [];					0.2523					0.2625	0.05	0.6875	43		
chrX	50130544	50130544	G	A	hom	222	DGKK			0.25	0.25	0.25	rs7883609 [];					0.2500					0.2625	0.05	0.6875	42		
chrX	50130717	50130717	T	C	hom	222	DGKK			0.25	0.25	0.25	rs67155896 [];										0.0875	0.05	0.8625	14		
chrX	50134383	50134383	G	A	hom	222	DGKK			0.25	0.25	0.25	rs1934192 [];										0.0875	0.05	0.8625	14		
chrX	50135327	50135327	C	A	hom	222	DGKK			0.24	0.24	0.24	rs17328222 [];					0.2494					0.0875	0.05	0.8625	22		
chrX	50146570	50146570	C	T	hom	222	DGKK	unknown	UNKNOWN	0.45	0.45	0.45	rs4143304 [];					0.3357					0.3	0.0625	0.6375	50		
chrX	50338473	50338473	A	G	hom	222	SHROOM4			0	0	0	rs192118411 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.0125	0	0.9875	1		
chrX	50339363	50339363	T	C	hom	222	SHROOM4			0.01	0.01	0.01	rs28362303 [];								300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.05	0	0.95	13		
chrX	50350674	50350674	T	C	hom	222	SHROOM4	synonymous SNV	SHROOM4:NM_020717:exon6:c.A3468G:p.E1156E [1(skin)]; 	0.28	0.28	0.28	rs3747282 [];					0.3393	235350 [1(skin)]; 	525	300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0.3	0.075	0.625	71		
chrX	50350751	50350751	-	CCT	hom	214	SHROOM4	nonframeshift insertion	SHROOM4:NM_020717:exon6:c.3390_3391insAGG:p.Q1131delinsRQ,	0	0	0								243	300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0	0	1	0		
chrX	50350778	50350778	-	GCTGTTGCTGCT	hom	214	SHROOM4	nonframeshift insertion	SHROOM4:NM_020717:exon6:c.3363_3364insAGCAGCAACAGC:p.K1122delinsSSNSK,	0	0	0								243	300579 [Shroom family member 4 - Stocco dos Santos X-linked mental retardation syndrome, 300434 (3)];		0	0	1	0		
chrX	50557149	50557149	C	T	hom	195	SHROOM4			0	0	0											0	0	1	0		
chrX	50653775	50653775	C	G	hom	222	BMP15			0.15	0.15	0.15	rs3810682 [];					0.2302					0.1375	0.025	0.8375	32		
chrX	51075151	51075151	G	A	hom	222	NUDT10			0.32	0.32	0.32	rs1151715 [];										0.325	0.025	0.65	35		
chrX	51075841	51075841	A	G	het	62	NUDT10	synonymous SNV	NUDT10:NM_153183:exon2:c.A24G:p.T8T [1(prostate)]; 	0	0	0	rs2625875 [];						1132288 [1(prostate)]; 				0.0125	0.675	0.3125	135		
chrX	51239296	51239309	TCCTCGAGGCAGCC	-	hom	42.7	NUDT11	frameshift deletion	NUDT11:NM_018159:wholegene [1(breast),1(skin),1(prostate),2(upper_aerodigestive_tract),1(central_nervous_system)]; 	0	0	0						0.9486	127214 [1(breast),1(skin),1(prostate),2(upper_aerodigestive_tract),1(central_nervous_system)]; 				0.8125	0	0.1875	132		
chrX	51486659	51486659	C	T	hom	222	GSPT2			0.78	0.78	0.78	rs974285 [];										0.5875	0.0625	0.35	69		
chrX	52662823	52662824	AC	-	het	154	SSX8			0	0	0								244			0	0.85	0.15	82		
chrX	52790419	52790419	-	CACACA	hom	196	SSX2B			0	0	0								514			0	0	1	0		
chrX	52825471	52825471	A	G	hom	222	SPANXN5			0.98	0.98	0.98	rs2806837 [];										0.975	0	0.025	98		
chrX	52825546	52825546	C	G	hom	222	SPANXN5	synonymous SNV	SPANXN5:NM_001009616:exon2:c.G201C:p.L67L,	0.98	0.98	0.98	rs2806838 [];					0.9704					0.9625	0	0.0375	145		
chrX	52891565	52891565	A	G	het	45	XAGE3			0	0	0	rs79831867 [];										0	0.8375	0.1625	115		
chrX	52891584	52891584	C	T	hom	59	XAGE3			0	0	0	rs5943751 [];										0.4125	0.0375	0.55	61		
chrX	52891623	52891623	T	-	het	19.5	XAGE3			0	0	0											0	0.8	0.2	139		
chrX	52891645	52891645	A	G	het	187	XAGE3			0	0	0	rs75808475 [];						COSN215910 [1(central_nervous_system)]; 				0	0.8875	0.1125	156		
chrX	52891653	52891653	C	T	het	218	XAGE3	synonymous SNV	XAGE3:NM_130776:exon5:c.G330A:p.Q110Q [1(large_intestine)]; XAGE3:NM_133179:exon5:c.G330A:p.Q110Q [1(large_intestine)]; 	0	0	0	rs73206488 [];						287951 [1(large_intestine)]; 				0	0.8875	0.1125	157		
chrX	52895580	52895581	GT	-	hom	197	XAGE3			0	0	0	rs5902508 [];							243			0.425	0.0125	0.5625	71		
chrX	53113905	53113905	-	G	hom	214	TSPYL2			0	0	0											0	0	1	0		
chrX	53171516	53171516	-	T	het	41.5	TSPYL2;KDM5C		TSPYL2:dist=53788;KDM5C:dist=48987	0	0	0								2369			0.025	0.35	0.625	34		
chrX	53220836	53220836	G	T	hom	222	KDM5C			0.82	0.82	0.82	rs1886889 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.925	0	0.075	152		
chrX	53222044	53222044	-	C	hom	120	KDM5C			0	0	0	rs150558161 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.9	0	0.1	138		
chrX	53226311	53226311	T	C	hom	222	KDM5C			0.81	0.81	0.81	rs5933555 [];								314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.4375	0	0.5625	46		
chrX	53228148	53228148	C	A	hom	222	KDM5C			0.75	0.75	0.75	rs1977364 [];					0.9752			314690 [Lysine-specific demethylase 5C - Mental retardation, X-linked, syndromic, JARID1C-related, 300534 (3)];		0.425	0	0.575	104		
chrX	53271147	53271147	T	G	hom	222	IQSEC2			0.7	0.7	0.7	rs2274307 [];								300522 [IQ motif- and Sec7 domain-containing protein 2 - Mental retardation, X-linked 1, 309530 (3)];		0.3625	0.025	0.6125	41		
chrX	53436232	53436232	G	T	hom	222	SMC1A			0.98	0.98	0.98	rs1264008 [];					0.9417			300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.3875	0.0125	0.6	95		
chrX	53449337	53449337	-	G	hom	214	SMC1A			0	0	0	rs11462431 [];								300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.4375	0	0.5625	45		
chrX	53449568	53449568	G	A	hom	222	SMC1A			0.45	0.45	0.45	rs1264011 [];					0.5838			300040 [Segregation of mitotic chromosomes 1 (SMC1, yeast, homolog of; - Cornelia de Lange syndrome 2, 300590 (3)];		0.45	0.0375	0.5125	113		
chrX	53457622	53457622	T	C	hom	222	RIBC1	synonymous SNV	RIBC1:NM_001267053:exon6:c.T597C:p.T199T,RIBC1:NM_001031745:exon7:c.T942C:p.T314T,	0.48	0.48	0.48	rs1264013 [];					0.5871					0.4625	0.0625	0.475	80		
chrX	53461359	53461359	G	C	hom	175	HSD17B10			0.45	0.45	0.45	rs1264014 [];					0.5820					0.1625	0.0375	0.8	59		
chrX	53563589	53563589	A	G	hom	222	HUWE1	synonymous SNV	HUWE1:NM_031407:exon79:c.T12177C:p.G4059G,	0.99	0.99	0.99	rs426298 [];	-0.2100				0.9997			300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.95	0	0.05	207		
chrX	53565659	53565660	AC	-	hom	62	HUWE1			0	0	0								252	300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.125	0.0125	0.8625	13		
chrX	53641647	53641647	T	C	hom	222	HUWE1	synonymous SNV	HUWE1:NM_031407:exon23:c.A2109G:p.S703S,	0.42	0.42	0.42	rs6638360 [];					0.5378			300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0.3875	0.05	0.5625	112		
chrX	53654501	53654502	TA	-	het	93.5	HUWE1			0	0	0						0.2237		24	300697 [HECT, UBA, and WWE domains-containing protein 1 - Mental retardation, X-linked syndromic, Turner type, 300706 (3)];		0	0.325	0.675	35		
chrX	54043254	54043254	C	A	hom	222	PHF8			0	0	0									300560 [PHD finger protein 8 - Mental retardation syndrome, X-linked, Siderius type, 300263 (3)];		0	0.0125	0.9875	1		
chrX	54098635	54098635	-	CACACA	hom	102	FAM120C			0	0	0											0.15	0.025	0.825	14		
chrX	54107692	54107692	T	C	hom	222	FAM120C			1	1	1	rs2516098 [];										0.4375	0	0.5625	46		
chrX	54117740	54117740	C	A	hom	222	FAM120C			1	1	1	rs2495797 [];					0.9999					0.9375	0	0.0625	142		
chrX	54161859	54161859	C	T	hom	222	FAM120C			0.99	0.99	0.99	rs4826523 [];										0.4375	0	0.5625	46		
chrX	54186193	54186193	A	T	het	33	FAM120C			0	0	0											0	0.125	0.875	13		
chrX	54209387	54209387	A	G	hom	222	FAM120C	nonsynonymous SNV	FAM120C:NM_198456:exon1:c.T245C:p.I82T,FAM120C:NM_017848:exon1:c.T245C:p.I82T,	1	1	1	rs2495783 [];	0.1380	0.0000	0.5300	0.0000						0.9375	0	0.0625	161		
chrX	54224404	54224404	-	A	het	6.55	WNK3			0	0	0											0	0.0625	0.9375	6		
chrX	54265542	54265546	ACAAA	-	hom	214	WNK3			0	0	0						0.1246		441			0.125	0.0125	0.8625	12		
chrX	54321349	54321349	-	T	het	3.25	WNK3			0	0	0								2374			0	0	1	0		
chrX	54953647	54953647	G	A	hom	222	TRO			0.46	0.46	0.46	rs2273138 [];										0.2875	0.025	0.6875	34		
chrX	54975785	54975785	A	G	hom	180	PFKFB1			0.0024	0.0024	0.0024	rs143124713 [];										0.0125	0.025	0.9625	3		
chrX	55116466	55116466	C	G	hom	222	PAGE2	nonsynonymous SNV	PAGE2:NM_207339:exon2:c.C13G:p.L5V,	0.95	0.95	0.95	rs1845444 [];	-0.9520	0.0000	1.0000	0.0000	0.9943					0.95	0	0.05	143		
chrX	55172359	55172359	C	T	het	44	FAM104B			0	0	0	rs5000153 [];										0	0.2625	0.7375	26		
chrX	55172373	55172373	A	G	het	199	FAM104B			0	0	0	rs1047069 [];										0	0.9375	0.0625	86		
chrX	55172427	55172427	G	T	het	37	FAM104B			0	0	0	rs1047068 [];										0	0.2375	0.7625	23		
chrX	55172471	55172471	G	A	het	181	FAM104B			0	0	0	rs1047059 [];										0	0.625	0.375	64		
chrX	55246965	55246965	C	T	hom	222	PAGE5			0.86	0.86	0.86	rs5914272 [];					0.9736					0.9	0.025	0.075	119		
chrX	55247030	55247030	C	G	hom	222	PAGE5			0.87	0.87	0.87	rs5914273 [];					0.9680					0.9	0.025	0.075	139		
chrX	55248320	55248320	G	A	hom	222	PAGE5			0.31	0.31	0.31	rs55950057 [];					0.3151					0.1375	0.05	0.8125	29		
chrX	55286887	55286887	G	T	hom	190	PAGE3			0.34	0.34	0.34	rs3761559 [];										0.1375	0.0375	0.825	18		
chrX	55287031	55287031	T	G	hom	222	PAGE3			0.32	0.32	0.32	rs3761560 [];					0.3204					0.275	0.05	0.675	46		
chrX	55289774	55289774	T	C	hom	222	PAGE3			0.86	0.86	0.86	rs4826381 [];	0.0030	0.0000	0.9100	0.0010	0.9682					0.9125	0.025	0.0625	143		
chrX	55479299	55479299	G	A	hom	222	MAGEH1	synonymous SNV	MAGEH1:NM_014061:exon1:c.G492A:p.G164G,	0.25	0.25	0.25	rs11545211 [];					0.2827					0.2625	0.0625	0.675	48		
chrX	55651001	55651001	T	C	hom	222	FOXR2	nonsynonymous SNV	FOXR2:NM_198451:exon1:c.T857C:p.V286A,	0.86	0.86	0.86	rs2375465 [];	-0.0900	0.0008	1.0000	0.0010	0.9729					0.925	0.0125	0.0625	141		
chrX	55744285	55744285	C	G	hom	222	RRAGB			0.33	0.33	0.33	rs5960093 [];										0.2625	0.0625	0.675	31		
chrX	55748820	55748820	A	G	hom	199	RRAGB			0.87	0.87	0.87	rs1473761 [];										0.4125	0	0.5875	44		
chrX	55757744	55757744	T	G	hom	222	RRAGB			0.87	0.87	0.87	rs5960480 [];										0.4125	0	0.5875	44		
chrX	55779959	55779959	C	A	hom	222	RRAGB			0	0	0	rs201483847 [];					0.0010					0	0.0125	0.9875	1		
chrX	57003437	57003437	T	C	hom	222	LOC550643;SPIN3		LOC550643:dist=159433;SPIN3:dist=13827	0	0	0											0	0.0125	0.9875	1		
chrX	57019862	57019862	G	A	hom	222	SPIN3			0.29	0.29	0.29	rs10521485 [];										0.25	0.075	0.675	30		
chrX	57020115	57020115	C	T	hom	222	SPIN3			0.87	0.87	0.87	rs1325856 [];										0.9625	0	0.0375	94		
chrX	57147944	57147944	G	T	hom	222	SPIN2B			0.23	0.23	0.23	rs2071722 [];										0.25	0.075	0.675	29		
chrX	57313357	57313357	T	C	hom	222	FAAH2	synonymous SNV	FAAH2:NM_174912:exon1:c.T99C:p.G33G,	0.45	0.45	0.45	rs2516023 [];					0.2664					0.3	0.075	0.625	52		
chrX	57318907	57318907	T	A	hom	222	FAAH2			0.36	0.36	0.36	rs4030473 [];					0.2661					0.1625	0.05	0.7875	26		
chrX	57405163	57405163	T	C	hom	222	FAAH2	synonymous SNV	FAAH2:NM_174912:exon6:c.T822C:p.R274R,	0.93	0.93	0.93	rs4826543 [];					0.9994					0.9875	0	0.0125	145		
chrX	57474943	57474943	A	T	hom	222	FAAH2			0.92	0.92	0.92	rs1821118 [];					0.9991					0.4375	0	0.5625	74		
chrX	57475253	57475253	A	C	hom	189	FAAH2			0.37	0.37	0.37	rs7059676 [];										0.2	0.0375	0.7625	22		
chrX	57515140	57515140	T	G	hom	187	FAAH2			0.37	0.37	0.37	rs5915052 [];					0.2641					0.1625	0.05	0.7875	21		
chrX	57618870	57618870	G	A	het	17.1	ZXDB	nonsynonymous SNV	ZXDB:NM_007157:exon1:c.G389A:p.G130D,	0.11	0.11	0.11	rs189164178 [];	0.3740	0.0055	0.4800	0.0020						0	0.1125	0.8875	17		
chrX	57619648	57619648	G	T	hom	222	ZXDB	synonymous SNV	ZXDB:NM_007157:exon1:c.G1167T:p.P389P,	1	1	1	rs1057328 [];					0.9997					0.9625	0	0.0375	147		
chrX	57622607	57622607	G	A	hom	222	ZXDB			0.45	0.45	0.45	rs1997715 [];										0.2875	0.075	0.6375	33		
chrX	57935999	57935999	T	C	hom	222	ZXDA	nonsynonymous SNV	ZXDA:NM_007156:exon1:c.A856G:p.M286V,	0	0	0	rs141858271 [];	0.7910	0.0000		0.0000	0.0021					0	0.0125	0.9875	2		
chrX	64734415	64734416	CA	-	hom	185	LAS1L			0	0	0	rs200255138 [];							297			0.45	0.0625	0.4875	48		
chrX	64739077	64739077	G	A	hom	217	LAS1L			0.03	0.03	0.03	rs139898791 [];										0.0375	0	0.9625	5		
chrX	65247409	65247409	T	A	hom	222	VSIG4			0.29	0.29	0.29	rs9633155 [];					0.1618					0.0625	0.0125	0.925	17		
chrX	65253769	65253769	T	C	hom	180	VSIG4			0.29	0.29	0.29	rs5964488 [];										0.0625	0.0125	0.925	7		
chrX	65259893	65259893	C	T	hom	222	VSIG4			0.05	0.05	0.05	rs41305393 [];					0.0661	COSN414087 [1(urinary_tract)]; 				0.05	0	0.95	8		
chrX	65382685	65382685	T	C	hom	222	HEPH	nonsynonymous SNV	HEPH:NM_138737:exon1:c.T116C:p.V39A,	0.88	0.88	0.88	rs5919015 [];	-2.2110	0.2894			0.6888					0.7625	0.0125	0.225	118		
chrX	65393658	65393658	A	G	hom	222	HEPH			1	1	1	rs5918591 [];										0.4375	0	0.5625	72		
chrX	65420609	65420609	A	G	hom	222	HEPH			0.98	0.98	0.98	rs1264215 [];					0.9359					0.4375	0	0.5625	74		
chrX	65478923	65478923	-	A	hom	214	HEPH			0	0	0	rs35431478 [];										0.35	0.0375	0.6125	41		
chrX	65815591	65815591	T	C	hom	222	EDA2R			0.77	0.77	0.77	rs1485682 [];										0.7	0.0625	0.2375	75		
chrX	65815817	65815817	G	A	hom	222	EDA2R			0.71	0.71	0.71	rs11093958 [];										0.7125	0.0625	0.225	74		
chrX	65817522	65817522	A	G	hom	222	EDA2R			0.77	0.77	0.77	rs12855916 [];										0.675	0.0625	0.2625	72		
chrX	65817740	65817740	A	C	hom	222	EDA2R			0.77	0.77	0.77	rs4827380 [];										0.6875	0.075	0.2375	74		
chrX	65819223	65819223	A	G	hom	160	EDA2R			0.68	0.68	0.68	rs4827499 [];										0.35	0.0375	0.6125	40		
chrX	65819287	65819287	-	T	hom	11.8	EDA2R			0	0	0	rs76899814 [];										0.3125	0.0375	0.65	50		
chrX	65822607	65822607	T	C	hom	222	EDA2R	nonsynonymous SNV	EDA2R:NM_001199687:exon5:c.A385G:p.T129A,EDA2R:NM_001242310:exon4:c.A385G:p.T129A,EDA2R:NM_021783:exon5:c.A385G:p.T129A,	0.95	0.95	0.95	rs1385698 [];	0.1700		0.1400	0.0000	0.9996					0.925	0	0.075	137		
chrX	65824846	65824846	-	AAAGCA	het	25.5	EDA2R			0	0	0											0	0	1	0		
chrX	65824986	65824986	C	T	hom	222	EDA2R	nonsynonymous SNV	EDA2R:NM_001199687:exon3:c.G170A:p.R57K,EDA2R:NM_001242310:exon2:c.G170A:p.R57K,EDA2R:NM_021783:exon3:c.G170A:p.R57K,	0.69	0.69	0.69	rs1385699 [];	1.8410	0.1249	1.0000	0.1260	0.7977					0.65	0.0625	0.2875	111		
chrX	66941597	66941597	T	G	hom	222	AR			0.91	0.91	0.91	rs1337076 [];								313700 [Androgen receptor (dihydrotestosterone receptor) - Androgen insensitivity, 300068 (3); Spinal and bulbar muscularatrophy of Kennedy, 313200 (3); Androgen insensitivity, partial, with or without breast cancer, 312300 (3); {Prostate cancer, susceptibility to},176807 (3); Hypospadias 1, X-linked, 300633 (3)];		0.4375	0	0.5625	46		
chrX	67412906	67412906	G	A	hom	222	OPHN1			1	1	1	rs1191948 [];								300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.425	0.0125	0.5625	46		
chrX	67429846	67429847	TT	-	hom	40.6	OPHN1			0	0	0									300127 [Oligophrenin-1 - Mental retardation, X-linked, with cerebellar hypoplasia anddistinctive facial appearance, 300486 (3)];		0.15	0.5	0.35	57		
chrX	67719085	67719085	G	T	hom	173	YIPF6			0.64	0.64	0.64	rs12843249 [];										0.3125	0.0375	0.65	37		
chrX	67936140	67936140	T	G	het	59	STARD8			0	0	0											0	0.4375	0.5625	46		
chrX	67937275	67937275	C	T	hom	222	STARD8	synonymous SNV	STARD8:NM_014725:exon5:c.C279T:p.P93P,STARD8:NM_001142503:exon6:c.C519T:p.P173P,STARD8:NM_001142504:exon5:c.C279T:p.P93P,	0.05	0.05	0.05	rs41310627 [];					0.0911					0.0875	0.05	0.8625	20		
chrX	67945398	67945399	AT	-	het	187	STARD8			0	0	0								420			0.0125	0.35	0.6375	33		
chrX	68061201	68061202	CA	-	het	11.8	EFNB1			0	0	0								252	300035 [eph-related receptor tyrosine kinase ligand 2 (ephrin B1) - Craniofrontonasal dysplasia, 304110 (3)];		0	0.05	0.95	11		
chrX	68381264	68381264	C	A	hom	222	PJA1	nonsynonymous SNV	PJA1:NM_022368:exon3:c.G1254T:p.E418D,PJA1:NM_145119:exon2:c.G1818T:p.E606D,PJA1:NM_001032396:exon2:c.G1653T:p.E551D,	0.11	0.11	0.11	rs11539157 [];	0.3060	0.9951	0.5800	0.9890	0.2369					0.35	0.05	0.6	55		
chrX	68381787	68381787	C	T	hom	222	PJA1	nonsynonymous SNV	PJA1:NM_022368:exon3:c.G731A:p.S244N,PJA1:NM_145119:exon2:c.G1295A:p.S432N,PJA1:NM_001032396:exon2:c.G1130A:p.S377N,	0.13	0.13	0.13	rs5937160 [];	1.0290	0.0004	0.5600	0.0380	0.2365					0.35	0.0375	0.6125	53		
chrX	68382836	68382836	G	A	hom	222	PJA1	synonymous SNV	PJA1:NM_022368:exon2:c.C246T:p.S82S,PJA1:NM_145119:exon2:c.C246T:p.S82S,PJA1:NM_001032396:exon2:c.C81T:p.S27S,	0.13	0.13	0.13	rs7067170 [];					0.2368					0.3625	0.0375	0.6	56		
chrX	68725640	68725640	T	C	hom	222	FAM155B	nonsynonymous SNV	FAM155B:NM_015686:exon1:c.T515C:p.L172P,	0.61	0.61	0.61	rs1171942 [];	-0.0050	0.0001	0.4000	0.0000	0.3270					0.35	0	0.65	46		
chrX	68750467	68750467	C	G	hom	222	FAM155B			0.03	0.03	0.03	rs41305385 [];										0.0875	0	0.9125	7		
chrX	68836851	68836851	-	C	hom	101	EDA			0	0	0	rs34637582 [];								300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.1625	0.0625	0.775	21		
chrX	68837190	68837190	T	A	hom	222	EDA			0.78	0.78	0.78	rs762663 [];								300451 [Ectodysplasin A - Ectodermal dysplasia, anhidrotic, X-linked, 305100 (3); Toothagenesis, selective, X-linked 1, 313500 (3)];		0.175	0.0125	0.8125	19		
chrX	69262855	69262857	TCT	-	hom	214	AWAT2			0	0	0	rs72284868 [];										0.4	0.0125	0.5875	43		
chrX	69424664	69424664	G	T	hom	222	DGAT2L6			0.06	0.06	0.06	rs5980905 [];										0.0375	0.0375	0.925	8		
chrX	69425374	69425374	T	A	hom	222	DGAT2L6			0	0	0											0.0125	0	0.9875	1		
chrX	69459945	69459945	C	T	hom	222	AWAT1			0.95	0.95	0.95	rs74490344 [];					0.9099					0.3625	0.025	0.6125	65		
chrX	69496228	69496228	T	C	hom	222	ARR3			0.6	0.6	0.6	rs1572732 [];					0.7608					0.3125	0.0375	0.65	57		
chrX	69502054	69502054	A	G	hom	222	RAB41			0.81	0.81	0.81	rs5936549 [];					0.8653					0.35	0.025	0.625	65		
chrX	69502479	69502479	A	G	hom	222	RAB41			0.95	0.95	0.95	rs1626469 [];					0.9145					0.375	0.0125	0.6125	68		
chrX	69504073	69504073	T	C	hom	222	RAB41			0.73	0.73	0.73	rs2275412 [];										0.2875	0.0875	0.625	50		
chrX	69504078	69504078	T	G	hom	222	RAB41			0.63	0.63	0.63	rs12556489 [];										0.2375	0.1375	0.625	52		
chrX	69510335	69510335	C	T	hom	222	KIF4A	synonymous SNV	KIF4A:NM_012310:exon2:c.C27T:p.P9P,	0.92	0.92	0.92	rs1199470 [];					0.9905					0.9625	0	0.0375	203		
chrX	69561650	69561650	G	A	hom	222	KIF4A	nonsynonymous SNV	KIF4A:NM_012310:exon11:c.G1135A:p.V379M,	0	0	0	rs202011451 [];	0.5770	0.0002	0.1000	0.0160						0	0	1	0		
chrX	69595909	69595909	C	G	hom	222	KIF4A			0.96	0.96	0.96	rs1199407 [];					0.9147					0.375	0.0125	0.6125	90		
chrX	69639698	69639698	G	T	hom	222	KIF4A			0.99	0.99	0.99	rs1886892 [];										0.4375	0	0.5625	46		
chrX	69652762	69652762	A	G	hom	222	GDPD2	synonymous SNV	GDPD2:NM_001171192:exon16:c.A1692G:p.R564R,GDPD2:NM_001171191:exon13:c.A1302G:p.R434R,GDPD2:NM_017711:exon15:c.A1539G:p.R513R,GDPD2:NM_001171193:exon14:c.A1302G:p.R434R,	0.88	0.88	0.88	rs2296542 [];					0.9510					0.9	0.025	0.075	138		
chrX	69749852	69749852	A	G	hom	222	TEX11		TEX11:NM_001003811:exon31:c.2566-3T>C,NM_031276:exon30:c.2521-3T>C	0.8	0.8	0.8	rs1536250 [];					0.9034					0.875	0.0125	0.1125	131		
chrX	69749853	69749853	T	A	hom	222	TEX11		TEX11:NM_001003811:exon31:c.2566-4A>T,NM_031276:exon30:c.2521-4A>T	0.82	0.82	0.82	rs1536251 [];					0.9077					0.875	0.0125	0.1125	131		
chrX	69774517	69774517	A	T	hom	222	TEX11	synonymous SNV	TEX11:NM_001003811:exon27:c.T2319A:p.T773T,TEX11:NM_031276:exon26:c.T2274A:p.T758T,	0.98	0.98	0.98	rs4844240 [];					0.9996					0.9625	0	0.0375	139		
chrX	69844797	69844797	G	A	hom	222	TEX11			0.68	0.68	0.68	rs1325094 [];					0.6000	COSN168751 [1(large_intestine)]; 				0.2625	0.0375	0.7	49		
chrX	70053469	70053469	A	G	hom	222	TEX11			0.05	0.05	0.05	rs17301944 [];					0.1045					0.025	0	0.975	4		
chrX	70148927	70148927	T	A	hom	222	SLC7A3			0.9	0.9	0.9	rs5936605 [];										0.4125	0	0.5875	44		
chrX	70151043	70151044	AC	-	hom	109	SLC7A3			0	0	0								439			0.0625	0	0.9375	5		
chrX	70279492	70279492	A	C	hom	222	SNX12			0.61	0.61	0.61	rs6780 [];										0.6375	0.0875	0.275	66		
chrX	70282696	70282696	A	G	hom	222	SNX12			0.61	0.61	0.61	rs34211894 [];					0.5544					0.6	0.0875	0.3125	101		
chrX	70321631	70321631	T	G	hom	222	FOXO4			0.56	0.56	0.56	rs5980742 [];					0.4597					0.175	0.0625	0.7625	29		
chrX	70324157	70324157	C	T	hom	222	CXorf65	synonymous SNV	CXorf65:NM_001025265:exon5:c.G417A:p.A139A,	0.15	0.15	0.15	rs1130009 [];					0.3200					0.2375	0.0875	0.675	58		
chrX	70324397	70324397	G	A	hom	222	CXorf65			0.18	0.18	0.18	rs12857595 [];										0.1125	0.0625	0.825	17		
chrX	70331101	70331101	-	AAGA	hom	214	IL2RG			0	0	0	rs67165954 [];								308380 [Interleukin-2 receptor, gamma - Severe combined immunodeficiency, X-linked, 300400 (3); Combinedimmunodeficiency, X-linked, moderate, 312863 (3)];		0.1	0.0625	0.8375	16		
chrX	70338399	70338399	A	G	hom	222	MED12			0.53	0.53	0.53	rs11796153 [];										0.45	0.1	0.45	92		
chrX	70339498	70339498	C	T	hom	222	MED12			0.15	0.15	0.15	rs12850852 [];					0.3188			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	43		
chrX	70341128	70341128	-	CTCTGCTTCACTTT	het	218	MED12			0	0	0									300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0	0	1	0		
chrX	70341169	70341169	A	C	hom	222	MED12			0.16	0.16	0.16	rs62609586 [];					0.3206			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.275	0.0875	0.6375	125		
chrX	70342820	70342820	A	G	hom	222	MED12			0.15	0.15	0.15	rs7053139 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70343621	70343621	A	G	hom	222	MED12			0.16	0.16	0.16	rs12841977 [];					0.2594			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70344331	70344331	G	C	hom	222	MED12			0.36	0.36	0.36	rs59024650 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.125	0.0625	0.8125	18		
chrX	70344763	70344763	G	T	hom	222	MED12			0.16	0.16	0.16	rs5030616 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70345683	70345683	T	G	hom	222	MED12			0.16	0.16	0.16	rs73214869 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70348344	70348344	G	A	hom	222	MED12			0.16	0.16	0.16	rs5030618 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70349947	70349947	A	C	hom	222	MED12	synonymous SNV	MED12:NM_005120:exon28:c.A3930C:p.P1310P,	0.15	0.15	0.15	rs5030619 [];					0.3176			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.25	0.0875	0.6625	123		
chrX	70352417	70352417	T	C	hom	222	MED12			0.16	0.16	0.16	rs10521349 [];					0.3148			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	43		
chrX	70352516	70352516	A	G	hom	222	MED12			0.16	0.16	0.16	rs12843026 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	17		
chrX	70352618	70352647	CTCTTCTCTTCTCTTCTCTTCTCTTCTCTT	-	hom	214	MED12			0	0	0								713	300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.0375	0.025	0.9375	7		
chrX	70356642	70356642	T	C	hom	222	MED12			0.55	0.55	0.55	rs12852829 [];								300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1875	0.075	0.7375	27		
chrX	70361967	70361967	G	A	hom	222	MED12			0.19	0.19	0.19	rs36072155 [];					0.3317			300188 [Mediator of RNA polymerase II transcription, subunit 12, S. - Opitz-Kaveggia syndrome, 305450 (3); Lujan-Fryns syndrome, 309520 (3)];		0.1125	0.0625	0.825	33		
chrX	70367328	70367328	A	G	hom	212	NLGN3			0.55	0.55	0.55	rs11795613 [];								300336 [Neuroligin 3 - {Autism susceptibility, X-linked 1}, 300425 (3);{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)];		0.1875	0.075	0.7375	27		
chrX	70375023	70375023	G	A	hom	222	NLGN3			0.01	0.01	0.01	rs185402974 [];					0.0199			300336 [Neuroligin 3 - {Autism susceptibility, X-linked 1}, 300425 (3);{Asperger syndrome susceptibility, X-linked 1}, 300494 (3)];		0.0125	0	0.9875	1		
chrX	70469182	70469182	G	A	hom	222	ZMYM3			1	1	1	rs2341539 [];							373			0.9875	0	0.0125	153		
chrX	70596747	70596747	G	A	hom	222	BCYRN1			0	0	0									313650 [TAF1 RNA polymerase II, TATA box-binding protein-associated factor, - Dystonia-Parkinsonism, X-linked, 314250 (3)];		0	0	1	0		
chrX	70609379	70609379	-	A	hom	141	BCYRN1			0	0	0									313650 [TAF1 RNA polymerase II, TATA box-binding protein-associated factor, - Dystonia-Parkinsonism, X-linked, 314250 (3)];		0	0	1	0		
chrX	70613075	70613076	TG	-	het	120	BCYRN1			0	0	0	rs201372159 [];							390	313650 [TAF1 RNA polymerase II, TATA box-binding protein-associated factor, - Dystonia-Parkinsonism, X-linked, 314250 (3)];		0.0125	0.05	0.9375	9		
chrX	70776730	70776730	G	A	hom	222	BCYRN1			0.33	0.33	0.33	rs3736670 [];										0.05	0.0375	0.9125	7		
chrX	70784393	70784393	T	A	hom	222	BCYRN1			0.0006	0.0006	0.0006	rs189860468 [];										0	0	1	0		
chrX	70794603	70794604	GT	-	het	126	OGT			0	0	0											0	0.0125	0.9875	1		
chrX	70794620	70794621	TT	-	hom	70.5	OGT			0	0	0											0	0.0375	0.9625	3		
chrX	71350133	71350133	T	G	hom	222	RGAG4	nonsynonymous SNV	RGAG4:NM_001024455:exon1:c.A1258C:p.S420R,	0.21	0.21	0.21	rs6624595 [];	0.1530			0.0180	0.0876					0.0875	0	0.9125	14		
chrX	71351519	71351519	C	A	hom	149	RGAG4			0.99	0.99	0.99	rs12390168 [];										0.9	0	0.1	85		
chrX	71364064	71364064	A	G	hom	222	FLJ44635			0.5	0.5	0.5	rs6525579 [];										0.1625	0.0125	0.825	17		
chrX	71364479	71364479	A	C	hom	222	FLJ44635			0.96	0.96	0.96	rs11094247 [];					1.0000					0.4375	0	0.5625	74		
chrX	71379881	71379881	G	A	hom	222	FLJ44635	nonsynonymous SNV	FLJ44635:NM_207422:exon2:c.G202A:p.E68K,	0.44	0.44	0.44	rs6624600 [];					0.2243					0.1625	0	0.8375	31		
chrX	71401607	71401607	G	A	hom	222	PIN4	nonsynonymous SNV	PIN4:NM_006223:exon1:c.G47A:p.R16Q,PIN4:NM_001170747:exon1:c.G47A:p.R16Q,	0.76	0.76	0.76	rs6525589 [];	-0.9750	0.0000	1.0000	0.0000	0.9631					0.9375	0	0.0625	140		
chrX	71401614	71401614	C	A	hom	222	PIN4	nonsynonymous SNV	PIN4:NM_006223:exon1:c.C54A:p.S18R,PIN4:NM_001170747:exon1:c.C54A:p.S18R,	0.76	0.76	0.76	rs7058353 [];	-1.6670	0.0000	0.9800	0.0000	0.9633					0.925	0	0.075	140		
chrX	71406301	71406301	T	C	hom	222	PIN4			0.6	0.6	0.6	rs6525591 [];					0.2559					0.0875	0.025	0.8875	27		
chrX	71424718	71424718	G	A	hom	222	ERCC6L			0.34	0.34	0.34	rs6625979 [];										0.1875	0.025	0.7875	19		
chrX	71495389	71495389	-	CTA	hom	214	RPS4X			0	0	0	rs146599276 [];										0.8125	0.0125	0.175	130		
chrX	71521867	71521867	G	C	hom	222	CITED1	nonsynonymous SNV	CITED1:NM_001144885:exon4:c.C366G:p.H122Q,CITED1:NM_004143:exon3:c.C288G:p.H96Q,CITED1:NM_001144887:exon3:c.C288G:p.H96Q,CITED1:NM_001144886:exon3:c.C288G:p.H96Q,	0.75	0.75	0.75	rs3012627 [];	0.1910	0.0000	1.0000	0.0000	0.8793					0.825	0.0125	0.1625	132		
chrX	71522126	71522126	C	T	hom	222	CITED1			0.31	0.31	0.31	rs2984343 [];					0.1072					0.025	0.025	0.95	12		
chrX	71527019	71527019	G	T	hom	222	CITED1			0.01	0.01	0.01	rs187368746 [];										0	0	1	0		
chrX	71813205	71813205	-	T	hom	71.5	PHKA1			0	0	0								2565			0.175	0.125	0.7	28		
chrX	71822945	71822945	-	AGA	het	3.8	PHKA1			0	0	0											0	0.0125	0.9875	1		
chrX	71896111	71896112	AT	-	het	74.5	PHKA1			0	0	0											0	0.2125	0.7875	20		
chrX	72224733	72224733	T	C	hom	4.11	PABPC1L2B			0.99	0.99	0.99	rs141917822 [];							485			0.05	0	0.95	4		
chrX	72297562	72297563	AC	-	hom	161	PABPC1L2A			0	0	0								354			0.575	0.225	0.2	80		
chrX	72298326	72298326	T	C	hom	97	PABPC1L2A			0.99	0.99	0.99	rs182890337 [];										0.1625	0	0.8375	17		
chrX	72347001	72347001	-	TT	het	45.5	NAP1L6			0	0	0								2260			0.0125	0.0125	0.975	2		
chrX	72899365	72899365	T	C	hom	222	CHIC1			0.1	0.1	0.1	rs6648376 [];										0.05	0.0125	0.9375	6		
chrX	73043817	73043817	T	C	hom	222	TSIX;XIST			0.6	0.6	0.6	rs1620574 [];					0.3353					0.275	0.0375	0.6875	44		
chrX	73066439	73066439	T	C	hom	222	XIST			0.36	0.36	0.36	rs1894271 [];					0.1703					0.15	0.025	0.825	15		
chrX	73290216	73290216	A	-	het	53.5	JPX			0	0	0	rs59904201 [];							396			0.4875	0.0625	0.45	50		
chrX	73499888	73499888	T	A	hom	222	FTX			0.9	0.9	0.9	rs174154 [];							747			0.8	0.025	0.175	77		
chrX	73499963	73499963	T	C	hom	222	FTX			0.89	0.89	0.89	rs174153 [];							747			0.8125	0.025	0.1625	78		
chrX	73501562	73501562	T	C	hom	222	FTX			0.89	0.89	0.89	rs174151 [];										0.85	0.025	0.125	86		
chrX	73749319	73749319	T	G	hom	222	SLC16A2			0.4	0.4	0.4	rs5937843 [];					0.7941			300095 [Solute carrier family 16 (monocarboxylic acid transporters), - Allan-Herndon-Dudley syndrome, 300523 (3)];		0.275	0.0625	0.6625	76		
chrX	73958629	73958629	G	A	hom	222	KIAA2022			0.47	0.47	0.47	rs2209549 [];										0.775	0.0125	0.2125	127		
chrX	74375871	74375871	G	C	hom	182	ABCB7			0.93	0.93	0.93	rs1039123 [];										0.4375	0	0.5625	46		
chrX	74494470	74494470	T	G	hom	222	UPRT	synonymous SNV	UPRT:NM_145052:exon1:c.T381G:p.R127R,	0.93	0.93	0.93	rs4892396 [];					0.9990					0.95	0	0.05	140		
chrX	74494483	74494483	A	G	hom	222	UPRT			0.84	0.84	0.84	rs5981831 [];					0.9722					0.9125	0	0.0875	137		
chrX	74494611	74494618	GTGTGTGT	-	hom	152	UPRT			0	0	0	rs201034223 [];							378			0.0875	0.0625	0.85	13		
chrX	74523367	74523367	A	G	hom	222	UPRT			0.85	0.85	0.85	rs972561 [];					0.9723					0.9125	0	0.0875	109		
chrX	74523871	74523871	G	A	hom	222	UPRT			0.93	0.93	0.93	rs5937351 [];										0.9875	0	0.0125	96		
chrX	74524280	74524280	C	A	hom	222	UPRT			0.85	0.85	0.85	rs6647687 [];										0.9375	0	0.0625	90		
chrX	74545290	74545290	C	T	hom	222	UPRT;ZDHHC15		UPRT:dist=20558;ZDHHC15:dist=42972	0.86	0.86	0.86	rs4255296 [];										0.9125	0	0.0875	85		
chrX	74598903	74598903	G	A	hom	202	ZDHHC15			0.43	0.43	0.43	rs5937369 [];								300576 [Zinc finger DHHC domain-containing protein 15 - Mental retardation, X-linked-91, 300577 (3)];		0.325	0.0125	0.6625	37		
chrX	75395172	75395172	T	C	hom	204	PBDC1			0.73	0.73	0.73	rs2301863 [];										0.3875	0	0.6125	42		
chrX	75395187	75395187	C	T	hom	214	PBDC1			0.44	0.44	0.44	rs2301862 [];										0.2625	0.05	0.6875	35		
chrX	76937963	76937963	G	C	hom	222	ATRX	nonsynonymous SNV	ATRX:NM_138270:exon8:c.C2671G:p.Q891E,ATRX:NM_000489:exon9:c.C2785G:p.Q929E,	0.51	0.51	0.51	rs3088074 [];	0.6070	0.0000	1.0000	0.0000	0.3060			300032 [ATR-X gene (helicase 2; X-linked nuclear protein) - Alpha-thalassemia/mental retardation syndrome, 301040 (3);Alpha-thalassemia myelodysplasia syndrome, somatic, 300448 (3); Mental retardation-hypotonic facies syndrome, X-linked, 309580 (3)];		0.3375	0.0875	0.575	98		
chrX	77219128	77219128	A	G	hom	207	ATP7A			0.11	0.11	0.11	rs148489456 [];							2438	300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.05	0.025	0.925	7		
chrX	77254268	77254268	-	T	hom	214	ATP7A			0	0	0									300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.1125	0.05	0.8375	16		
chrX	77264534	77264534	T	G	het	19.1	ATP7A			0	0	0									300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0	0.4	0.6	39		
chrX	77265580	77265580	A	C	hom	222	ATP7A			0.29	0.29	0.29	rs2157389 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2625	0.075	0.6625	30		
chrX	77267996	77267996	A	G	hom	222	ATP7A			0.47	0.47	0.47	rs112626820 [];							886	300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2625	0.075	0.6625	29		
chrX	77268502	77268502	G	C	hom	222	ATP7A	nonsynonymous SNV	ATP7A:NM_000052:exon10:c.G2299C:p.V767L,	0.28	0.28	0.28	rs2227291 [];	2.3770	0.7328	0.0900	0.9610	0.2139			300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2125	0.075	0.7125	70		
chrX	77276036	77276036	G	A	hom	222	ATP7A			0.28	0.28	0.28	rs7053543 [];							1932	300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.1125	0.05	0.8375	14		
chrX	77276413	77276413	C	A	hom	222	ATP7A			0.29	0.29	0.29	rs113968994 [];					0.2249			300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.1	0.05	0.85	37		
chrX	77286831	77286831	T	-	hom	26.5	ATP7A			1	1	1	rs5902762 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.4375	0	0.5625	46		
chrX	77296047	77296047	G	C	hom	222	ATP7A			1	1	1	rs5913631 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.4375	0	0.5625	98		
chrX	77298857	77298857	G	A	hom	222	ATP7A	nonsynonymous SNV	ATP7A:NM_000052:exon21:c.G4048A:p.E1350K,	1	1	1	rs4826245 [];	0.6310	0.0000	1.0000	0.0000				300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.9625	0	0.0375	208		
chrX	77301080	77301080	T	C	hom	222	ATP7A			0.0006	0.0006	0.0006	rs200009243 [];					0.0062			300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.025	0	0.975	4		
chrX	77302391	77302391	-	CCACCAAAAAAA	het	206	ATP7A			0	0	0									300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0	0	1	0		
chrX	77304027	77304027	T	C	hom	222	ATP7A			0.47	0.47	0.47	rs1062472 [];								300011 [ATPase, Cu++ transporting, alpha polypeptide - Menkes disease, 309400 (3); Occipital horn syndrome, 304150 (3);Spinal muscular atrophy, distal, X-linked 3, 300489 (3)];		0.2625	0.075	0.6625	65		
chrX	77373524	77373524	C	T	hom	222	PGK1			0.33	0.33	0.33	rs2007039 [];					0.2130			311800 [Phosphoglycerate kinase-1 - Phosphoglycerate kinase 1 deficiency, 300653 (3)];		0.1	0.05	0.85	36		
chrX	77381002	77381002	A	G	hom	222	PGK1			0.33	0.33	0.33	rs2073177 [];								311800 [Phosphoglycerate kinase-1 - Phosphoglycerate kinase 1 deficiency, 300653 (3)];		0.1	0.05	0.85	13		
chrX	77381014	77381014	G	A	hom	222	PGK1			0.33	0.33	0.33	rs2073178 [];								311800 [Phosphoglycerate kinase-1 - Phosphoglycerate kinase 1 deficiency, 300653 (3)];		0.1	0.05	0.85	13		
chrX	77385748	77385748	C	T	hom	222	TAF9B			0.33	0.33	0.33	rs10991 [];										0.2125	0.075	0.7125	27		
chrX	77386696	77386696	-	AAA	het	206	TAF9B			0	0	0											0	0.1125	0.8875	9		
chrX	78616364	78616364	A	G	hom	222	ITM2A			0.12	0.12	0.12	rs115951131 [];										0.15	0.0375	0.8125	18		
chrX	78618050	78618050	A	G	hom	222	ITM2A			0.91	0.91	0.91	rs1751134 [];					0.8711					0.425	0.0125	0.5625	65		
chrX	78618392	78618392	G	A	hom	222	ITM2A			0	0	0						0.0015					0	0	1	0		
chrX	78618841	78618841	C	A	hom	222	ITM2A			0.12	0.12	0.12	rs3761590 [];										0.0625	0.025	0.9125	9		
chrX	79281397	79281397	T	C	hom	222	TBX22			0.61	0.61	0.61	rs195294 [];										0.175	0.0625	0.7625	23		
chrX	79282873	79282873	G	-	het	6.55	TBX22			0	0	0											0	0	1	0		
chrX	79698593	79698593	C	G	hom	222	FAM46D	nonsynonymous SNV	FAM46D:NM_152630:exon3:c.C555G:p.D185E,FAM46D:NM_001170574:exon5:c.C555G:p.D185E,	0.43	0.43	0.43	rs1113265 [];	-2.2910	0.0272	1.0000	0.0030	0.7099					0.575	0.075	0.35	98		
chrX	79937084	79937084	G	A	hom	222	BRWD3			0.68	0.68	0.68	rs3122406 [];								300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.25	0.05	0.7	33		
chrX	79942600	79942603	TATA	-	hom	177	BRWD3			0	0	0	rs3029738 [];							225	300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.2	0.0375	0.7625	28		
chrX	79943569	79943569	T	C	hom	222	BRWD3	nonsynonymous SNV	BRWD3:NM_153252:exon34:c.A3863G:p.K1288R,	0.99	0.99	0.99	rs3122407 [];	1.1020	0.0000		0.0010	1.0000			300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.95	0	0.05	209		
chrX	79989109	79989109	-	T	het	82.5	BRWD3			0	0	0									300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0	0.0375	0.9625	3		
chrX	79999797	79999797	-	CAC	hom	214	BRWD3			0	0	0	rs67376083 [];								300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.4375	0	0.5625	91		
chrX	80001382	80001382	-	AATTTCATGAAA	het	5.08	BRWD3			0	0	0									300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0	0	1	0		
chrX	80064918	80064918	-	C	hom	214	BRWD3			0	0	0									300553 [Bromodomain-and WD repeat-containing protein 3 - Mental retardation, X-linked 93, 300659 (3)];		0.2125	0.0375	0.75	58		
chrX	80532783	80532783	C	T	hom	222	SH3BGRL			0.01	0.01	0.01	rs73231024 [];										0.0125	0	0.9875	3		
chrX	80553229	80553229	C	T	hom	222	SH3BGRL			0.56	0.56	0.56	rs1044828 [];										0.6375	0.0125	0.35	63		
chrX	82764040	82764040	A	G	hom	222	POU3F4	synonymous SNV	POU3F4:NM_000307:exon1:c.A708G:p.E236E,	0.92	0.92	0.92	rs5921978 [];										0.9625	0	0.0375	145		
chrX	82764042	82764042	G	C	hom	222	POU3F4	nonsynonymous SNV	POU3F4:NM_000307:exon1:c.G710C:p.G237A [1(upper_aerodigestive_tract)]; 	0.89	0.89	0.89	rs5921979 [];	1.0570	0.0001	1.0000	0.0000		1180653 [1(upper_aerodigestive_tract)]; 				0.9625	0	0.0375	145		
chrX	83124802	83124802	A	T	hom	89.5	CYLC1			0.99	0.99	0.99	rs5968237 [];										0.3125	0	0.6875	34		
chrX	83352970	83352970	T	C	hom	185	RPS6KA6			0.74	0.74	0.74	rs10521366 [];										0.3625	0	0.6375	38		
chrX	83599583	83599583	C	T	hom	148	HDX			0.2	0.2	0.2	rs66940146 [];										0.05	0.0125	0.9375	7		
chrX	84258843	84258843	C	G	hom	222	APOOL			0.75	0.75	0.75	rs3747422 [];					0.6847					0.325	0.0125	0.6625	59		
chrX	84343323	84343323	-	TTTT	hom	10	APOOL			0	0	0								261			0.0125	0	0.9875	1		
chrX	84343874	84343874	-	TACT	hom	214	APOOL			0	0	0											0	0	1	0		
chrX	84344249	84344249	A	G	hom	222	APOOL			0.65	0.65	0.65	rs5968443 [];							1991			0.7375	0.0125	0.25	72		
chrX	84350010	84350010	A	G	hom	196	SATL1			0.65	0.65	0.65	rs4828326 [];					0.6799					0.7375	0.0125	0.25	113		
chrX	84358864	84358864	C	T	hom	222	SATL1			0.76	0.76	0.76	rs5922146 [];					0.6816					0.75	0.0125	0.2375	117		
chrX	84363140	84363140	A	G	hom	222	SATL1	nonsynonymous SNV	SATL1:NM_001012980:exon1:c.T835C:p.W279R,	0.73	0.73	0.73	rs10126146 [];	-3.8980	0.0000	0.5500	0.0040	0.6824					0.7875	0.0125	0.2	122		
chrX	84534383	84534383	A	C	hom	222	POF1B			1	1	1	rs2227090 [];					0.9976					0.95	0	0.05	136		
chrX	84563135	84563135	T	A	hom	222	POF1B	nonsynonymous SNV	POF1B:NM_024921:exon10:c.A1045T:p.M349L,	0.9	0.9	0.9	rs363774 [];	0.3300	0.0000	1.0000	0.0000	0.7723					0.8	0.0125	0.1875	122		
chrX	86071151	86071151	C	G	hom	174	DACH2			0.24	0.24	0.24	rs12837683 [];					0.4264					0.1375	0.0875	0.775	37		
chrX	86083044	86083047	AGTT	-	hom	214	DACH2			0	0	0								214			0.7625	0.0375	0.2	75		
chrX	86083760	86083760	G	T	hom	222	DACH2			0.24	0.24	0.24	rs7062863 [];										0.3125	0.1125	0.575	41		
chrX	86084856	86084856	T	C	hom	222	DACH2			0.71	0.71	0.71	rs5969011 [];										0.7875	0.0375	0.175	77		
chrX	86085179	86085179	G	A	hom	222	DACH2			0.29	0.29	0.29	rs11092827 [];										0.3125	0.1125	0.575	41		
chrX	86086609	86086609	G	A	hom	222	DACH2			0.32	0.32	0.32	rs5923653 [];										0.3	0.1125	0.5875	40		
chrX	86086810	86086810	-	G	hom	65.5	DACH2			0	0	0	rs67991204 [];										0.7375	0.025	0.2375	72		
chrX	86087385	86087385	A	T	hom	222	DACH2			0.71	0.71	0.71	rs3087525 [];										0.775	0.0375	0.1875	78		
chrX	86877348	86877348	G	T	hom	222	KLHL4	synonymous SNV	KLHL4:NM_057162:exon5:c.G1062T:p.G354G,KLHL4:NM_019117:exon5:c.G1062T:p.G354G,	0.19	0.19	0.19	rs2273050 [];					0.1960					0.0625	0.025	0.9125	17		
chrX	86887244	86887244	C	T	hom	222	KLHL4	synonymous SNV	KLHL4:NM_057162:exon7:c.C1359T:p.T453T,KLHL4:NM_019117:exon7:c.C1359T:p.T453T,	0.59	0.59	0.59	rs222084 [];					0.7432					0.7125	0.025	0.2625	110		
chrX	86922097	86922097	-	A	hom	214	KLHL4			0	0	0											0.7375	0.025	0.2375	72		
chrX	88009170	88009170	G	C	hom	222	CPXCR1	nonsynonymous SNV	CPXCR1:NM_001184771:exon3:c.G755C:p.G252A,CPXCR1:NM_033048:exon3:c.G755C:p.G252A,	0.01	0.01	0.01	rs41307393 [];	-0.4190	0.0078		0.0020	0.0137					0	0	1	2		
chrX	89177673	89177673	G	A	hom	222	TGIF2LX	nonsynonymous SNV	TGIF2LX:NM_138960:exon2:c.G589A:p.V197I,	0.74	0.74	0.74	rs2290380 [];	-0.3200	0.0000		0.0000	0.6819					0.6875	0.0625	0.25	105		
chrX	91456467	91456467	C	A	hom	222	PCDH11X			0.2	0.2	0.2	rs4252207 [];					0.1905					0.05	0.0125	0.9375	19		
chrX	91873255	91873255	C	T	hom	210	PCDH11X			0	0	0	rs200485075 [];					0.0024					0	0	1	0		
chrX	91876149	91876150	AC	-	het	63.5	PCDH11X			0	0	0								288			0	0.2875	0.7125	26		
chrX	92926025	92926025	A	G	hom	222	NAP1L3			0.07	0.07	0.07	rs9501 [];										0.1	0.0375	0.8625	13		
chrX	92926201	92926201	T	-	hom	214	NAP1L3			0.06	0.06	0.06	rs200831796 [];										0.1	0.0375	0.8625	12		
chrX	92927634	92927634	G	C	hom	222	NAP1L3	nonsynonymous SNV	NAP1L3:NM_004538:exon1:c.C670G:p.P224A,	0.57	0.57	0.57	rs1045686 [];	1.9280	0.0405	0.3000	0.0670	0.6452					0.55	0.0875	0.3625	96		
chrX	96194485	96194485	-	GTGTATATATATATATAT	hom	137	DIAPH2			0	0	0								681			0	0	1	0		
chrX	96197175	96197175	G	A	hom	222	DIAPH2			1	1	1	rs5920973 [];					0.9999					0.425	0	0.575	71		
chrX	96213213	96213213	T	C	hom	222	DIAPH2			0.32	0.32	0.32	rs5966792 [];										0.1625	0.075	0.7625	25		
chrX	96854685	96854685	-	A	hom	214	DIAPH2			0	0	0											0.275	0.1	0.625	34		
chrX	96855750	96855750	-	ATA	hom	214	DIAPH2			0	0	0											0	0	1	0		
chrX	96856457	96856457	-	A	hom	214	DIAPH2			0	0	0											0.5	0.05	0.45	49		
chrX	96860054	96860054	G	C	hom	222	DIAPH2;XRCC6P5		DIAPH2:dist=4457;XRCC6P5:dist=1856546	0.85	0.85	0.85	rs5967330 [];										0.4125	0	0.5875	42		
chrX	99890204	99890204	C	T	hom	222	TSPAN6	nonsynonymous SNV	TSPAN6:NM_003270:exon3:c.G322A:p.A108T,	0.08	0.08	0.08	rs1802288 [];	2.2980	0.9750		0.9000	0.1707					0.175	0.0375	0.7875	27		
chrX	99919733	99919733	G	A	hom	222	SRPX2			0.8	0.8	0.8	rs2022475 [];					0.9778			300642 [SUSHI repeat-containing protein, X-linked, 2 - Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643(3)];		0.425	0.0125	0.5625	101		
chrX	99926122	99926122	G	A	hom	222	SRPX2			0.97	0.97	0.97	rs5967163 [];								300642 [SUSHI repeat-containing protein, X-linked, 2 - Rolandic epilepsy, mental retardation, and speech dyspraxia, 300643(3)];		0.9875	0	0.0125	158		
chrX	99926455	99926455	-	TT	het	38.5	SRPX2			0	0	0								2435			0.0125	0.075	0.9125	10		
chrX	99929532	99929532	G	C	hom	222	SYTL4			0.34	0.34	0.34	rs8780 [];										0.3375	0.0875	0.575	42		
chrX	99930890	99930890	-	TACACACA	het	217	SYTL4			0	0	0								393			0	0	1	0		
chrX	99930918	99930918	-	CACACACA	hom	122	SYTL4			0	0	0								393			0.05	0	0.95	5		
chrX	99941369	99941369	T	C	hom	222	SYTL4			0.35	0.35	0.35	rs5921626 [];										0.3625	0.0625	0.575	39		
chrX	99941705	99941705	T	C	hom	222	SYTL4	nonsynonymous SNV	SYTL4:NM_001174068:exon12:c.A1258G:p.I420V,SYTL4:NM_080737:exon14:c.A1258G:p.I420V,SYTL4:NM_001129896:exon13:c.A1258G:p.I420V,	0.95	0.95	0.95	rs2022039 [];	-1.3330	0.7677		0.0030	0.9988					0.975	0	0.025	146		
chrX	99941980	99941980	T	C	hom	222	SYTL4			0.95	0.95	0.95	rs2022040 [];										0.9875	0	0.0125	91		
chrX	99943103	99943103	A	C	hom	222	SYTL4			0.35	0.35	0.35	rs5920842 [];										0.3625	0.0625	0.575	39		
chrX	99943244	99943244	G	C	hom	222	SYTL4			0.34	0.34	0.34	rs5921627 [];										0.35	0.05	0.6	37		
chrX	99956157	99956157	T	C	hom	222	SYTL4			0.41	0.41	0.41	rs5967170 [];										0.2	0.05	0.75	25		
chrX	99957136	99957136	T	C	hom	222	SYTL4			0.33	0.33	0.33	rs5967171 [];										0.2	0.05	0.75	25		
chrX	99957238	99957238	G	C	hom	208	SYTL4			0.4	0.4	0.4	rs1343214 [];										0.2	0.05	0.75	25		
chrX	100081589	100081589	G	A	hom	222	CSTF2			0.05	0.05	0.05	rs3213559 [];					0.0101					0	0	1	0		
chrX	100081914	100081914	G	A	hom	196	CSTF2			0.59	0.59	0.59	rs3830149 [];							614			0.2	0.0625	0.7375	27		
chrX	100098358	100098360	GAA	-	hom	214	NOX1			0	0	0	rs66513781 [];										0	0	1	0		
chrX	100105008	100105008	T	C	hom	222	NOX1			1	1	1	rs1476011 [];										0.425	0	0.575	45		
chrX	100105418	100105418	A	G	hom	222	NOX1			0.61	0.61	0.61	rs5921669 [];					0.6337		1124			0.2125	0.0625	0.725	42		
chrX	100168408	100168408	-	CA	hom	180	XKRX			0	0	0											0	0	1	0		
chrX	100242305	100242305	G	A	hom	222	ARL13A			0.81	0.81	0.81	rs5921702 [];										0.375	0.0375	0.5875	43		
chrX	100243459	100243459	G	T	hom	222	ARL13A	nonsynonymous SNV	ARL13A:NM_001012990:exon8:c.G837T:p.M279I,ARL13A:NM_001162490:exon8:c.G837T:p.M279I,	0.91	0.91	0.91	rs3934462 [];					0.9146					0.9125	0	0.0875	126		
chrX	100245606	100245606	A	G	hom	222	ARL13A			0.86	0.86	0.86	rs6523438 [];					0.8595					0.85	0.0375	0.1125	120		
chrX	100265552	100265552	T	A	hom	222	TRMT2B			0.37	0.37	0.37	rs5921705 [];					0.4150					0.375	0.0625	0.5625	56		
chrX	100350301	100350301	C	T	hom	222	TMEM35			0	0	0	rs62602432 [];							202			0.2375	0.1125	0.65	34		
chrX	100350312	100350313	GC	-	het	27.5	TMEM35			0	0	0								202			0.125	0.2125	0.6625	33		
chrX	100350684	100350684	A	-	hom	214	TMEM35			0.41	0.41	0.41	rs34994578 [];										0.525	0.0625	0.4125	54		
chrX	100356022	100356026	TAACT	-	hom	214	CENPI			0.12	0.12	0.12	rs200931377 [];					0.2040					0.0875	0.0125	0.9	22		
chrX	100357194	100357194	C	G	hom	222	CENPI			0.41	0.41	0.41	rs12156858 [];										0.1875	0.0625	0.75	29		
chrX	100357201	100357201	T	C	hom	204	CENPI			0.41	0.41	0.41	rs12156663 [];										0.1875	0.0625	0.75	29		
chrX	100357418	100357418	T	-	hom	7.34	CENPI			0.41	0.41	0.41	rs59141949 [];					0.4794					0.0125	0	0.9875	5		
chrX	100396344	100396344	T	A	hom	222	CENPI			0.12	0.12	0.12	rs11798509 [];							1922			0.0875	0.0375	0.875	13		
chrX	100400023	100400023	A	G	hom	222	CENPI			0.67	0.67	0.67	rs2295376 [];					0.7491					0.3	0.025	0.675	60		
chrX	100475276	100475276	-	GT	hom	59.4	DRP2			0	0	0								339			0.025	0.025	0.95	4		
chrX	100505617	100505617	G	C	hom	222	DRP2			0.32	0.32	0.32	rs3747280 [];					0.3573		245			0.175	0.0375	0.7875	35		
chrX	100505881	100505881	C	G	hom	222	DRP2			0.12	0.12	0.12	rs4827893 [];					0.2157					0.0875	0.025	0.8875	18		
chrX	100511098	100511098	C	T	hom	222	DRP2			0.32	0.32	0.32	rs3213505 [];					0.3563					0.4	0.0375	0.5625	69		
chrX	100514986	100514986	G	A	hom	222	DRP2			0.44	0.44	0.44	rs5967281 [];					0.3737					0.2125	0	0.7875	19		
chrX	100515332	100515332	A	G	hom	222	DRP2			0.33	0.33	0.33	rs5967282 [];							187			0.2	0.0125	0.7875	19		
chrX	100515792	100515792	A	G	hom	222	DRP2			0.44	0.44	0.44	rs4828078 [];										0.4625	0	0.5375	42		
chrX	100531204	100531204	T	C	hom	222	TAF7L			0.33	0.33	0.33	rs3761514 [];										0.1625	0.0375	0.8	18		
chrX	100531419	100531419	C	T	het	36	TAF7L	synonymous SNV	TAF7L:NM_024885:exon10:c.G1047A:p.E349E,TAF7L:NM_001168474:exon10:c.G789A:p.E263E,	0	0	0	rs147505183 [];							312			0	0	1	0		
chrX	100531437	100531442	CTCATC	-	hom	214	TAF7L	nonframeshift deletion	TAF7L:NM_024885:exon10:c.1024_1029del:p.342_343del,TAF7L:NM_001168474:exon10:c.766_771del:p.256_257del,	0	0	0								312			0	0	1	0		
chrX	100532924	100532924	A	G	hom	222	TAF7L			0.36	0.36	0.36	rs3788765 [];										0.1625	0.0375	0.8	18		
chrX	100532985	100532985	T	C	hom	222	TAF7L			0.35	0.35	0.35	rs3788764 [];					0.3609					0.1625	0.0375	0.8	33		
chrX	100547933	100547933	A	G	hom	222	TAF7L	nonsynonymous SNV	TAF7L:NM_024885:exon1:c.T101C:p.L34P,	0.99	0.99	0.99	rs5951328 [];	-1.4180	0.0000	0.3600	0.0000	0.9886					0.95	0	0.05	205		
chrX	100604757	100604757	T	G	hom	222	BTK			0.3	0.3	0.3	rs700 [];						COSN168778 [1(large_intestine)]; 		300300 [Bruton agammaglobulinemia tyrosine kinase - Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemiaand isolated hormone deficiency, 307200 (3)];		0.35	0.05	0.6	83		
chrX	100609547	100609547	G	A	hom	222	BTK			0.73	0.73	0.73	rs2071223 [];						COSN168779 [1(large_intestine)]; 		300300 [Bruton agammaglobulinemia tyrosine kinase - Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemiaand isolated hormone deficiency, 307200 (3)];		0.2375	0.0375	0.725	31		
chrX	100617372	100617372	T	C	hom	222	BTK			0.75	0.75	0.75	rs2071222 [];							395	300300 [Bruton agammaglobulinemia tyrosine kinase - Agammaglobulinemia, X-linked 1, 300755 (3); Agammaglobulinemiaand isolated hormone deficiency, 307200 (3)];		0.2875	0.05	0.6625	37		
chrX	100742272	100742272	T	C	hom	222	ARMCX4			0.62	0.62	0.62	rs2253062 [];										0.275	0.05	0.675	35		
chrX	100742551	100742551	G	A	hom	222	ARMCX4			0.49	0.49	0.49	rs2361298 [];										0.25	0.0375	0.7125	32		
chrX	100743037	100743037	C	T	hom	222	ARMCX4			0.65	0.65	0.65	rs963618 [];										0.5625	0.0625	0.375	64		
chrX	100743826	100743826	A	G	hom	222	ARMCX4	nonsynonymous SNV	ARMCX4:NM_001256155:exon2:c.A250G:p.R84G,	0.62	0.62	0.62	rs5951332 [];	-0.4070	0.0003	1.0000							0.575	0.0625	0.3625	66		
chrX	100809674	100809674	-	AA	hom	214	ARMCX1			0	0	0	rs35047340 [];										0.35	0.0375	0.6125	39		
chrX	100911066	100911066	C	T	hom	222	ARMCX2	synonymous SNV	ARMCX2:NM_177949:exon6:c.G1509A:p.Q503Q,ARMCX2:NM_014782:exon5:c.G1509A:p.Q503Q,	0.96	0.96	0.96	rs3850315 [];					0.9191					0.8625	0.025	0.1125	130		
chrX	100912776	100912776	G	A	hom	222	ARMCX2			0.19	0.19	0.19	rs5951282 [];										0.1625	0.0375	0.8	23		
chrX	100914185	100914185	T	C	hom	222	ARMCX2			1	1	1	rs7877615 [];										0.4375	0	0.5625	46		
chrX	100914701	100914701	-	C	hom	214	ARMCX2			0	0	0	rs61487673 [];										0.4375	0	0.5625	46		
chrX	101087051	101087051	G	C	hom	222	NXF5			0.13	0.13	0.13	rs6616305 [];										0.125	0.0375	0.8375	18		
chrX	101087497	101087497	A	T	hom	222	NXF5			0.12	0.12	0.12	rs76289014 [];										0.125	0.0375	0.8375	18		
chrX	101087498	101087498	T	C	hom	222	NXF5			0.12	0.12	0.12	rs2027832 [];										0.125	0.0375	0.8375	18		
chrX	101087618	101087618	T	C	hom	222	NXF5			0.14	0.14	0.14	rs2027833 [];										0.125	0.0375	0.8375	18		
chrX	101090953	101090953	G	A	hom	222	NXF5			0.14	0.14	0.14	rs6621219 [];										0.125	0.0375	0.8375	18		
chrX	101091164	101091164	T	C	hom	222	NXF5			0.14	0.14	0.14	rs6621220 [];					0.1925					0.2375	0.05	0.7125	44		
chrX	101093049	101093049	A	-	hom	173	NXF5			1	1	1	rs66689050 [];										0.4375	0	0.5625	46		
chrX	101093122	101093122	-	G	hom	56.5	NXF5			0	0	0	rs145072756 [];										0.4125	0	0.5875	43		
chrX	101095482	101095482	A	G	hom	222	NXF5	synonymous SNV	NXF5:NM_032946:exon10:c.T687C:p.S229S,	0	0	0	rs146382081 [];					0.0780					0.3	0	0.7	36		
chrX	101096219	101096219	G	A	hom	137	NXF5			0	0	0	rs201887839 [];					0.1883					0.0875	0.025	0.8875	14		
chrX	101097890	101097890	T	C	hom	222	NXF5			0.14	0.14	0.14	rs5945086 [];										0.125	0.0375	0.8375	18		
chrX	101098376	101098376	T	C	hom	222	NXF5			0.46	0.46	0.46	rs5945087 [];										0.225	0.075	0.7	30		
chrX	101137796	101137796	G	A	hom	222	ZMAT1			0.14	0.14	0.14	rs75619572 [];										0.2375	0.05	0.7125	28		
chrX	101138283	101138283	T	-	hom	214	ZMAT1			0.46	0.46	0.46	rs56868909 [];										0.4875	0.0875	0.425	53		
chrX	101138792	101138792	T	C	hom	222	ZMAT1	nonsynonymous SNV	ZMAT1:NM_001011657:exon7:c.A1607G:p.Q536R,	1	1	1	rs5944882 [];	-0.2600	0.0000	1.0000	0.0000						0.9625	0	0.0375	144		
chrX	101382005	101382005	G	C	hom	222	TCEAL2	nonsynonymous SNV	TCEAL2:NM_080390:exon3:c.G203C:p.G68A,	0.13	0.13	0.13	rs5944856 [];	-2.0870	0.0053	0.2900	0.0210	0.1855		491			0.2125	0.05	0.7375	40		
chrX	101382411	101382411	T	C	hom	222	TCEAL2	synonymous SNV	TCEAL2:NM_080390:exon3:c.T609C:p.Y203Y,	0.08	0.08	0.08	rs5944857 [];					0.1246					0.225	0.05	0.725	41		
chrX	101382417	101382417	G	A	hom	222	TCEAL2	synonymous SNV	TCEAL2:NM_080390:exon3:c.G615A:p.R205R,	0.08	0.08	0.08	rs5944858 [];					0.1060					0.225	0.05	0.725	39		
chrX	101395784	101395784	-	G	hom	214	TCEAL6	frameshift insertion	TCEAL6:NM_001006938:exon3:c.519_520insC:p.A174fs,	0	0	0											0.975	0	0.025	167		
chrX	101396602	101396623	GGGTCCCAATTTGGCCTTGGCC	-	hom	214	TCEAL6			0.14	0.14	0.14	rs200376832 [];										0.0875	0.0375	0.875	14		
chrX	101409271	101409271	-	T	het	137	BEX5			0	0	0											0	0.5875	0.4125	56		
chrX	101409586	101409586	-	G	hom	214	BEX5			0	0	0	rs11424734 [];										0.4375	0	0.5625	46		
chrX	101410777	101410777	G	C	hom	185	BEX5			0.73	0.73	0.73	rs929009 [];										0.2625	0.0875	0.65	38		
chrX	101410823	101410823	-	C	hom	214	BEX5			0	0	0	rs11451071 [];										0.9375	0	0.0625	92		
chrX	101410995	101410995	T	C	hom	222	BEX5			0.73	0.73	0.73	rs6621362 [];										0.625	0.1	0.275	73		
chrX	101473117	101473117	G	A	hom	162	LOC100996648			0	0	0	rs495346 [];										0.05	0.0125	0.9375	5		
chrX	101502275	101502275	C	T	hom	10.4	NXF2;NXF2B			0	0	0											0.025	0	0.975	2		
chrX	101576166	101576166	-	CA	hom	141	NXF2;NXF2B			0	0	0											0.05	0.0125	0.9375	6		
chrX	101624751	101624751	C	T	het	78	NXF2;NXF2B			0	0	0	rs579970 [];										0.1125	0.075	0.8125	17		
chrX	101817814	101817814	G	A	hom	222	NXF4			0.07	0.07	0.07	rs17284949 [];										0.1375	0.05	0.8125	17		
chrX	101820794	101820794	A	G	hom	222	NXF4			0.4	0.4	0.4	rs5945733 [];										0.2125	0.0625	0.725	26		
chrX	101821792	101821792	G	C	hom	222	NXF4			0.14	0.14	0.14	rs6418223 [];										0.0875	0.0375	0.875	13		
chrX	101823022	101823022	C	G	hom	222	NXF4			0.37	0.37	0.37	rs5987617 [];										0.4875	0.0875	0.425	52		
chrX	101823177	101823177	G	A	hom	222	NXF4			0.4	0.4	0.4	rs5945893 [];										0.4875	0.075	0.4375	51		
chrX	101856718	101856718	A	T	hom	222	ARMCX5;ARMCX5-GPRASP2			1	1	1	rs2379211 [];										0.4375	0	0.5625	46		
chrX	101909785	101909785	C	G	hom	222	GPRASP1	nonsynonymous SNV	GPRASP1:NM_001099410:exon4:c.C944G:p.A315G,GPRASP1:NM_001099411:exon3:c.C944G:p.A315G,GPRASP1:NM_014710:exon5:c.C944G:p.A315G,GPRASP1:NM_001184727:exon6:c.C944G:p.A315G,	0.03	0.03	0.03	rs17339512 [];	-0.1070	0.0125	0.1100	0.0390	0.0612					0.075	0.0125	0.9125	12		
chrX	101913611	101913611	A	-	hom	34.5	GPRASP1			0	0	0											0.1625	0	0.8375	18		
chrX	101975725	101975725	G	C	hom	222	BHLHB9			0.03	0.03	0.03	rs73254202 [];										0.0625	0.0125	0.925	8		
chrX	102006896	102006897	TT	-	hom	14.6	BHLHB9			0	0	0								180			0.2625	0.025	0.7125	25		
chrX	102082173	102082173	C	T	hom	222	LINC00630			0.71	0.71	0.71	rs4907856 [];										0.4125	0	0.5875	41		
chrX	102120342	102120342	A	G	hom	222	LINC00630			0.9	0.9	0.9	rs5945905 [];										0.775	0.0625	0.1625	77		
chrX	102339606	102339606	T	C	hom	222	NXF3			0.81	0.81	0.81	rs1029305 [];					0.6975					0.3	0.05	0.65	59		
chrX	102585902	102585902	G	C	hom	222	TCEAL7			0.63	0.63	0.63	rs1045761 [];										0.4	0.075	0.525	50		
chrX	102863108	102863108	T	G	hom	51	TCEAL3			0.99	0.99	0.99	rs221939 [];										0.3875	0	0.6125	38		
chrX	102930684	102930684	A	-	hom	54.5	MORF4L2			0	0	0											0.5375	0	0.4625	47		
chrX	102930960	102930960	A	G	hom	222	MORF4L2			0.4	0.4	0.4	rs874 [];										0.4375	0.025	0.5375	42		
chrX	102941063	102941064	CC	-	hom	79.5	MORF4L2			0	0	0											0.075	0.025	0.9	8		
chrX	102941747	102941747	A	G	hom	180	MORF4L2			0.82	0.82	0.82	rs5987565 [];										0.25	0.025	0.725	28		
chrX	102942666	102942666	A	G	hom	187	MORF4L2-AS1			0.84	0.84	0.84	rs2057101 [];										0.2375	0.0125	0.75	23		
chrX	102946721	102946721	C	T	hom	222	MORF4L2-AS1			0.84	0.84	0.84	rs1543384 [];										0.2375	0.0375	0.725	26		
chrX	103031704	103031704	-	G	hom	214	PLP1			0	0	0								200	300401 [Proteolipid protein 1 - Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,312920 (3)];		0.4375	0	0.5625	46		
chrX	103042882	103042882	T	C	hom	222	PLP1	synonymous SNV	PLP1:NM_001128834:exon5:c.T609C:p.D203D,PLP1:NM_000533:exon4:c.T609C:p.D203D,PLP1:NM_199478:exon4:c.T504C:p.D168D,	0.23	0.23	0.23	rs1126707 [];					0.3121			300401 [Proteolipid protein 1 - Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,312920 (3)];		0.25	0.0625	0.6875	110		
chrX	103046531	103046531	G	-	hom	214	PLP1			0	0	0									300401 [Proteolipid protein 1 - Pelizaeus-Merzbacher disease, 312080 (3); Spastic paraplegia-2,312920 (3)];		0.9875	0	0.0125	156		
chrX	103173633	103173633	A	C	hom	222	MIR1256			0.29	0.29	0.29	rs151143781 [];										0.3125	0.0625	0.625	35		
chrX	103217138	103217138	A	C	hom	222	MIR1256			0.04	0.04	0.04	rs45493994 [];										0.0875	0	0.9125	9		
chrX	103219004	103219004	C	T	hom	209	MIR1256			0.58	0.58	0.58	rs1180753 [];							2324			0.3125	0.0125	0.675	34		
chrX	103231579	103231579	T	A	het	37	H2BFXP			0	0	0	rs604623 [];										0.0875	0.0375	0.875	11		
chrX	103232030	103232030	T	-	hom	3.24	H2BFXP;MIR1256			0	0	0	rs5903232 [];							359			0.0625	0	0.9375	6		
chrX	103267865	103267865	C	T	hom	222	H2BFWT	nonsynonymous SNV	H2BFWT:NM_001002916:exon1:c.G368A:p.R123H,	0.58	0.58	0.58	rs553509 [];	-0.9440	0.8365	0.0300	0.0170	0.6654					0.625	0.025	0.35	105		
chrX	103268241	103268241	G	A	hom	222	H2BFWT			0.33	0.33	0.33	rs7885967 [];					0.4303					0.4125	0.0625	0.525	73		
chrX	103294760	103294760	C	T	hom	222	H2BFM	stopgain SNV	H2BFM:NM_001164416:exon1:c.C217T:p.Q73X,	0.33	0.33	0.33	rs2301384 [];	-2.5870	1.0000	0.0400		0.4408					0.4125	0.0625	0.525	74		
chrX	103348230	103348230	C	T	hom	222	SLC25A53			0.33	0.33	0.33	rs5916825 [];										0.425	0.0625	0.5125	46		
chrX	103348398	103348398	-	C	hom	214	SLC25A53			0	0	0	rs67397909 [];										0.9875	0	0.0125	96		
chrX	103435618	103435618	T	C	hom	222	FAM199X			0.03	0.03	0.03	rs17332064 [];										0.0625	0.0125	0.925	7		
chrX	103495552	103495552	T	C	hom	222	ESX1	nonsynonymous SNV	ESX1:NM_153448:exon4:c.A578G:p.K193R,	0.03	0.03	0.03	rs41305431 [];	1.9020	0.6287	0.0300	0.9930	0.0874					0.0625	0	0.9375	12		
chrX	104464283	104464283	-	CACAACCTCCACAT	hom	214	TEX13A	frameshift insertion	TEX13A:NM_031274:exon3:c.594_595insATGTGGAGGTTGTG:p.D199fs,	0	0	0											0	0	1	0		
chrX	104992963	104992963	T	C	hom	222	IL1RAPL2	synonymous SNV	IL1RAPL2:NM_017416:exon9:c.T1059C:p.Y353Y,	0.17	0.17	0.17	rs3764765 [];					0.0901					0.075	0.025	0.9	14		
chrX	105152282	105152282	G	A	hom	222	NRK	nonsynonymous SNV	NRK:NM_198465:exon12:c.G1072A:p.V358M,	0.31	0.31	0.31	rs209373 [];	-0.0130		0.2700	0.0010	0.2166					0.175	0.075	0.75	47		
chrX	105153001	105153001	A	G	hom	222	NRK	synonymous SNV	NRK:NM_198465:exon13:c.A1368G:p.K456K,	1	1	1	rs209372 [];										0.9625	0	0.0375	145		
chrX	105179132	105179132	C	T	hom	222	NRK			0.53	0.53	0.53	rs209095 [];					0.6170					0.2375	0.025	0.7375	46		
chrX	105200690	105200690	G	T	hom	222	NRK			0.17	0.17	0.17	rs41304468 [];										0.175	0.075	0.75	24		
chrX	105201635	105201635	A	G	hom	222	NRK			0.31	0.31	0.31	rs209109 [];										0.1875	0.075	0.7375	25		
chrX	105202600	105202600	A	T	hom	222	NRK			0.53	0.53	0.53	rs209111 [];										0.5375	0.025	0.4375	55		
chrX	105278361	105278361	C	A	hom	222	SERPINA7	nonsynonymous SNV	SERPINA7:NM_000354:exon4:c.G909T:p.L303F,	0.14	0.14	0.14	rs1804495 [];	0.3520	0.6527	0.0100	0.7350	0.1116				RCV000010442.1 [pathogenic]; RCV000010443.1 [other]; 	0.125	0	0.875	14		
chrX	105415129	105415129	A	G	hom	222	MUM1L1			0.99	0.99	0.99	rs5916976 [];										0.9375	0	0.0625	87		
chrX	105937221	105937221	A	G	hom	222	RNF128			0.0012	0.0012	0.0012	rs187766177 [];										0	0	1	0		
chrX	106184602	106184603	GA	-	het	217	MORC4			0	0	0								391			0	0.1625	0.8375	15		
chrX	106201494	106201494	T	C	hom	204	MORC4			0.03	0.03	0.03	rs17253746 [];										0.025	0.0125	0.9625	3		
chrX	106201527	106201527	G	C	hom	222	MORC4			0.03	0.03	0.03	rs17253753 [];					0.0823					0.025	0.0125	0.9625	3		
chrX	106367102	106367102	G	A	hom	222	NUP62CL			0.55	0.55	0.55	rs1285582 [];										0.3	0.05	0.65	32		
chrX	107019298	107019298	-	G	hom	156	TSC22D3			0	0	0	rs66853123 [];										0.4375	0	0.5625	46		
chrX	107084075	107084075	A	C	hom	222	MID2	synonymous SNV	MID2:NM_012216:exon2:c.A180C:p.S60S,MID2:NM_052817:exon2:c.A180C:p.S60S,	0.11	0.11	0.11	rs2236083 [];					0.0645					0.0625	0.025	0.9125	8		
chrX	107174169	107174169	T	A	hom	222	MID2			0.16	0.16	0.16	rs742584 [];										0.1625	0.0375	0.8	17		
chrX	107328436	107328436	G	A	hom	222	PSMD10			0.79	0.79	0.79	rs807178 [];					0.6696					0.2625	0.025	0.7125	45		
chrX	107330842	107330842	G	T	hom	210	PSMD10			0.24	0.24	0.24	rs59547029 [];										0.1625	0.025	0.8125	22		
chrX	107332134	107332134	A	-	hom	77.5	PSMD10			0.32	0.32	0.32	rs201894843 [];										0.175	0.0125	0.8125	22		
chrX	107393331	107393331	-	G	hom	214	ATG4A			0	0	0	rs3215492 [];										0.175	0.0125	0.8125	22		
chrX	107396365	107396365	G	A	hom	222	ATG4A			0.38	0.38	0.38	rs1883411 [];					0.4619					0.175	0.0125	0.8125	30		
chrX	107399421	107399421	T	C	hom	222	COL4A6			0.37	0.37	0.37	rs5973850 [];										0.425	0.025	0.55	47		
chrX	107399513	107399513	A	G	hom	222	COL4A6			0.37	0.37	0.37	rs1042071 [];										0.4125	0.025	0.5625	46		
chrX	107415825	107415825	T	C	hom	222	COL4A6			0.99	0.99	0.99	rs2881142 [];					1.0000					0.4375	0	0.5625	74		
chrX	107418281	107418281	C	T	hom	222	COL4A6			0.51	0.51	0.51	rs2295914 [];					0.7718					0.35	0	0.65	60		
chrX	107418906	107418906	A	G	hom	222	COL4A6	synonymous SNV	COL4A6:NM_033641:exon29:c.T2808C:p.R936R,COL4A6:NM_001847:exon29:c.T2811C:p.R937R,	0.99	0.99	0.99	rs4623610 [];					0.9999					0.95	0	0.05	143		
chrX	107423698	107423701	CACA	-	hom	214	COL4A6			0	0	0								294			0	0	1	0		
chrX	107430579	107430579	G	A	hom	222	COL4A6			0.59	0.59	0.59	rs1266715 [];										0.35	0	0.65	37		
chrX	107433688	107433688	A	G	hom	222	COL4A6	nonsynonymous SNV	COL4A6:NM_033641:exon20:c.T1360C:p.S454P [1(stomach)]; COL4A6:NM_001847:exon20:c.T1363C:p.S455P [1(stomach)]; 	0.59	0.59	0.59	rs1042065 [];	-0.3780	0.0000	1.0000	0.0000	0.7949	150805 [1(stomach)]; 				0.725	0	0.275	108		
chrX	107437848	107437848	G	C	hom	222	COL4A6			0.48	0.48	0.48	rs1266719 [];	-1.6180				0.7742					0.35	0	0.65	73		
chrX	107438119	107438119	G	T	hom	222	COL4A6			0.59	0.59	0.59	rs1266720 [];										0.35	0	0.65	37		
chrX	107448639	107448639	G	T	hom	222	COL4A6			0.6	0.6	0.6	rs1266730 [];					0.7947	COSN168790 [1(large_intestine)]; 				0.35	0	0.65	74		
chrX	107455014	107455014	C	T	hom	222	COL4A6			0.99	0.99	0.99	rs1266736 [];					0.9999					0.4375	0	0.5625	61		
chrX	107463091	107463102	CCATATTGTATT	-	hom	214	COL4A6			0.49	0.49	0.49	rs201304389 [];										0.35	0	0.65	37		
chrX	107510915	107510915	G	-	hom	214	COL4A6			0.89	0.89	0.89	rs11351626 [];							725			0.9375	0	0.0625	87		
chrX	107511012	107511012	G	A	hom	222	COL4A6			0.89	0.89	0.89	rs1266765 [];							725			0.9625	0	0.0375	89		
chrX	107511150	107511150	T	C	hom	222	COL4A6			0.07	0.07	0.07	rs41304064 [];							1067			0.125	0.0125	0.8625	13		
chrX	107511430	107511430	C	T	hom	222	COL4A6			0.49	0.49	0.49	rs1266766 [];							1067			0.7125	0	0.2875	66		
chrX	107908690	107908690	-	ACATTAGTTTTATAAAAC	het	9.93	COL4A5			0	0	0									303630 [Collagen IV, alpha-5 polypeptide - Alport syndrome, 301050 (3)];		0	0	1	0		
chrX	107940920	107940920	-	AT	hom	214	COL4A5			0	0	0	rs66932703 [];										0.4375	0	0.5625	46		
chrX	108708516	108708516	C	T	hom	222	GUCY2F	nonsynonymous SNV	GUCY2F:NM_001522:exon3:c.G887A:p.R296Q,	0.92	0.92	0.92	rs502209 [];	0.6690	0.0000	0.6500	0.0000	0.8320					0.8375	0.025	0.1375	124		
chrX	108708552	108708552	A	G	hom	222	GUCY2F	nonsynonymous SNV	GUCY2F:NM_001522:exon3:c.T851C:p.L284P,	0.19	0.19	0.19	rs12008095 [];	1.7640	0.9843	0.2100	0.8410	0.3671					0.3	0.05	0.65	55		
chrX	108725136	108725136	G	A	hom	222	GUCY2F			0.23	0.23	0.23	rs494589 [];										0.325	0.05	0.625	34		
chrX	108786314	108786314	G	A	hom	222	NXT2			0.35	0.35	0.35	rs5943382 [];										0.3125	0.05	0.6375	33		
chrX	108787014	108787014	T	C	hom	222	NXT2			0.19	0.19	0.19	rs3204027 [];										0.3125	0.0625	0.625	34		
chrX	108904729	108904729	C	T	hom	213	ACSL4			1	1	1	rs839408 [];					0.9923			300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.4375	0	0.5625	96		
chrX	108917757	108917757	T	C	hom	222	ACSL4			0.31	0.31	0.31	rs5942830 [];					0.5668			300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.2	0.0625	0.7375	37		
chrX	108917773	108917773	A	G	hom	222	ACSL4			0.31	0.31	0.31	rs5943413 [];								300157 [Acyl-CoA synthetase long-chain family member 4 - Mental retardation, X-linked nonspecific, 63, 300387 (3)];		0.2	0.0625	0.7375	26		
chrX	109416702	109416702	T	-	hom	5.07	TMEM164			0	0	0											0.075	0	0.925	8		
chrX	109419165	109419165	G	A	hom	222	TMEM164			0.64	0.64	0.64	rs2795995 [];										0.3	0.05	0.65	33		
chrX	109439634	109439634	T	G	hom	222	AMMECR1			0.1	0.1	0.1	rs76491193 [];							279			0.2	0.0125	0.7875	20		
chrX	109694685	109694685	T	A	hom	222	RGAG1	synonymous SNV	RGAG1:NM_020769:exon3:c.T840A:p.G280G,	0.36	0.36	0.36	rs2073787 [];					0.4144					0.2875	0.0625	0.65	55		
chrX	109698759	109698759	G	T	hom	222	RGAG1			0.35	0.35	0.35	rs2073785 [];										0.3125	0.0625	0.625	35		
chrX	109763603	109763603	G	C	hom	222	TDGF1P3			0.34	0.34	0.34	rs5942955 [];										0.3375	0.075	0.5875	39		
chrX	109763753	109763753	G	A	hom	222	TDGF1P3			0	0	0	rs5942956 [];										0.325	0.1	0.575	41		
chrX	109763937	109763937	-	T	hom	158	TDGF1P3			0	0	0											0.275	0.075	0.65	34		
chrX	109765216	109765216	C	T	hom	202	TDGF1P3			0.31	0.31	0.31	rs5942642 [];							2240			0.3125	0.075	0.6125	37		
chrX	109766154	109766154	-	AA	hom	64.5	TDGF1P3			0	0	0											0.05	0.15	0.8	20		
chrX	109918851	109918851	C	T	hom	222	CHRDL1			0.34	0.34	0.34	rs2223782 [];										0.3375	0.075	0.5875	39		
chrX	109918881	109918881	C	A	hom	222	CHRDL1			0.34	0.34	0.34	rs2404177 [];										0.3375	0.075	0.5875	39		
chrX	109918933	109918938	GTGTGT	-	hom	214	CHRDL1			0	0	0								342			0.1625	0.0625	0.775	20		
chrX	109918954	109918957	GGAG	-	hom	214	CHRDL1			0	0	0								290			0.1125	0.025	0.8625	13		
chrX	109931799	109931799	A	G	hom	222	CHRDL1			0.37	0.37	0.37	rs5943052 [];					0.3919					0.1375	0.0625	0.8	32		
chrX	109931856	109931856	T	C	hom	222	CHRDL1	synonymous SNV	CHRDL1:NM_001143983:exon7:c.A714G:p.K238K,CHRDL1:NM_001143981:exon9:c.A954G:p.K318K,CHRDL1:NM_001143982:exon9:c.A951G:p.K317K,CHRDL1:NM_145234:exon9:c.A951G:p.K317K,	0.37	0.37	0.37	rs5943053 [];					0.3968					0.35	0.075	0.575	65		
chrX	110248758	110248758	G	T	hom	222	PAK3			0.91	0.91	0.91	rs4893477 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9625	0	0.0375	89		
chrX	110248776	110248776	C	T	hom	222	PAK3			0.92	0.92	0.92	rs4893478 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9625	0	0.0375	89		
chrX	110368113	110368113	-	A	hom	214	PAK3			0	0	0									300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9	0	0.1	84		
chrX	110368657	110368657	T	A	hom	222	PAK3			0.93	0.93	0.93	rs1361321 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.9875	0	0.0125	91		
chrX	110368829	110368829	A	G	hom	222	PAK3			1	1	1	rs77566096 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.95	0	0.05	88		
chrX	110371452	110371452	T	C	hom	222	PAK3			0.86	0.86	0.86	rs5943137 [];								300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0.95	0.0125	0.0375	89		
chrX	110435664	110435664	-	TTATTTTC	het	8.18	PAK3			0	0	0									300142 [p21-activated kinase-3 - Mental retardation, X-linked 30/47, 300558 (3)];		0	0	1	0		
chrX	110489520	110489520	A	G	hom	222	CAPN6			0.98	0.98	0.98	rs6642884 [];										0.95	0.0125	0.0375	93		
chrX	110513652	110513654	TGC	-	het	55.5	CAPN6			0	0	0								423			0	0	1	0		
chrX	110543234	110543235	CA	-	het	52.5	DCX			0	0	0								234	300121 [Doublecortin - Lissencephaly, X-linked, 300067 (3); Subcortical laminalheteropia, X-linked, 300067 (3)];		0	0.2375	0.7625	52		
chrX	111017461	111017461	T	C	hom	185	TRPC5			0.0024	0.0024	0.0024	rs145481512 [];										0	0	1	0		
chrX	111923376	111923376	C	T	hom	68.3	LHFPL1			0.74	0.74	0.74	rs75345634 [];							297			0.1	0.5375	0.3625	59		
chrX	113818582	113818582	G	C	hom	222	HTR2C			0.29	0.29	0.29	rs518147 [];										0.325	0.0625	0.6125	36		
chrX	113961410	113961410	G	A	hom	222	HTR2C			0.17	0.17	0.17	rs2248440 [];					0.1739					0.0625	0.0375	0.9	23		
chrX	113965735	113965735	G	C	hom	222	HTR2C	nonsynonymous SNV	HTR2C:NM_001256760:exon5:c.G68C:p.C23S,HTR2C:NM_001256761:exon4:c.G68C:p.C23S,HTR2C:NM_000868:exon4:c.G68C:p.C23S,	0.17	0.17	0.17	rs6318 [];	0.5860	0.0039	0.4100	0.0690	0.1752				RCV000010563.1 [non-pathogenic]; 	0.1375	0.0375	0.825	31		
chrX	114238774	114238774	T	G	hom	222	IL13RA2			0.07	0.07	0.07	rs17094994 [];										0.0625	0.0375	0.9	9		
chrX	114239897	114239897	C	T	hom	222	IL13RA2			0.07	0.07	0.07	rs17095003 [];					0.1589					0.0625	0.0375	0.9	17		
chrX	114400318	114400318	T	G	hom	222	LRCH2			0.94	0.94	0.94	rs4361922 [];										0.4375	0	0.5625	46		
chrX	114753754	114753762	AATTGGTGA	-	hom	214	LUZP4;PLS3		LUZP4:dist=211633;PLS3:dist=41415	0.19	0.19	0.19	rs141856697 [];										0.3375	0.0375	0.625	34		
chrX	114827827	114827827	C	T	hom	222	PLS3			0.08	0.08	0.08	rs12847396 [];										0.05	0.025	0.925	9		
chrX	114883932	114883932	G	T	hom	222	PLS3			0	0	0											0	0	1	0		
chrX	114952661	114952661	-	TT	hom	79.5	PLS3;AGTR2		PLS3:dist=67482;AGTR2:dist=349297	0	0	0											0.05	0.025	0.925	7		
chrX	114953061	114953061	A	T	hom	222	PLS3;AGTR2		PLS3:dist=67882;AGTR2:dist=348897	0.09	0.09	0.09	rs5988005 [];										0.125	0.025	0.85	14		
chrX	115586325	115586325	G	A	hom	222	SLC6A14			0.45	0.45	0.45	rs5905287 [];										0.1875	0.05	0.7625	22		
chrX	117031744	117031744	A	G	hom	222	KLHL13			0.05	0.05	0.05	rs62609214 [];										0.025	0.025	0.95	5		
chrX	117032973	117032973	C	G	hom	222	KLHL13	synonymous SNV	KLHL13:NM_033495:exon7:c.G1866C:p.L622L,KLHL13:NM_001168303:exon7:c.G1740C:p.L580L,KLHL13:NM_001168299:exon8:c.G1875C:p.L625L,KLHL13:NM_001168302:exon8:c.G1818C:p.L606L,KLHL13:NM_001168300:exon7:c.G1848C:p.L616L,KLHL13:NM_001168301:exon8:c.G1818C:p.L606L,	0.17	0.17	0.17	rs6645983 [];					0.0762					0.1125	0.025	0.8625	22		
chrX	117053499	117053499	C	T	hom	222	KLHL13	synonymous SNV	KLHL13:NM_033495:exon4:c.G555A:p.V185V,KLHL13:NM_001168303:exon4:c.G429A:p.V143V,KLHL13:NM_001168299:exon5:c.G564A:p.V188V,KLHL13:NM_001168302:exon5:c.G507A:p.V169V,KLHL13:NM_001168300:exon4:c.G537A:p.V179V,KLHL13:NM_001168301:exon5:c.G507A:p.V169V,	0.22	0.22	0.22	rs6645994 [];					0.0762					0.1125	0.025	0.8625	20		
chrX	117106630	117106630	A	G	hom	174	KLHL13			0.14	0.14	0.14	rs6646017 [];										0.025	0.025	0.95	5		
chrX	117584008	117584008	C	A	hom	196	WDR44			1	1	1	rs5910351 [];										0.4375	0	0.5625	46		
chrX	117700141	117700141	A	G	hom	222	DOCK11	synonymous SNV	DOCK11:NM_144658:exon8:c.A867G:p.A289A [1(prostate)]; 	0.37	0.37	0.37	rs2286977 [];					0.3699	1179702 [1(prostate)]; 				0.375	0.0625	0.5625	68		
chrX	117727327	117727327	T	C	hom	222	DOCK11			0.25	0.25	0.25	rs5909551 [];					0.3676					0.15	0.0375	0.8125	29		
chrX	117742356	117742356	C	T	hom	222	DOCK11			0.57	0.57	0.57	rs5910394 [];					0.5792					0.225	0.0375	0.7375	39		
chrX	117810831	117810831	C	T	hom	222	DOCK11			0.59	0.59	0.59	rs5957040 [];							989			0.3125	0.0375	0.65	35		
chrX	117817266	117817266	C	T	hom	222	DOCK11			0.92	0.92	0.92	rs4372173 [];										0.3875	0.0375	0.575	44		
chrX	117874898	117874898	T	C	hom	222	IL13RA1			0.96	0.96	0.96	rs2246663 [];										0.3875	0.0375	0.575	45		
chrX	117973846	117973846	A	C	hom	175	ZCCHC12;LONRF3		ZCCHC12:dist=12915;LONRF3:dist=134867	0.47	0.47	0.47	rs5910424 [];										0.1875	0.05	0.7625	23		
chrX	117979189	117979190	TT	-	hom	134	ZCCHC12;LONRF3		ZCCHC12:dist=18258;LONRF3:dist=129523	0	0	0	rs202152657 [];										0.35	0.05	0.6	36		
chrX	117979899	117979899	-	TG	hom	26.5	ZCCHC12;LONRF3		ZCCHC12:dist=18968;LONRF3:dist=128814	0	0	0											0.1125	0	0.8875	12		
chrX	118108785	118108785	T	C	hom	222	LONRF3	synonymous SNV	LONRF3:NM_001031855:exon1:c.T42C:p.A14A,LONRF3:NM_024778:exon1:c.T42C:p.A14A,	0.52	0.52	0.52	rs3813933 [];					0.4261					0.3875	0.0875	0.525	65		
chrX	118146810	118146810	C	T	hom	222	LONRF3			0.36	0.36	0.36	rs5910481 [];										0.15	0.075	0.775	23		
chrX	118533299	118533299	A	G	hom	191	SLC25A43			0.86	0.86	0.86	rs217975 [];										0.75	0.0125	0.2375	71		
chrX	118533366	118533366	G	A	hom	142	SLC25A43			0.71	0.71	0.71	rs217976 [];										0.6	0.0375	0.3625	64		
chrX	118533550	118533550	G	A	het	42.8	SLC25A43	nonsynonymous SNV	SLC25A43:NM_145305:exon1:c.G184A:p.A62T,	0	0	0		-0.9410	0.0009	0.6100	0.0050						0	0	1	0		
chrX	118544448	118544448	T	C	hom	222	SLC25A43			0.98	0.98	0.98	rs16274 [];										0.4	0	0.6	42		
chrX	118587003	118587003	C	T	hom	222	SLC25A43	nonsynonymous SNV	SLC25A43:NM_145305:exon5:c.C1001T:p.P334L,	0.55	0.55	0.55	rs3810755 [];	0.6530	0.0000	0.8700	0.0000	0.5796					0.6125	0.0375	0.35	90		
chrX	118587669	118587669	T	G	hom	222	SLC25A43			0.55	0.55	0.55	rs3747454 [];							1810			0.5625	0.0375	0.4	53		
chrX	118588371	118588371	C	T	hom	222	SLC25A43			0.55	0.55	0.55	rs10907045 [];										0.575	0.0375	0.3875	53		
chrX	118600323	118600323	T	C	hom	222	SLC25A5-AS1			0.09	0.09	0.09	rs12010266 [];										0.075	0.025	0.9	8		
chrX	118601473	118601473	T	C	hom	222	SLC25A5-AS1			0.78	0.78	0.78	rs392020 [];										0.7	0.0625	0.2375	71		
chrX	118601707	118601707	A	G	hom	222	SLC25A5-AS1			0.64	0.64	0.64	rs6603508 [];										0.575	0.025	0.4	54		
chrX	118602222	118602222	G	C	hom	126	SLC25A5-AS1			0.19	0.19	0.19	rs62599439 [];										0.05	0.0125	0.9375	7		
chrX	118602246	118602246	T	C	hom	63	SLC25A5-AS1			0.06	0.06	0.06	rs62599440 [];										0.05	0.0125	0.9375	5		
chrX	118603844	118603844	T	G	hom	222	SLC25A5	nonsynonymous SNV	SLC25A5:NM_001152:exon2:c.T332G:p.L111R,	0.77	0.77	0.77	rs371749 [];	0.9400	0.0022	1.0000	0.0000						0.15	0.6375	0.2125	115		
chrX	118604436	118604436	T	C	hom	222	SLC25A5	synonymous SNV	SLC25A5:NM_001152:exon3:c.T699C:p.T233T,	0.78	0.78	0.78	rs12390 [];					0.7570					0.7	0.0625	0.2375	115		
chrX	118604554	118604554	-	A	hom	214	SLC25A5			0	0	0	rs3216181 [];										0.3	0.05	0.65	34		
chrX	118699320	118699320	A	G	hom	222	CXorf56			0.94	0.94	0.94	rs5910616 [];					0.8579					0.7875	0.05	0.1625	125		
chrX	118718417	118718417	-	TT	het	64.5	UBE2A			0	0	0											0	0.0875	0.9125	11		
chrX	118751103	118751112	GTGTGTGTGT	-	het	217	SEPT6			0	0	0								489			0.075	0.0625	0.8625	14		
chrX	118751218	118751218	-	T	hom	214	SEPT6			0	0	0											0.0375	0.025	0.9375	5		
chrX	118783881	118783881	G	A	hom	222	SEPT6			0.25	0.25	0.25	rs6603539 [];					0.1421					0.0625	0.0125	0.925	12		
chrX	118787022	118787022	A	T	hom	222	SEPT6			0.17	0.17	0.17	rs5957203 [];					0.1428					0.0625	0.0125	0.925	12		
chrX	118827317	118827317	A	C	hom	222	SEPT6			0.59	0.59	0.59	rs17261138 [];										0.525	0.075	0.4	57		
chrX	118920809	118920809	C	T	hom	179	RPL39			0.36	0.36	0.36	rs7885997 [];										0.1625	0.0625	0.775	22		
chrX	118921530	118921530	A	C	hom	222	RPL39			0.28	0.28	0.28	rs73214964 [];										0.15	0.0625	0.7875	20		
chrX	118921593	118921593	T	C	hom	222	RPL39			0.28	0.28	0.28	rs34447789 [];										0.15	0.0625	0.7875	20		
chrX	118925705	118925705	C	T	hom	179	RPL39			0.3	0.3	0.3	rs2240448 [];										0.15	0.05	0.8	20		
chrX	119054001	119054001	C	T	hom	222	AKAP14			0.26	0.26	0.26	rs3829719 [];					0.2710					0.125	0.0625	0.8125	17		
chrX	119065893	119065893	G	A	hom	222	NKAP			0.65	0.65	0.65	rs194302 [];					0.5431					0.5125	0.0625	0.425	87		
chrX	119068419	119068419	-	A	hom	13.6	NKAP			0	0	0								2309			0	0	1	0		
chrX	119070411	119070411	T	A	hom	222	NKAP			0.58	0.58	0.58	rs194307 [];					0.5317					0.2375	0.05	0.7125	41		
chrX	119070567	119070567	A	T	hom	222	NKAP			0.58	0.58	0.58	rs194308 [];					0.5042					0.525	0.0625	0.4125	80		
chrX	119071803	119071803	C	T	hom	188	NKAP			0.24	0.24	0.24	rs11797947 [];										0.275	0.0875	0.6375	31		
chrX	119387842	119387842	-	GTG	het	151	ZBTB33	nonframeshift insertion	ZBTB33:NM_006777:exon2:c.572_573insGTG:p.D191delinsEC,ZBTB33:NM_001184742:exon3:c.572_573insGTG:p.D191delinsEC,	0	0	0								180			0	0	1	0		
chrX	119387854	119387854	-	ATG	hom	214	ZBTB33	nonframeshift insertion	ZBTB33:NM_006777:exon2:c.584_585insATG:p.V195delinsVC,ZBTB33:NM_001184742:exon3:c.584_585insATG:p.V195delinsVC,	0	0	0											0	0	1	0		
chrX	119389966	119389966	C	T	hom	222	ZBTB33			0.65	0.65	0.65	rs7882480 [];										0.6375	0.075	0.2875	66		
chrX	119390465	119390465	A	G	hom	222	ZBTB33			0.53	0.53	0.53	rs11537755 [];										0.5625	0.0875	0.35	60		
chrX	119391880	119391880	G	A	hom	222	ZBTB33			0.54	0.54	0.54	rs1044413 [];										0.5375	0.0875	0.375	57		
chrX	119392796	119392796	G	A	hom	222	TMEM255A			0.99	0.99	0.99	rs5910811 [];										0.9375	0	0.0625	91		
chrX	119394904	119394904	G	T	hom	222	TMEM255A			0.5	0.5	0.5	rs3752341 [];					0.6174					0.2125	0.075	0.7125	42		
chrX	119421167	119421167	C	A	hom	207	TMEM255A			0.29	0.29	0.29	rs45453700 [];							261			0.175	0.0125	0.8125	22		
chrX	120069150	120069150	G	A	hom	222	CT47A1;CT47A10;CT47A11;CT47A12;CT47A2;CT47A3;CT47A4;CT47A5;CT47A6;CT47A8;CT47A9			0	0	0	rs200454159 [];										0.325	0	0.675	36		
chrX	122318387	122318387	-	G	hom	214	GRIA3			0	0	0	rs66632982 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.975	0	0.025	210		
chrX	122336601	122336601	-	G	hom	214	GRIA3	frameshift insertion	GRIA3:NM_001256743:exon3:c.382_383insG:p.G128fs,	0	0	0	rs11452643 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.975	0	0.025	157		
chrX	122338205	122338205	T	A	hom	222	GRIA3			0.14	0.14	0.14	rs41312596 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.1	0.0625	0.8375	23		
chrX	122338415	122338415	A	G	hom	222	GRIA3			0.01	0.01	0.01	rs113256877 [];								305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.0375	0	0.9625	7		
chrX	122528803	122528803	T	C	hom	222	GRIA3			0.59	0.59	0.59	rs550640 [];					0.6112			305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.2625	0.05	0.6875	65		
chrX	122537277	122537277	T	C	hom	222	GRIA3	synonymous SNV	GRIA3:NM_000828:exon9:c.T1200C:p.N400N,GRIA3:NM_007325:exon9:c.T1200C:p.N400N,	0.6	0.6	0.6	rs502434 [];					0.6116			305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.6	0.0625	0.3375	141		
chrX	122537418	122537418	C	T	hom	222	GRIA3			0.62	0.62	0.62	rs504096 [];					0.6090			305915 [Glutamate receptor, ionotropic, AMPA 3 - Mental retardation, X-linked 94, 300699 (3)];		0.2625	0.05	0.6875	65		
chrX	122735221	122735221	G	C	hom	222	THOC2			0.44	0.44	0.44	rs2473181 [];										0.125	0.0625	0.8125	31		
chrX	122758529	122758529	G	A	hom	222	THOC2			0.46	0.46	0.46	rs2072914 [];					0.3129					0.3125	0.05	0.6375	89		
chrX	122761967	122761967	T	C	hom	201	THOC2			0.47	0.47	0.47	rs2498051 [];										0.1375	0.0375	0.825	15		
chrX	122765750	122765750	T	C	hom	209	THOC2			0.39	0.39	0.39	rs3764750 [];					0.2993					0.125	0.0375	0.8375	29		
chrX	122779301	122779301	A	C	hom	222	THOC2			0.0024	0.0024	0.0024	rs145692199 [];										0	0	1	0		
chrX	123034511	123034511	A	C	hom	222	XIAP	nonsynonymous SNV	XIAP:NM_001167:exon6:c.A1268C:p.Q423P,XIAP:NM_001204401:exon6:c.A1268C:p.Q423P,	0.33	0.33	0.33	rs5956583 [];	1.7090	0.0307	0.0200	0.0020	0.3536			300079 [Inhibitor of apoptosis, X-linked - Lymphoproliferative syndrome, X-linked, 2, 300635 (3)];		0.3625	0.0875	0.55	87		
chrX	123047668	123047668	G	C	het	66	XIAP			0	0	0	rs114568994 [];								300079 [Inhibitor of apoptosis, X-linked - Lymphoproliferative syndrome, X-linked, 2, 300635 (3)];		0	0.225	0.775	28		
chrX	123047709	123047709	G	A	het	105	XIAP			0	0	0	rs72610614 [];								300079 [Inhibitor of apoptosis, X-linked - Lymphoproliferative syndrome, X-linked, 2, 300635 (3)];		0	0.2125	0.7875	28		
chrX	123480147	123480147	C	T	hom	222	SH2D1A			0.51	0.51	0.51	rs12164382 [];								300490 [SH2 domain protein 1A - Lymphoproliferative syndrome, X-linked, 308240 (3)];		0.325	0.0625	0.6125	72		
chrX	123506104	123506104	T	A	hom	222	SH2D1A			0.79	0.79	0.79	rs7876065 [];								300490 [SH2 domain protein 1A - Lymphoproliferative syndrome, X-linked, 308240 (3)];		0.875	0	0.125	137		
chrX	123513104	123513104	T	G	hom	222	TENM1			0.98	0.98	0.98	rs5958476 [];										0.925	0.025	0.05	91		
chrX	123514006	123514006	G	A	hom	222	TENM1			0.33	0.33	0.33	rs6648597 [];										0.1375	0.0125	0.85	14		
chrX	123540315	123540315	G	T	hom	222	TENM1	synonymous SNV	TENM1:NM_001163279:exon26:c.C5004A:p.T1668T,TENM1:NM_014253:exon25:c.C4986A:p.T1662T,TENM1:NM_001163278:exon26:c.C5007A:p.T1669T,	0.4	0.4	0.4	rs960869 [];					0.4217					0.3375	0.0375	0.625	57		
chrX	123554646	123554646	T	C	hom	222	TENM1	synonymous SNV	TENM1:NM_001163279:exon25:c.A4494G:p.A1498A,TENM1:NM_014253:exon24:c.A4476G:p.A1492A,TENM1:NM_001163278:exon25:c.A4497G:p.A1499A,	0.16	0.16	0.16	rs12013090 [];					0.1293					0.1625	0.0375	0.8	28		
chrX	123554726	123554726	A	G	hom	222	TENM1			0.11	0.11	0.11	rs2076164 [];										0.1	0.05	0.85	14		
chrX	125686536	125686536	T	C	hom	52	DCAF12L1	nonsynonymous SNV	DCAF12L1:NM_178470:exon1:c.A56G:p.D19G,	0.11	0.11	0.11	rs11095722 [];	-1.3500	0.0000	0.5300	0.0000	0.0269					0.025	0	0.975	4		
chrX	128925156	128925156	T	G	hom	130	SASH3			0.26	0.26	0.26	rs5932684 [];							507			0.075	0.0375	0.8875	13		
chrX	128927890	128927890	T	C	hom	207	SASH3			0.75	0.75	0.75	rs859577 [];										0.4	0.0625	0.5375	44		
chrX	128938958	128938958	T	C	hom	222	ZDHHC9			0.67	0.67	0.67	rs1053486 [];								300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.95	0	0.05	154		
chrX	128948893	128948893	T	C	hom	222	ZDHHC9			0.94	0.94	0.94	rs5932686 [];								300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.4375	0	0.5625	46		
chrX	128957640	128957640	T	C	hom	222	ZDHHC9			0.81	0.81	0.81	rs2275605 [];					0.9894			300646 [Zinc finger DHHC domain-containing protein 9 - Mental retardation, X-linked, ZDHHC9-related, 300799 (3)];		0.425	0	0.575	104		
chrX	128978131	128978131	G	A	hom	222	ZDHHC9			0	0	0											0.0125	0	0.9875	1		
chrX	129147079	129147079	T	C	hom	222	BCORL1	nonsynonymous SNV	BCORL1:NM_021946:exon3:c.T331C:p.F111L,	1	1	1	rs4830173 [];	1.0250	0.0000	0.3700	0.0000						0.9375	0	0.0625	139		
chrX	129159287	129159287	C	T	hom	222	BCORL1	synonymous SNV	BCORL1:NM_021946:exon6:c.C4011T:p.S1337S,	0.0006	0.0006	0.0006	rs138530347 [];					0.0036					0	0	1	1		
chrX	129200301	129200301	C	G	hom	222	ELF4			0.27	0.27	0.27	rs3788845 [];										0.2125	0.05	0.7375	23		
chrX	129244261	129244261	C	G	hom	72.5	ELF4			1	1	1	rs210015 [];										0.225	0	0.775	23		
chrX	129244268	129244268	C	G	hom	102	ELF4			1	1	1	rs210016 [];										0.2375	0	0.7625	24		
chrX	129269980	129269980	G	A	hom	222	AIFM1			0.44	0.44	0.44	rs209998 [];					0.3964			300169 [Apoptosis-inducing factor, mitochondrion-associated, 1 - Combined oxidative phosphorylation deficiency 6, 300816 (3)];		0.15	0.075	0.775	60		
chrX	129283520	129283520	A	G	hom	222	AIFM1	synonymous SNV	AIFM1:NM_145812:exon3:c.T261C:p.D87D,AIFM1:NM_004208:exon3:c.T273C:p.D91D,AIFM1:NM_001130847:exon3:c.T273C:p.D91D,	0.46	0.46	0.46	rs1139851 [];					0.3971			300169 [Apoptosis-inducing factor, mitochondrion-associated, 1 - Combined oxidative phosphorylation deficiency 6, 300816 (3)];		0.375	0.0875	0.5375	115		
chrX	129290699	129290699	T	C	hom	222	AIFM1			0.45	0.45	0.45	rs189994 [];								300169 [Apoptosis-inducing factor, mitochondrion-associated, 1 - Combined oxidative phosphorylation deficiency 6, 300816 (3)];		0.15	0.075	0.775	26		
chrX	129337831	129337831	C	T	hom	222	ZNF280C			0.48	0.48	0.48	rs593323 [];										0.375	0.0625	0.5625	47		
chrX	129338766	129338766	G	A	hom	222	ZNF280C			0.5	0.5	0.5	rs608117 [];										0.375	0.0625	0.5625	47		
chrX	129349295	129349295	T	G	hom	222	ZNF280C	synonymous SNV	ZNF280C:NM_017666:exon15:c.A1851C:p.G617G,	0.49	0.49	0.49	rs209238 [];					0.4010					0.3625	0.0875	0.55	79		
chrX	130220176	130220176	G	A	hom	222	ARHGAP36			0.23	0.23	0.23	rs16999801 [];										0.05	0.0125	0.9375	6		
chrX	130223137	130223137	G	A	hom	222	ARHGAP36			0.82	0.82	0.82	rs3810727 [];										0.8375	0.0625	0.1	84		
chrX	130223760	130223760	C	T	hom	222	ARHGAP36			0.16	0.16	0.16	rs3788 [];										0.1375	0.0125	0.85	13		
chrX	130408431	130408431	T	C	hom	222	IGSF1			0.73	0.73	0.73	rs6418944 [];										0.225	0.025	0.75	26		
chrX	130409884	130409884	A	T	hom	222	IGSF1			0.28	0.28	0.28	rs55936630 [];					0.3470					0.1375	0.0375	0.825	16		
chrX	130410965	130410965	A	G	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon14:c.T2556C:p.Y852Y,IGSF1:NM_001170961:exon14:c.T2571C:p.Y857Y,IGSF1:NM_001170962:exon13:c.T2529C:p.Y843Y,	0.27	0.27	0.27	rs4830219 [];					0.3472					0.2875	0.05	0.6625	58		
chrX	130412178	130412178	C	G	hom	222	IGSF1			0.72	0.72	0.72	rs4524963 [];										0.225	0.025	0.75	26		
chrX	130415818	130415818	T	C	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon8:c.A1347G:p.E449E,IGSF1:NM_001170961:exon8:c.A1347G:p.E449E,IGSF1:NM_001170962:exon7:c.A1320G:p.E440E,	0.56	0.56	0.56	rs1128617 [];					0.4475					0.4	0.0625	0.5375	74		
chrX	130416285	130416285	-	GT	hom	214	IGSF1			0	0	0	rs68177532 [];							228			0.1625	0.0625	0.775	21		
chrX	130416958	130416958	C	T	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon6:c.G948A:p.V316V,IGSF1:NM_001170961:exon6:c.G948A:p.V316V,IGSF1:NM_001170962:exon5:c.G921A:p.V307V,	0.92	0.92	0.92	rs5932877 [];					0.9991					0.975	0	0.025	143		
chrX	130419646	130419646	A	G	hom	222	IGSF1			0.96	0.96	0.96	rs4830221 [];										0.4375	0	0.5625	46		
chrX	130420006	130420006	T	C	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon4:c.A114G:p.P38P,IGSF1:NM_001170961:exon4:c.A114G:p.P38P,IGSF1:NM_001170963:exon4:c.A114G:p.P38P,IGSF1:NM_205833:exon4:c.A114G:p.P38P,IGSF1:NM_001170962:exon3:c.A87G:p.P29P,	0.96	0.96	0.96	rs5930458 [];					0.9999					0.9875	0	0.0125	144		
chrX	130420415	130420415	T	C	hom	222	IGSF1	synonymous SNV	IGSF1:NM_001555:exon3:c.A93G:p.S31S,IGSF1:NM_001170961:exon3:c.A93G:p.S31S,IGSF1:NM_001170963:exon3:c.A93G:p.S31S,IGSF1:NM_205833:exon3:c.A93G:p.S31S,	0.98	0.98	0.98	rs4495600 [];					0.9999					0.95	0	0.05	142		
chrX	130423359	130423359	C	G	hom	208	IGSF1			0.47	0.47	0.47	rs6637829 [];										0.1875	0.0375	0.775	24		
chrX	130533791	130533791	T	C	hom	222	IGSF1;OR13H1		IGSF1:dist=110388;OR13H1:dist=144257	0.65	0.65	0.65	rs2281669 [];										0.2875	0.0375	0.675	31		
chrX	130902745	130902748	CAAA	-	hom	214	LOC286467			0	0	0											0	0.0125	0.9875	1		
chrX	130938985	130938985	T	C	hom	222	LOC286467			0.56	0.56	0.56	rs6634843 [];										0.2625	0.075	0.6625	33		
chrX	130939010	130939010	T	C	hom	222	LOC286467			0.04	0.04	0.04	rs17250838 [];										0.1125	0.025	0.8625	15		
chrX	131203783	131203783	T	C	hom	222	MST4			0.27	0.27	0.27	rs5930544 [];										0.1625	0.025	0.8125	19		
chrX	131206596	131206596	-	T	hom	214	MST4			0	0	0											0.1625	0.025	0.8125	19		
chrX	131211235	131211235	T	A	hom	222	FRMD7			0.26	0.26	0.26	rs3764771 [];										0.3	0.05	0.65	35		
chrX	131212512	131212512	A	G	hom	222	FRMD7	synonymous SNV	FRMD7:NM_194277:exon12:c.T1533C:p.I511I [1(prostate)]; 	0.26	0.26	0.26	rs5977623 [];					0.3080	1132405 [1(prostate)]; 				0.3	0.0625	0.6375	51		
chrX	131212944	131212944	A	G	hom	222	FRMD7	synonymous SNV	FRMD7:NM_194277:exon12:c.T1101C:p.N367N,	0.07	0.07	0.07	rs7051368 [];					0.0979					0.1125	0.0375	0.85	22		
chrX	131231257	131231257	G	A	hom	183	FRMD7			0.19	0.19	0.19	rs2064650 [];					0.1952					0.075	0.0375	0.8875	20		
chrX	131231431	131231431	-	AC	het	105	FRMD7			0	0	0	rs72287532 [];							309			0.025	0.1	0.875	13		
chrX	131337579	131337590	GAGAGAGAGAGA	-	hom	90.7	RAP2C			0	0	0								504			0.0875	0.025	0.8875	10		
chrX	131348510	131348510	A	G	hom	222	RAP2C			0.04	0.04	0.04	rs41310444 [];					0.0758					0.0125	0.025	0.9625	7		
chrX	131518737	131518737	C	T	hom	222	MBNL3			0.35	0.35	0.35	rs3736748 [];					0.2889					0.1	0.0375	0.8625	31		
chrX	131803353	131803354	TC	-	hom	193	HS6ST2-AS1			0	0	0	rs10550199 [];							198			0.225	0.1	0.675	35		
chrX	132161159	132161159	G	A	hom	222	USP26	nonsynonymous SNV	USP26:NM_031907:exon1:c.C1090T:p.L364F,	0.03	0.03	0.03	rs35397110 [];	-0.9320	0.0002	0.6400	0.0070	0.0626					0.05	0.025	0.925	10		
chrX	132351016	132351017	AA	-	het	22.5	TFDP3			0	0	0											0	0.0125	0.9875	1		
chrX	132435030	132435030	T	G	hom	146	GPC4			0.03	0.03	0.03	rs41299096 [];										0.025	0.025	0.95	5		
chrX	132435036	132435036	A	G	hom	141	GPC4			0.03	0.03	0.03	rs41300203 [];										0.025	0.025	0.95	5		
chrX	133511988	133511988	G	A	hom	222	PHF6			0.82	0.82	0.82	rs5978001 [];					0.7439			300414 [PHD finger protein 6 - Borjeson-Forssman-Lehmann syndrome, 301900 (3)];		0.325	0.0625	0.6125	62		
chrX	133678852	133678852	G	A	hom	222	MGC16121			0.81	0.81	0.81	rs2503985 [];										0.35	0	0.65	37		
chrX	133680547	133680547	G	A	hom	114	MGC16121			0.54	0.54	0.54	rs757309 [];										0.2125	0.0125	0.775	26		
chrX	133955298	133955298	C	-	het	14.6	FAM122C			0	0	0											0.0125	0.0625	0.925	7		
chrX	134229381	134229381	T	C	hom	222	LINC00087			0.64	0.64	0.64	rs1135844 [];										0.6625	0.0625	0.275	74		
chrX	134493385	134493385	A	G	hom	222	ZNF449			0.23	0.23	0.23	rs2531372 [];										0.15	0.025	0.825	16		
chrX	134558119	134558119	C	T	hom	222	LINC00086			0.32	0.32	0.32	rs45601034 [];										0.3	0.05	0.65	33		
chrX	134654818	134654818	T	C	hom	222	DDX26B			0.95	0.95	0.95	rs1890584 [];										0.9375	0.025	0.0375	93		
chrX	134683864	134683864	A	G	hom	184	DDX26B			0.86	0.86	0.86	rs6635060 [];										0.425	0.0125	0.5625	46		
chrX	134708023	134708023	-	T	het	7.35	DDX26B			0	0	0											0	0.0375	0.9625	3		
chrX	134715274	134715274	G	A	hom	222	DDX26B			0.37	0.37	0.37	rs3737330 [];										0.175	0.05	0.775	23		
chrX	134947727	134947727	A	G	hom	181	CT45A5			0	0	0	rs6635166 [];										0.35	0	0.65	37		
chrX	134948034	134948034	A	G	hom	222	CT45A5	synonymous SNV	CT45A5:NM_001172288:exon3:c.T291C:p.N97N [1(prostate)]; CT45A5:NM_001007551:exon3:c.T291C:p.N97N [1(prostate)]; 	0.8	0.8	0.8	rs2034920 [];					0.7359	1178534 [1(prostate)]; 				0.8375	0.0125	0.15	129		
chrX	134971152	134971152	A	G	hom	37.5	CT45A6			0.24	0.24	0.24	rs3003343 [];							704			0.1375	0	0.8625	12		
chrX	134971176	134971176	T	C	hom	70.1	CT45A6			0.22	0.22	0.22	rs3003342 [];							704			0.2625	0.0125	0.725	25		
chrX	134971197	134971197	A	G	hom	68.1	CT45A6			0.24	0.24	0.24	rs3003341 [];							704			0.45	0	0.55	40		
chrX	134971230	134971230	T	C	hom	73.1	CT45A6			0	0	0	rs3003340 [];							704			0.55	0.025	0.425	48		
chrX	134993589	134993589	A	G	hom	222	SAGE1			0.99	0.99	0.99	rs4829798 [];										0.4375	0	0.5625	46		
chrX	135055694	135055694	T	C	hom	162	MMGT1			0.82	0.82	0.82	rs6635201 [];										0.4	0.0125	0.5875	41		
chrX	135080636	135080636	-	T	hom	199	SLC9A6			0	0	0									300231 [Solute carrier family 9 (sodium/hydrogen exchanger), member 6 - Mental retardation, X-linked syndromic, Christianson type, 300243 (3)];		0.2875	0.05	0.6625	58		
chrX	135129010	135129010	A	T	hom	222	SLC9A6			0.0024	0.0024	0.0024	rs10493 [];								300231 [Solute carrier family 9 (sodium/hydrogen exchanger), member 6 - Mental retardation, X-linked syndromic, Christianson type, 300243 (3)];		0.0125	0	0.9875	2		
chrX	135251689	135251689	-	A	hom	214	FHL1			0	0	0									300163 [Four-and-a-half LIM domains 1 - Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)];		0.6875	0	0.3125	105		
chrX	135252235	135252235	C	-	hom	180	FHL1			0.65	0.65	0.65	rs3215593 [];								300163 [Four-and-a-half LIM domains 1 - Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)];		0.325	0	0.675	33		
chrX	135292022	135292022	C	T	hom	222	FHL1			0.5	0.5	0.5	rs2076705 [];					0.4397		231	300163 [Four-and-a-half LIM domains 1 - Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)];		0.4125	0.0875	0.5	110		
chrX	135293082	135293082	G	A	hom	222	FHL1			0.52	0.52	0.52	rs9018 [];								300163 [Four-and-a-half LIM domains 1 - Scapuloperoneal myopathy, X-linked dominant, 300695 (3); Myopathy,X-linked, with postural muscle atrophy, 300696 (3); Myopathy, reducing body, X-linked, severe early-onset, 300717 (3); Myopathy, reducing body, X-linked,childhood-onset, 300718 (3); Emery-Dreifuss muscular dystrophy 6, X-linked, 300696 (3)];		0.4125	0.0625	0.525	92		
chrX	135296409	135296409	C	T	hom	222	MAP7D3			0.53	0.53	0.53	rs5930900 [];										0.4375	0.0875	0.475	49		
chrX	135297040	135297040	T	C	hom	222	MAP7D3			0.51	0.51	0.51	rs5975700 [];										0.4375	0.1	0.4625	50		
chrX	135307049	135307049	G	A	hom	222	MAP7D3			0.52	0.52	0.52	rs5929742 [];					0.5155					0.4125	0.0875	0.5	74		
chrX	135310785	135310785	T	C	hom	222	MAP7D3	nonsynonymous SNV	MAP7D3:NM_001173517:exon10:c.A1778G:p.Q593R [1(prostate)]; MAP7D3:NM_024597:exon11:c.A1883G:p.Q628R [1(prostate)]; MAP7D3:NM_001173516:exon11:c.A1829G:p.Q610R [1(prostate)]; 	0.53	0.53	0.53	rs2273221 [];	-2.1180	0.0001	0.3400	0.0030	0.5385	1132401 [1(prostate)]; 				0.425	0.0875	0.4875	76		
chrX	135313034	135313034	T	G	hom	222	MAP7D3	nonsynonymous SNV	MAP7D3:NM_001173517:exon8:c.A1400C:p.E467A,MAP7D3:NM_024597:exon9:c.A1505C:p.E502A,MAP7D3:NM_001173516:exon9:c.A1451C:p.E484A,	0.57	0.57	0.57	rs1055497 [];	-0.5270	0.0001	1.0000	0.0000	0.5457					0.4125	0.125	0.4625	78		
chrX	135323452	135323452	G	A	hom	222	MAP7D3			0.53	0.53	0.53	rs5975707 [];					0.5375					0.175	0.0625	0.7625	29		
chrX	135426693	135426693	A	G	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.A828G:p.I276M,	0.43	0.43	0.43	rs4829829 [];	-2.1900	0.0003	0.1900	0.0040	0.4761					0.425	0.1	0.475	80		
chrX	135426968	135426968	C	A	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.C1103A:p.P368H,	0.43	0.43	0.43	rs5930931 [];	0.2380	0.0029	0.0200	0.5990	0.4756					0.4375	0.1	0.4625	79		
chrX	135429503	135429503	C	A	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.C3638A:p.T1213N,	0.45	0.45	0.45	rs4829830 [];	-0.3470	0.0012	0.1900	0.0110	0.4786					0.45	0.0875	0.4625	80		
chrX	135430044	135430044	T	C	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon6:c.T4179C:p.T1393T,	0.51	0.51	0.51	rs877761 [];					0.4802					0.45	0.0875	0.4625	80		
chrX	135430483	135430483	T	C	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.T4618C:p.S1540P,	0.45	0.45	0.45	rs912002 [];	1.1950	0.0311	0.0000	0.9940	0.4790					0.45	0.1	0.45	81		
chrX	135431236	135431236	T	C	hom	222	GPR112	nonsynonymous SNV	GPR112:NM_153834:exon6:c.T5371C:p.F1791L [1(prostate)]; 	0.47	0.47	0.47	rs5930932 [];	-1.0130	0.0012	0.4200	0.0000	0.4799	1132400 [1(prostate)]; 				0.45	0.1	0.45	80		
chrX	135431358	135431358	C	T	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon6:c.C5493T:p.P1831P,	0.46	0.46	0.46	rs5930933 [];					0.4798					0.45	0.0875	0.4625	80		
chrX	135433718	135433718	A	G	hom	222	GPR112			0.03	0.03	0.03	rs150978520 [];					0.0470					0	0.025	0.975	3		
chrX	135438388	135438388	A	G	hom	222	GPR112			0.46	0.46	0.46	rs6635268 [];					0.4797					0.1875	0.075	0.7375	44		
chrX	135474420	135474420	C	A	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon17:c.C7941A:p.T2647T,	0.72	0.72	0.72	rs1329546 [];					0.6057					0.575	0.0375	0.3875	109		
chrX	135474445	135474447	GAT	-	hom	214	GPR112	nonframeshift deletion	GPR112:NM_153834:exon17:c.7966_7968del:p.2656_2656del,	0	0	0	rs34255702 [];					0.6067					0.575	0.05	0.375	112		
chrX	135480126	135480126	T	C	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon20:c.T8271C:p.F2757F,	0.75	0.75	0.75	rs5974595 [];					0.6069					0.5875	0.0375	0.375	98		
chrX	135496398	135496398	G	A	hom	222	GPR112	synonymous SNV	GPR112:NM_153834:exon25:c.G9117A:p.T3039T,	0.75	0.75	0.75	rs5930942 [];					0.6064					0.5875	0.0375	0.375	98		
chrX	135574099	135574099	-	TTTTTTTTTT	hom	113	BRS3			0	0	0											0.0375	0	0.9625	3		
chrX	135593629	135593629	C	T	hom	222	HTATSF1	synonymous SNV	HTATSF1:NM_001163280:exon10:c.C1725T:p.D575D,HTATSF1:NM_014500:exon9:c.C1725T:p.D575D,	0.1	0.1	0.1	rs3027849 [];					0.1337					0.0875	0.05	0.8625	20		
chrX	135829865	135829865	-	AAA	het	67.5	ARHGEF6			0	0	0									300267 [Rho guanine nucleotide exchange factor-6 - Mental retardation, X-linked nonspecific, type 46, 300436 (3)];		0	0	1	0		
chrX	135956107	135956107	G	A	het	225	RBMX			0	0	0	rs4020659 [];										0	0.7375	0.2625	73		
chrX	135956218	135956218	G	A	het	225	RBMX			0	0	0	rs75376102 [];										0	0.775	0.225	78		
chrX	135956342	135956342	C	G	het	225	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon9:c.G1135C:p.G379R,	0	0	0	rs72615484 [];	2.3130	0.9999	0.2900	0.9960						0	0.75	0.25	112		
chrX	135956370	135956370	G	A	het	172	RBMX	synonymous SNV	RBMX:NM_002139:exon9:c.C1107T:p.R369R,	0	0	0	rs74509382 [];										0	0.725	0.275	100		
chrX	135956391	135956391	A	G	het	164	RBMX	synonymous SNV	RBMX:NM_002139:exon9:c.T1086C:p.D362D,	0	0	0	rs34606958 [];										0	0.35	0.65	49		
chrX	135956408	135956408	A	G	het	225	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon9:c.T1069C:p.Y357H,	0	0	0	rs76876438 [];	1.9000	0.9932	0.0800	0.9690						0	0.7	0.3	113		
chrX	135958730	135958730	C	A	het	77	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon5:c.G473T:p.G158V,	0	0	0	rs78702689 [];	1.0750	0.9999	0.0900	0.3580						0	0.3	0.7	61		
chrX	135960119	135960119	C	T	het	165	RBMX	nonsynonymous SNV	RBMX:NM_002139:exon4:c.G343A:p.G115R [1(prostate)]; 	0	0	0	rs76812369 [];	2.3880	0.9991	0.1200	0.9960		1179950 [1(prostate)]; 				0	0.325	0.675	79		
chrX	135960147	135960147	-	AA	het	217	RBMX	frameshift insertion	RBMX:NM_002139:exon4:c.314_315insTT:p.P105fs,	0	0	0											0	0.575	0.425	107		
chrX	137793642	137793642	C	G	hom	152	FGF13			1	1	1	rs12849923 [];							228			0.9375	0	0.0625	88		
chrX	137793653	137793653	C	G	hom	156	FGF13			1	1	1	rs12849929 [];							228			0.9375	0	0.0625	88		
chrX	137821355	137821355	-	TTAGATATGCCTT	het	10.8	FGF13			0	0	0											0	0	1	0		
chrX	138633280	138633280	A	G	hom	222	F9	nonsynonymous SNV	F9:NM_000133:exon6:c.A580G:p.T194A,	0.16	0.16	0.16	rs6048 [];	-0.1180	0.0695	0.5400	0.0080	0.2983				RCV000011334.1 [other]; 	0.2625	0.075	0.6625	74		
chrX	138644917	138644917	G	A	hom	222	F9			0.16	0.16	0.16	rs440051 [];										0.1625	0.0375	0.8	42		
chrX	138645058	138645058	-	GT	hom	214	F9			0	0	0											0.1625	0.0375	0.8	41		
chrX	138724725	138724725	G	A	hom	222	MCF2			1	1	1	rs926563 [];										0.9375	0	0.0625	119		
chrX	138809002	138809002	T	C	hom	222	ATP11C			0.76	0.76	0.76	rs2805901 [];										0.925	0	0.075	89		
chrX	138811003	138811003	G	A	hom	222	ATP11C			0.95	0.95	0.95	rs2094702 [];					0.9992					0.975	0	0.025	121		
chrX	138825675	138825675	T	C	hom	181	ATP11C			0.99	0.99	0.99	rs1268015 [];					0.9998					0.4375	0	0.5625	67		
chrX	138897130	138897130	A	C	hom	222	ATP11C	nonsynonymous SNV	ATP11C:NM_001010986:exon5:c.T342G:p.C114W,ATP11C:NM_173694:exon5:c.T342G:p.C114W,	0.99	0.99	0.99	rs2491014 [];	0.9710	0.0000	1.0000	0.0000	0.9778					0.9125	0	0.0875	131		
chrX	139099429	139099429	T	G	hom	222	CXorf66;LOC389895		CXorf66:dist=51752;LOC389895:dist=74397	0.94	0.94	0.94	rs5907565 [];										0.9625	0	0.0375	89		
chrX	139099699	139099699	C	T	hom	220	CXorf66;LOC389895		CXorf66:dist=52022;LOC389895:dist=74127	0.76	0.76	0.76	rs56013383 [];										0.3375	0.0375	0.625	40		
chrX	139099828	139099828	T	A	hom	222	CXorf66;LOC389895		CXorf66:dist=52151;LOC389895:dist=73998	0.95	0.95	0.95	rs5909002 [];										0.9	0	0.1	84		
chrX	139100148	139100148	A	C	hom	24	CXorf66;LOC389895		CXorf66:dist=52471;LOC389895:dist=73678	0.68	0.68	0.68	rs17402 [];										0.5375	0.025	0.4375	51		
chrX	139100153	139100153	T	C	hom	5.45	CXorf66;LOC389895		CXorf66:dist=52476;LOC389895:dist=73673	0	0	0	rs17401 [];										0.25	0	0.75	22		
chrX	139863318	139863318	C	T	hom	222	RP1-177G6.2;CDR1		2:dist=66322;CDR1:dist=2107	0.88	0.88	0.88	rs5907055 [];										0.9625	0	0.0375	89		
chrX	139865162	139865162	G	A	hom	222	CDR1			0.12	0.12	0.12	rs6636116 [];										0.1	0.0125	0.8875	10		
chrX	140786796	140786796	G	A	hom	63	SPANXD;SPANXE			0.24	0.24	0.24	rs142076675 [];										0.1625	0	0.8375	15		
chrX	140983031	140983031	A	G	hom	199	MAGEC3			0.81	0.81	0.81	rs176023 [];					0.9845					0.4125	0	0.5875	72		
chrX	140983064	140983064	G	A	hom	222	MAGEC3	nonsynonymous SNV	MAGEC3:NM_138702:exon5:c.G919A:p.A307T,	0.76	0.76	0.76	rs176024 [];	-0.5680	0.0002	0.1300	0.0000	0.9518					0.8375	0.0125	0.15	131		
chrX	140983103	140983103	C	T	hom	222	MAGEC3	synonymous SNV	MAGEC3:NM_138702:exon5:c.C958T:p.L320L,	0.25	0.25	0.25	rs176025 [];					0.2629					0.225	0.025	0.75	44		
chrX	140983127	140983127	G	A	hom	222	MAGEC3	nonsynonymous SNV	MAGEC3:NM_138702:exon5:c.G982A:p.A328T,	0.68	0.68	0.68	rs176026 [];	0.6230	0.0000	0.4600	0.8110	0.9291					0.825	0.025	0.15	133		
chrX	140993852	140993852	C	G	het	211	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C662G:p.T221S,	0	0	0	rs176038 [];	-2.4900	0.0000	0.8100	0.0010						0.0125	0.475	0.5125	78		
chrX	140993875	140993875	G	C	het	225	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.G685C:p.A229P,	0	0	0	rs79206435 [];	0.0540	0.0003	0.7200	0.0530						0.0125	0.0875	0.9	25		
chrX	140993877	140993877	C	A	het	88	MAGEC1	synonymous SNV	MAGEC1:NM_005462:exon4:c.C687A:p.A229A,	0	0	0	rs176039 [];										0.0125	0.2125	0.775	31		
chrX	140993905	140993905	C	T	het	121	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C715T:p.P239S [2(stomach)]; 	0.41	0.41	0.41	rs176040 [];	-2.2120	0.0001	0.7300	0.0000		150830 [2(stomach)]; 				0.225	0.3	0.475	77		
chrX	140993913	140993913	C	G	het	77.3	MAGEC1	synonymous SNV	MAGEC1:NM_005462:exon4:c.C723G:p.S241S [1(stomach)]; 	0	0	0	rs176041 [];						150831 [1(stomach)]; 				0.25	0.3125	0.4375	83		
chrX	140994031	140994031	G	C	hom	176	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.G841C:p.V281L,	0.16	0.16	0.16	rs176044 [];	-2.1470	0.0000	1.0000	0.0000	0.1169					0.2625	0.0375	0.7	38		
chrX	140994123	140994123	C	G	het	61	MAGEC1	synonymous SNV	MAGEC1:NM_005462:exon4:c.C933G:p.S311S,	0	0	0	rs77196611 [];										0.025	0.3625	0.6125	48		
chrX	140994136	140994136	T	C	het	69	MAGEC1	synonymous SNV	MAGEC1:NM_005462:exon4:c.T946C:p.L316L,	0	0	0	rs78484597 [];										0.0125	0.3625	0.625	50		
chrX	140994171	140994171	C	G	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C981G:p.H327Q,	0.68	0.68	0.68	rs176047 [];	-2.3540	0.0001	1.0000	0.0000	0.7289					0.675	0.05	0.275	110		
chrX	140994591	140994591	C	G	hom	222	MAGEC1	nonsynonymous SNV	MAGEC1:NM_005462:exon4:c.C1401G:p.H467Q,	0.15	0.15	0.15	rs176048 [];	-3.6350	0.0016	0.6400	0.0000	0.2532					0.2375	0.0625	0.7	50		
chrX	141290865	141290865	C	T	hom	222	MAGEC2	synonymous SNV	MAGEC2:NM_016249:exon3:c.G909A:p.P303P,	0.73	0.73	0.73	rs3765272 [];					0.7001					0.6375	0.0375	0.325	105		
chrX	141293039	141293039	T	C	hom	222	MAGEC2			0.66	0.66	0.66	rs11095951 [];										0.6125	0.0375	0.35	64		
chrX	142716114	142716114	G	A	hom	222	SLITRK4			0.49	0.49	0.49	rs5907446 [];										0.475	0.0375	0.4875	50		
chrX	142795225	142795225	G	A	hom	222	SPANXN2	synonymous SNV	SPANXN2:NM_001009615:exon2:c.C453T:p.D151D,	0.65	0.65	0.65	rs3859898 [];					0.5525					0.625	0.0625	0.3125	95		
chrX	142795697	142795697	T	G	hom	222	SPANXN2			0.59	0.59	0.59	rs67375287 [];										0.275	0.05	0.675	33		
chrX	142795709	142795709	G	T	hom	222	SPANXN2			0.7	0.7	0.7	rs12389451 [];										0.275	0.05	0.675	33		
chrX	142804305	142804305	-	T	hom	214	SPANXN2			0	0	0	rs66592761 [];										0.6	0.025	0.375	63		
chrX	142804326	142804326	C	T	hom	222	SPANXN2			0.59	0.59	0.59	rs851091 [];										0.6375	0.0625	0.3	68		
chrX	142804493	142804493	T	C	hom	222	SPANXN2			0.62	0.62	0.62	rs851090 [];										0.6375	0.0625	0.3	67		
chrX	144337667	144337667	C	A	hom	222	SPANXN1			0.87	0.87	0.87	rs485945 [];										0.375	0.0375	0.5875	45		
chrX	144902664	144902664	-	AACACACACACA	het	217	SLITRK2			0	0	0								389			0	0	1	0		
chrX	144904882	144904882	T	C	hom	222	SLITRK2	synonymous SNV	SLITRK2:NM_001144006:exon3:c.T939C:p.P313P,SLITRK2:NM_001144003:exon5:c.T939C:p.P313P,SLITRK2:NM_001144008:exon3:c.T939C:p.P313P,SLITRK2:NM_032539:exon5:c.T939C:p.P313P,SLITRK2:NM_001144009:exon2:c.T939C:p.P313P,SLITRK2:NM_001144004:exon5:c.T939C:p.P313P,SLITRK2:NM_001144010:exon3:c.T939C:p.P313P,SLITRK2:NM_001144005:exon5:c.T939C:p.P313P,	0.94	0.94	0.94	rs2748588 [];					0.8644					0.7625	0.0375	0.2	127		
chrX	144906710	144906712	CTT	-	het	103	SLITRK2			0	0	0								231			0.05	0.0125	0.9375	5		
chrX	144910142	144910142	G	A	hom	222	TMEM257			0.53	0.53	0.53	rs5919909 [];										0.5125	0.0625	0.425	58		
chrX	144910925	144910925	C	A	hom	222	TMEM257			0.02	0.02	0.02	rs116637437 [];										0.025	0	0.975	2		
chrX	144910936	144910936	C	T	hom	222	TMEM257			0.93	0.93	0.93	rs2474402 [];										0.775	0.0375	0.1875	80		
chrX	147003564	147003564	T	C	hom	222	FMR1-AS1			1	1	1	rs1270092 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.4375	0	0.5625	87		
chrX	147026331	147026331	C	-	hom	106	FMR1			0.97	0.97	0.97	rs11293471 [];								309550 [FMR1 gene - Fragile X syndrome, 300624 (3); Fragile X tremor/ataxia syndrome,300623 (3)];		0.425	0	0.575	45		
chrX	147106677	147106677	C	A	hom	208	FMR1NB			1	1	1	rs215110 [];										0.4375	0	0.5625	46		
chrX	147108312	147108312	A	G	hom	222	FMR1NB			0.98	0.98	0.98	rs215112 [];										0.3875	0.025	0.5875	43		
chrX	147891558	147891558	T	C	hom	201	AFF2			0.95	0.95	0.95	rs11117555 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.425	0	0.575	44		
chrX	148037055	148037055	G	C	hom	189	AFF2			0.75	0.75	0.75	rs16994868 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.4125	0.0125	0.575	44		
chrX	148055144	148055144	A	G	hom	222	AFF2			0.96	0.96	0.96	rs5980615 [];					0.9993			300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9625	0	0.0375	210		
chrX	148062377	148062377	G	A	hom	222	AFF2			0.63	0.63	0.63	rs12688573 [];					0.7206			300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.2875	0.0375	0.675	56		
chrX	148079639	148079639	A	C	hom	222	AFF2			0.87	0.87	0.87	rs16994920 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.925	0.0125	0.0625	150		
chrX	148079740	148079740	A	C	hom	222	AFF2			0.86	0.86	0.86	rs58901446 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	149		
chrX	148079877	148079877	T	C	hom	222	AFF2			0.83	0.83	0.83	rs16994922 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	150		
chrX	148081131	148081132	TG	-	het	68.5	AFF2			0	0	0								222	300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0	0	1	0		
chrX	148081140	148081140	A	G	hom	222	AFF2			0.91	0.91	0.91	rs184050542 [];							222	300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9375	0	0.0625	153		
chrX	148081451	148081451	A	G	hom	222	AFF2			1	1	1	rs141776682 [];								300806 [AF4/FMR2 family, member 2 (fragile site, X-linked, E) - Mental retardation, X-linked, FRAXE type, 309548 (3)];		0.9875	0	0.0125	156		
chrX	148561332	148561332	C	T	hom	222	IDS			0.43	0.43	0.43	rs8965 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.425	0.05	0.525	87		
chrX	148563150	148563150	C	T	hom	222	IDS			0.39	0.39	0.39	rs4844025 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.425	0.05	0.525	88		
chrX	148564053	148564053	A	-	hom	84.5	IDS			0	0	0	rs71753099 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.25	0	0.75	45		
chrX	148582549	148582549	G	A	hom	222	IDS	synonymous SNV	IDS:NM_001166550:exon4:c.C168T:p.T56T,IDS:NM_000202:exon4:c.C438T:p.T146T,IDS:NM_006123:exon4:c.C438T:p.T146T,	0.24	0.24	0.24	rs1141608 [];					0.3948			300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.25	0.0375	0.7125	79		
chrX	148609338	148609338	T	A	hom	222	LOC100131434			0.76	0.76	0.76	rs15523 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.725	0.0375	0.2375	70		
chrX	148614478	148614478	C	T	hom	154	LOC100131434			0.8	0.8	0.8	rs2272561 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.8375	0.0125	0.15	81		
chrX	148614589	148614589	G	A	hom	196	LOC100131434			0.79	0.79	0.79	rs145413300 [];								300823 [Iduronate 2-sulfatase (Hunter syndrome) - Mucopolysaccharidosis II, 309900 (3)];		0.85	0	0.15	82		
chrX	148619842	148619843	AG	-	hom	93.5	LOC100131434			0.1	0.1	0.1								299			0.075	0.0125	0.9125	12		
chrX	148621334	148621334	G	C	hom	222	LOC100131434			0.84	0.84	0.84	rs12116320 [];										0.3625	0.05	0.5875	43		
chrX	148622385	148622385	G	C	hom	222	CXorf40A			1	1	1	rs113049484 [];										0.4375	0	0.5625	46		
chrX	148622398	148622398	C	G	hom	222	CXorf40A			0.96	0.96	0.96	rs112658167 [];										0.4375	0	0.5625	46		
chrX	148622508	148622508	A	C	hom	222	CXorf40A			0.99	0.99	0.99	rs111314546 [];										0.4375	0	0.5625	46		
chrX	148622730	148622730	G	A	hom	222	CXorf40A			0.84	0.84	0.84	rs3747443 [];										0.85	0.05	0.1	90		
chrX	148622745	148622745	T	A	hom	222	CXorf40A			0.84	0.84	0.84	rs3747442 [];										0.85	0.05	0.1	90		
chrX	148627384	148627384	A	G	hom	210	CXorf40A	nonsynonymous SNV	CXorf40A:NM_001171909:exon3:c.A208G:p.T70A,CXorf40A:NM_001171908:exon4:c.A208G:p.T70A,CXorf40A:NM_178124:exon4:c.A208G:p.T70A,CXorf40A:NM_001171907:exon4:c.A208G:p.T70A,	0.91	0.91	0.91	rs145921071 [];	-0.0490	0.0000	0.6800	0.0000						0.9375	0	0.0625	139		
chrX	148628490	148628490	A	T	hom	222	CXorf40A	synonymous SNV	CXorf40A:NM_001171908:exon5:c.A459T:p.P153P,CXorf40A:NM_178124:exon5:c.A459T:p.P153P,CXorf40A:NM_001171907:exon5:c.A459T:p.P153P,	0	0	0	rs12116111 [];										0.9875	0	0.0125	167		
chrX	148794953	148794953	G	A	hom	222	MAGEA11			0.5	0.5	0.5	rs1970766 [];					0.4777					0.325	0.0625	0.6125	50		
chrX	148795848	148795848	G	A	hom	222	MAGEA11			0.51	0.51	0.51	rs6540341 [];										0.3375	0.0625	0.6	37		
chrX	148797348	148797348	C	T	hom	222	MAGEA11			0.23	0.23	0.23	rs2233048 [];					0.4652					0.1125	0.05	0.8375	45		
chrX	148798223	148798223	T	C	hom	222	MAGEA11	synonymous SNV	MAGEA11:NM_001011544:exon5:c.T990C:p.L330L,MAGEA11:NM_005366:exon5:c.T1077C:p.L359L,	0.53	0.53	0.53	rs2233050 [];					0.4829					0.3375	0.0625	0.6	66		
chrX	148798670	148798670	C	T	hom	222	MAGEA11			0.39	0.39	0.39	rs10126316 [];										0.325	0.0625	0.6125	38		
chrX	148851541	148851541	G	-	hom	43.5	MAGEA11;HSFX1		MAGEA11:dist=52613;HSFX1:dist=4185	0.78	0.78	0.78											0.325	0	0.675	36		
chrX	149013727	149013727	A	G	hom	222	MAGEA8	synonymous SNV	MAGEA8:NM_001166401:exon3:c.A681G:p.A227A,MAGEA8:NM_001166400:exon4:c.A681G:p.A227A,MAGEA8:NM_005364:exon3:c.A681G:p.A227A,	0.87	0.87	0.87	rs5983916 [];					0.7948					0.775	0.025	0.2	127		
chrX	149105827	149105827	G	A	hom	222	CXorf40B			0.2	0.2	0.2	rs5945554 [];										0.1	0.0625	0.8375	16		
chrX	149109123	149109123	C	A	hom	222	LOC100272228			0.99	0.99	0.99	rs28454191 [];										0.4375	0	0.5625	46		
chrX	149391902	149391902	G	A	hom	222	LOC100272228;MIR2114		LOC100272228:dist=206884;MIR2114:dist=4337	0.26	0.26	0.26	rs12399776 [];										0.1125	0.0375	0.85	19		
chrX	149680221	149680221	G	C	hom	222	MAMLD1			0.61	0.61	0.61	rs659188 [];										0.225	0.0625	0.7125	31		
chrX	149680554	149680554	C	T	hom	222	MAMLD1	synonymous SNV	MAMLD1:NM_001177465:exon5:c.C2208T:p.S736S,	0.6	0.6	0.6	rs2070779 [];										0.5	0.0875	0.4125	57		
chrX	149681925	149681925	T	C	hom	222	MAMLD1			0.62	0.62	0.62	rs567517 [];										0.6	0.0875	0.3125	67		
chrX	149826503	149826503	G	A	hom	222	MTM1		MTM1:NM_000252:exon11:c.1260+3G>A	0.58	0.58	0.58	rs222410 [];					0.4987			300415 [Myotubularin - Myotubular myopathy, X-linked, 310400 (3)];		0.45	0.075	0.475	129		
chrX	149931106	149931106	C	T	hom	222	MTMR1	synonymous SNV	MTMR1:NM_003828:exon15:c.C1902T:p.G634G,	0.85	0.85	0.85	rs16995747 [];					0.8796					0.825	0.05	0.125	131		
chrX	149932703	149932703	G	A	hom	222	MTMR1			0.87	0.87	0.87	rs5925424 [];										0.775	0.05	0.175	74		
chrX	149933121	149933121	G	-	hom	127	MTMR1			0	0	0	rs11345559 [];										0.9	0.025	0.075	90		
chrX	149935100	149935100	T	C	hom	222	CD99L2			0.49	0.49	0.49	rs6877 [];										0.575	0.0625	0.3625	62		
chrX	149936103	149936103	C	A	hom	222	CD99L2			0.23	0.23	0.23	rs9866 [];										0.25	0.075	0.675	27		
chrX	149936748	149936748	C	G	hom	222	CD99L2			0.27	0.27	0.27	rs5925425 [];										0.3375	0.075	0.5875	36		
chrX	149937428	149937428	C	T	hom	222	CD99L2			0.03	0.03	0.03	rs41311370 [];										0.05	0.0125	0.9375	5		
chrX	150344067	150344067	T	C	hom	222	GPR50			0.29	0.29	0.29	rs736752 [];										0.475	0.075	0.45	48		
chrX	150344148	150344148	T	C	hom	222	GPR50			0.14	0.14	0.14	rs5969987 [];										0.25	0.1	0.65	31		
chrX	150344282	150344282	G	C	hom	222	GPR50			0	0	0											0	0	1	0		
chrX	150344434	150344434	A	C	hom	222	GPR50			0.39	0.39	0.39	rs573861 [];										0.325	0.1125	0.5625	39		
chrX	150349558	150349569	CACCACTGGCCA	-	hom	214	GPR50	nonframeshift deletion	GPR50:NM_004224:exon2:c.1503_1514del:p.501_505del [1(ovary),1(pancreas)]; 	0	0	0	rs68058591 [];					0.3940	1163654 [1(ovary),1(pancreas)]; 111706 [1(ovary),1(pancreas)]; 				0.325	0.025	0.65	62		
chrX	150349649	150349649	A	G	hom	222	GPR50	nonsynonymous SNV	GPR50:NM_004224:exon2:c.A1594G:p.T532A [1(stomach)]; 	0.45	0.45	0.45	rs561077 [];	-1.3070	0.0005	0.9500	0.0000	0.4162	150835 [1(stomach)]; 150834 [1(stomach)]; 				0.35	0.025	0.625	63		
chrX	150573747	150573747	-	AATTA	hom	214	VMA21			0	0	0											0	0	1	0		
chrX	150575385	150575385	A	G	hom	222	VMA21			0.37	0.37	0.37	rs7067140 [];										0.475	0.0375	0.4875	53		
chrX	150789690	150789690	C	T	hom	181	PASD1			0.8	0.8	0.8	rs5924976 [];										0.3875	0	0.6125	41		
chrX	150789767	150789767	C	T	hom	139	PASD1			0.91	0.91	0.91	rs5924653 [];										0.4375	0	0.5625	46		
chrX	150789950	150789950	C	T	hom	222	PASD1		PASD1:NM_173493:exon6:c.308-4C>T	0.8	0.8	0.8	rs945815 [];					0.9237					0.85	0.0125	0.1375	126		
chrX	150840916	150840916	C	T	hom	222	PASD1	synonymous SNV	PASD1:NM_173493:exon14:c.C1699T:p.L567L,	0.19	0.19	0.19	rs41299110 [];					0.2417		221			0.15	0.05	0.8	43		
chrX	150841225	150841225	A	G	hom	222	PASD1			0.22	0.22	0.22	rs2294101 [];										0.0625	0.05	0.8875	14		
chrX	150844844	150844844	G	T	hom	222	PASD1			0.19	0.19	0.19	rs4363323 [];										0.15	0.05	0.8	23		
chrX	150844967	150844967	T	A	hom	222	PASD1			0.19	0.19	0.19	rs41311680 [];										0.15	0.05	0.8	21		
chrX	150845179	150845179	T	A	hom	222	PASD1			0.19	0.19	0.19	rs2280923 [];										0.15	0.05	0.8	21		
chrX	150868799	150868799	C	G	hom	222	PRRG3			0.3	0.3	0.3	rs4469605 [];										0.1375	0.025	0.8375	15		
chrX	150869267	150869267	A	G	hom	222	PRRG3	nonsynonymous SNV	PRRG3:NM_024082:exon4:c.A458G:p.N153S,	0.93	0.93	0.93	rs4323608 [];	0.4060	0.0000		0.0000	0.9340					0.8625	0	0.1375	127		
chrX	150911501	150911501	-	TGTGTGTGTATATATATATATATATATATACACACA	het	81.5	CNGA2			0	0	0								831			0	0.05	0.95	4		
chrX	150911512	150911512	G	A	het	89	CNGA2			0.91	0.91	0.91	rs5924686 [];							831			0.15	0.2625	0.5875	44		
chrX	150911513	150911513	T	C	het	91	CNGA2			0	0	0	rs5924687 [];							831			0.1375	0.275	0.5875	44		
chrX	150913261	150913261	G	T	hom	222	CNGA2			0.03	0.03	0.03	rs41302160 [];										0.0125	0	0.9875	1		
chrX	151138179	151138179	A	C	hom	222	GABRE	nonsynonymous SNV	GABRE:NM_004961:exon3:c.T304G:p.S102A,	0.69	0.69	0.69	rs1139916 [];	0.2040	0.0000	0.4900	0.4150	0.6705					0.625	0.0125	0.3625	90		
chrX	151282592	151282592	T	A	hom	222	MAGEA10-MAGEA5;MAGEA5			0.77	0.77	0.77	rs2471978 [];										0.775	0.025	0.2	78		
chrX	151282610	151282610	G	A	hom	222	MAGEA10-MAGEA5;MAGEA5			0.99	0.99	0.99	rs210571 [];										0.95	0	0.05	91		
chrX	151282657	151282657	G	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.81	0.81	0.81	rs2452124 [];										0.7625	0.025	0.2125	77		
chrX	151283004	151283004	G	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.99	0.99	0.99	rs210573 [];										0.9875	0	0.0125	98		
chrX	151283336	151283336	T	C	hom	222	MAGEA10-MAGEA5;MAGEA5			0.78	0.78	0.78	rs3565 [];						COSN414020 [1(urinary_tract)]; 				0.7875	0.025	0.1875	82		
chrX	151283437	151283441	TTATC	-	hom	214	MAGEA10-MAGEA5;MAGEA5			0	0	0	rs67540048 [];										0.8125	0.025	0.1625	84		
chrX	151283567	151283567	A	T	hom	222	MAGEA10-MAGEA5;MAGEA5			0.98	0.98	0.98	rs210575 [];										1	0	0	100		
chrX	151283599	151283599	T	G	hom	222	MAGEA10-MAGEA5;MAGEA5			1	1	1	rs210576 [];					0.9999					1	0	0	126		
chrX	151286320	151286320	A	G	hom	178	MAGEA10-MAGEA5;MAGEA5			0.8	0.8	0.8	rs6627537 [];										0.3375	0.025	0.6375	38		
chrX	151303393	151303393	C	T	hom	222	MAGEA10	nonsynonymous SNV	MAGEA10:NM_001251828:exon5:c.G700A:p.V234I,MAGEA10:NM_021048:exon4:c.G700A:p.V234I,MAGEA10:NM_001011543:exon5:c.G700A:p.V234I,	0.99	0.99	0.99	rs210586 [];	0.2920	0.0000	1.0000	0.0020	0.9997					0.975	0	0.025	144		
chrX	151303596	151303596	C	T	hom	222	MAGEA10	nonsynonymous SNV	MAGEA10:NM_001251828:exon5:c.G497A:p.R166K,MAGEA10:NM_021048:exon4:c.G497A:p.R166K,MAGEA10:NM_001011543:exon5:c.G497A:p.R166K,	0.96	0.96	0.96	rs210585 [];	-1.5200	0.0000	1.0000	0.0060	0.9994					0.9875	0	0.0125	143		
chrX	151619708	151619708	T	G	hom	222	GABRA3			0.65	0.65	0.65	rs7391474 [];										0.7625	0.075	0.1625	81		
chrX	151619799	151619799	-	CT	het	133	GABRA3			0	0	0								417			0.0125	0.0375	0.95	4		
chrX	151821277	151821277	T	A	hom	222	GABRQ	nonsynonymous SNV	GABRQ:NM_018558:exon9:c.T1432A:p.F478I,	0.46	0.46	0.46	rs3810651 [];	-4.3390	0.0000	1.0000	0.0000						0.5625	0.05	0.3875	97		
chrX	151870629	151870629	A	T	hom	222	MAGEA6			0.38	0.38	0.38	rs3175206 [];										0.3875	0.05	0.5625	45		
chrX	151896273	151896273	C	T	hom	222	CSAG4			0.35	0.35	0.35	rs2471768 [];										0.4125	0.075	0.5125	43		
chrX	151896334	151896334	G	A	hom	222	CSAG4			0.45	0.45	0.45	rs2515828 [];						488108 [1(kidney),1(endometrium)]; 				0.4125	0.075	0.5125	43		
chrX	151896676	151896676	T	A	hom	222	CSAG4			0	0	0											0	0	1	0		
chrX	151899760	151899760	A	G	hom	222	MAGEA12			0.99	0.99	0.99	rs2515830 [];										0.9875	0	0.0125	96		
chrX	151909156	151909156	A	G	hom	222	CSAG1	nonsynonymous SNV	CSAG1:NM_001102576:exon4:c.A185G:p.K62R,CSAG1:NM_153478:exon5:c.A185G:p.K62R,	0.58	0.58	0.58	rs2515848 [];	-0.0980	0.0000	0.2500	0.0000	0.5847					0.5375	0.075	0.3875	97		
chrX	151909281	151909281	C	G	hom	222	CSAG1			0.41	0.41	0.41	rs2515849 [];										0.4125	0.075	0.5125	46		
chrX	151909305	151909305	C	T	hom	222	CSAG1			0.44	0.44	0.44	rs2471787 [];										0.4	0.075	0.525	45		
chrX	151909490	151909490	A	G	hom	222	CSAG1			0.57	0.57	0.57	rs2515850 [];										0.5625	0.0875	0.35	62		
chrX	151909576	151909576	A	G	hom	222	CSAG1			0.44	0.44	0.44	rs7882673 [];										0.2	0.0625	0.7375	25		
chrX	152018832	152018832	T	G	hom	222	NSDHL	synonymous SNV	NSDHL:NM_015922:exon3:c.T132G:p.G44G,NSDHL:NM_001129765:exon4:c.T132G:p.G44G,	0.87	0.87	0.87	rs5969919 [];					0.8639			300275 [NAD(P)H steroid dehydrogenase-like protein - CHILD syndrome, 308050 (3); CK syndrome, 300831 (3)];		0.825	0.025	0.15	186		
chrX	152090809	152090809	T	C	hom	222	ZNF185			0.13	0.13	0.13	rs12558188 [];					0.2215					0.125	0.0375	0.8375	31		
chrX	152158979	152158979	T	C	hom	222	PNMA5	synonymous SNV	PNMA5:NM_001184924:exon4:c.A1164G:p.P388P,PNMA5:NM_001103150:exon2:c.A1164G:p.P388P,PNMA5:NM_052926:exon2:c.A1164G:p.P388P,PNMA5:NM_001103151:exon3:c.A1164G:p.P388P,	0.06	0.06	0.06	rs56350208 [];					0.1064					0.1	0.05	0.85	23		
chrX	152225379	152225379	C	A	hom	222	PNMA3			0.21	0.21	0.21	rs73244173 [];					0.4362		2170			0.325	0.1	0.575	50		
chrX	152226542	152226542	T	C	hom	222	PNMA3	nonsynonymous SNV	PNMA3:NM_013364:exon2:c.T1130C:p.V377A,	0.91	0.91	0.91	rs6526155 [];	-0.8440	0.0010	1.0000	0.0000	0.8577					0.7625	0.05	0.1875	122		
chrX	152228361	152228361	G	A	hom	222	PNMA3			0.23	0.23	0.23	rs1045069 [];										0.3	0.1	0.6	37		
chrX	152228523	152228523	T	C	hom	222	PNMA3			0.81	0.81	0.81	rs9035 [];							271			0.7	0.05	0.25	76		
chrX	152228684	152228684	T	C	hom	222	PNMA3			0.05	0.05	0.05	rs45520141 [];										0.1	0.075	0.825	15		
chrX	152228778	152228778	T	G	hom	222	PNMA3			0.51	0.51	0.51	rs7122 [];										0.55	0.0625	0.3875	60		
chrX	152610051	152610051	A	T	hom	222	ZNF275			0.71	0.71	0.71	rs1467880 [];					0.5094					0.2125	0.0375	0.75	44		
chrX	152610108	152610108	G	C	hom	222	ZNF275			0.71	0.71	0.71	rs1467881 [];					0.5107					0.4875	0.05	0.4625	82		
chrX	152610225	152610233	GTGACCTCT	-	hom	214	ZNF275			0.71	0.71	0.71	rs35024993 [];					0.4866					0.4875	0.05	0.4625	82		
chrX	152610294	152610294	A	G	hom	222	ZNF275			0.71	0.71	0.71	rs1467882 [];										0.2125	0.0375	0.75	26		
chrX	152610947	152610947	T	C	hom	222	ZNF275			0.71	0.71	0.71	rs3213465 [];					0.5103					0.2125	0.0375	0.75	45		
chrX	152610985	152610985	T	C	hom	222	ZNF275	synonymous SNV	ZNF275:NM_001080485:exon3:c.T39C:p.P13P,	0.45	0.45	0.45	rs3213466 [];					0.3065					0.2625	0.0625	0.675	50		
chrX	152611195	152611233	TCCCAGCTGAGCTCTTGGAGTTGAGGTTAGGGTTTGGGG	-	hom	72.5	ZNF275			0	0	0											0	0	1	0		
chrX	152613112	152613112	C	T	hom	222	ZNF275	synonymous SNV	ZNF275:NM_001080485:exon4:c.C969T:p.C323C,	0.71	0.71	0.71	rs7066295 [];					0.5039					0.4875	0.05	0.4625	76		
chrX	152616741	152616741	A	T	hom	222	ZNF275			0.74	0.74	0.74	rs8781 [];										0.55	0.075	0.375	59		
chrX	152727723	152727723	G	A	hom	222	HAUS7			0.5	0.5	0.5	rs762735 [];										0.6	0.05	0.35	61		
chrX	152728155	152728155	T	C	hom	222	HAUS7			0.51	0.51	0.51	rs2980032 [];					0.6853					0.2125	0.05	0.7375	64		
chrX	152760532	152760532	G	T	hom	166	BGN			0.24	0.24	0.24	rs5945197 [];										0.3	0.0375	0.6625	35		
chrX	152760871	152760871	G	A	hom	169	BGN			0.93	0.93	0.93	rs2980045 [];							240			0.9375	0	0.0625	87		
chrX	152770230	152770230	G	A	hom	222	BGN	synonymous SNV	BGN:NM_001711:exon2:c.G141A:p.S47S,	0.41	0.41	0.41	rs4833 [];					0.4089					0.35	0.0625	0.5875	68		
chrX	152770402	152770402	A	G	hom	222	BGN			0.86	0.86	0.86	rs2980053 [];										0.375	0.025	0.6	43		
chrX	152770462	152770462	G	A	hom	222	BGN			0.4	0.4	0.4	rs11156580 [];										0.125	0.05	0.825	19		
chrX	152774517	152774526	TTCTGTGTGT	-	het	192	BGN			0	0	0								405			0	0	1	0		
chrX	152774559	152774564	GTGTGT	-	het	60.5	BGN			0	0	0								405			0	0	1	0		
chrX	152774745	152774745	A	G	hom	222	BGN			0.98	0.98	0.98	rs2980054 [];										0.95	0	0.05	95		
chrX	152807425	152807425	G	A	hom	222	ATP2B3			0.62	0.62	0.62	rs762733 [];					0.8594					0.2875	0.0375	0.675	56		
chrX	152807505	152807507	CTT	-	hom	214	ATP2B3			0	0	0	rs10531880 [];										0.35	0.05	0.6	39		
chrX	152807627	152807627	C	-	hom	32.5	ATP2B3			0	0	0	rs5904365 [];										0.35	0	0.65	32		
chrX	152807665	152807665	A	G	hom	171	ATP2B3			0.95	0.95	0.95	rs2980012 [];										0.4375	0	0.5625	44		
chrX	152807923	152807923	G	C	hom	222	ATP2B3			0.99	0.99	0.99	rs2980013 [];					0.9999					0.4375	0	0.5625	219		
chrX	152815089	152815089	A	G	hom	222	ATP2B3	synonymous SNV	ATP2B3:NM_001001344:exon9:c.A1473G:p.G491G,ATP2B3:NM_021949:exon9:c.A1473G:p.G491G,	0.99	0.99	0.99	rs3020949 [];					0.9999					0.9625	0	0.0375	289		
chrX	152821887	152821887	C	T	hom	222	ATP2B3			0.96	0.96	0.96	rs3020957 [];					0.9994					0.4375	0	0.5625	239		
chrX	152823728	152823728	G	C	hom	222	ATP2B3	synonymous SNV	ATP2B3:NM_001001344:exon15:c.G2592C:p.V864V,ATP2B3:NM_021949:exon15:c.G2592C:p.V864V,	0.49	0.49	0.49	rs2269415 [];					0.5288					0.375	0.0375	0.5875	181		
chrX	152825414	152825414	G	T	hom	222	ATP2B3			0.91	0.91	0.91	rs3020959 [];					0.9489					0.4	0.0125	0.5875	212		
chrX	152825433	152825433	A	G	hom	222	ATP2B3			0.99	0.99	0.99	rs2980018 [];					0.9987					0.4375	0	0.5625	74		
chrX	152830322	152830322	A	G	hom	171	ATP2B3			0.94	0.94	0.94	rs4243536 [];										0.4	0.0125	0.5875	42		
chrX	152830684	152830684	C	T	hom	123	ATP2B3			0.92	0.92	0.92	rs5987097 [];										0.3	0.0125	0.6875	32		
chrX	152846255	152846255	-	A	het	213	ATP2B3			0	0	0											0	0.3125	0.6875	32		
chrX	152846545	152846545	-	G	hom	34.5	ATP2B3			0	0	0	rs67391061 [];										0	0	1	1		
chrX	152847291	152847291	T	C	hom	222	ATP2B3			0.85	0.85	0.85	rs4898425 [];										0.8125	0.05	0.1375	88		
chrX	152847301	152847301	G	C	hom	222	ATP2B3			0.85	0.85	0.85	rs4898426 [];										0.825	0.05	0.125	89		
chrX	152847488	152847488	T	G	hom	222	ATP2B3			0.85	0.85	0.85	rs5945311 [];										0.825	0.05	0.125	85		
chrX	152848425	152848425	A	C	hom	222	ATP2B3			0.85	0.85	0.85	rs5945312 [];										0.3625	0.05	0.5875	43		
chrX	152848459	152848459	T	G	hom	222	ATP2B3			0.85	0.85	0.85	rs5945313 [];										0.3625	0.05	0.5875	43		
chrX	152864478	152864478	-	C	hom	77.5	FAM58A	unknown	UNKNOWN	0	0	0											0.6375	0	0.3625	120		
chrX	152916023	152916023	T	G	hom	222	DUSP9			1	1	1	rs6643635 [];										0.9375	0	0.0625	92		
chrX	152916113	152916113	-	CACAGGG	hom	214	DUSP9			0	0	0											0.3125	0.0625	0.625	34		
chrX	152916126	152916126	-	CCCGCCCCTGTCCCCAAGT	hom	214	DUSP9			0	0	0											0.175	0.0375	0.7875	19		
chrX	152916237	152916237	-	G	hom	214	DUSP9			0	0	0	rs11407625 [];										0.95	0	0.05	92		
chrX	152935655	152935655	C	T	hom	222	PNCK			0.75	0.75	0.75	rs12848840 [];										0.325	0.0125	0.6625	34		
chrX	152935705	152935705	C	A	hom	160	PNCK			0.77	0.77	0.77	rs5945339 [];										0.2625	0.0125	0.725	29		
chrX	152937546	152937546	C	T	hom	222	PNCK			0.003	0.003	0.003	rs200709145 [];					0.0132					0.025	0	0.975	4		
chrX	152961521	152961523	ATT	-	hom	214	SLC6A8			0.03	0.03	0.03	rs200806041 [];								300036 [Solute carrier family 6 (neurotransmitter transporter, creatine), - Creatine deficiency syndrome, X-linked, 300352 (3)];		0.1	0	0.9	16		
chrX	152989830	152989830	A	C	hom	154	BCAP31			0	0	0	rs5987137 [];										0.7125	0	0.2875	64		
chrX	153008476	153008476	T	C	het	17.1	ABCD1	nonsynonymous SNV	ABCD1:NM_000033:exon8:c.T1816C:p.S606P [1(haematopoietic_and_lymphoid_tissue)]; 	0	0	0	rs201774661 [];	1.8270	0.9969	0.0000	0.8590		145040 [1(haematopoietic_and_lymphoid_tissue)]; 		300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.75	0.25	139		
chrX	153008483	153008483	G	A	het	20	ABCD1	nonsynonymous SNV	ABCD1:NM_000033:exon8:c.G1823A:p.G608D,	0	0	0	rs78993751 [];	2.2830	0.9992	0.0000	0.9990				300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.7625	0.2375	145		
chrX	153008911	153008911	C	T	hom	222	ABCD1			0.58	0.58	0.58	rs4898368 [];					0.6245			300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.2875	0.025	0.6875	75		
chrX	153009197	153009197	G	C	hom	222	ABCD1			0.7	0.7	0.7	rs2229539 [];					0.6915			300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.6125	0.025	0.3625	185		
chrX	153009448	153009448	A	G	het	42	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.6625	0.3375	115		
chrX	153009665	153009665	A	G	het	4.77	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.6125	0.3875	108		
chrX	153009670	153009670	G	T	het	64	ABCD1			0	0	0	rs199942817 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.775	0.225	127		
chrX	153009719	153009719	G	A	het	152	ABCD1			0	0	0	rs67211405 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.9375	0.0625	146		
chrX	153009876	153009876	G	C	het	47	ABCD1			0	0	0									300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.4375	0.5625	101		
chrX	153010059	153010059	G	T	het	112	ABCD1			0	0	0	rs72616452 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0.0125	0.9375	0.05	142		
chrX	153010066	153010066	C	T	het	225	ABCD1			0	0	0	rs11803 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.625	0.375	100		
chrX	153010083	153010083	G	A	het	225	ABCD1			0.17	0.17	0.17	rs1055847 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.45	0.55	76		
chrX	153010090	153010090	G	A	het	160	ABCD1			0	0	0	rs75637470 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.95	0.05	137		
chrX	153010092	153010092	G	A	het	147	ABCD1			0	0	0	rs78155328 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.95	0.05	135		
chrX	153010137	153010137	C	T	het	30	ABCD1			0	0	0	rs112109783 [];								300371 [ATP-binding cassette, subfamily D, member 1 - Adrenoleukodystrophy, 300100 (3); Adrenomyeloneuropathy, 300100 (3)];		0	0.75	0.25	104		
chrX	153010224	153010224	C	T	hom	222	ABCD1			0.7	0.7	0.7	rs6643782 [];										0.3	0.025	0.675	84		
chrX	153010267	153010267	G	A	het	225	ABCD1			0.61	0.61	0.61	rs6643784 [];										0.1	0.2125	0.6875	31		
chrX	153010314	153010314	G	A	het	6.2	ABCD1			0	0	0											0	0.225	0.775	20		
chrX	153034752	153034752	C	T	hom	160	PLXNB3			0.36	0.36	0.36	rs2266877 [];					0.5243					0.1625	0.0125	0.825	31		
chrX	153035798	153035798	G	A	hom	222	PLXNB3	nonsynonymous SNV	PLXNB3:NM_001163257:exon10:c.G1861A:p.V621I,PLXNB3:NM_005393:exon9:c.G1792A:p.V598I,	0.37	0.37	0.37	rs2266879 [];	-1.0330	0.0008	0.2800	0.1610	0.6448					0.5375	0.075	0.3875	96		
chrX	153037275	153037275	C	T	hom	222	PLXNB3			0.82	0.82	0.82	rs6643644 [];					0.7925					0.2875	0.05	0.6625	60		
chrX	153037594	153037594	C	G	hom	222	PLXNB3			0.8	0.8	0.8	rs11156607 [];					0.7826					0.2875	0.05	0.6625	60		
chrX	153037808	153037808	G	A	hom	173	PLXNB3			0.46	0.46	0.46	rs2266882 [];										0.25	0.05	0.7	30		
chrX	153038516	153038516	C	G	hom	222	PLXNB3			1	1	1	rs5945161 [];										0.4375	0	0.5625	73		
chrX	153038661	153038661	G	C	hom	222	PLXNB3			0.82	0.82	0.82	rs2266885 [];					0.7839					0.2875	0.05	0.6625	60		
chrX	153039502	153039502	G	C	hom	197	PLXNB3	nonsynonymous SNV	PLXNB3:NM_001163257:exon21:c.G3537C:p.E1179D,PLXNB3:NM_005393:exon20:c.G3468C:p.E1156D,	0.78	0.78	0.78	rs6643791 [];	-0.2450	0.4929	0.2300	0.0180	0.7887					0.6625	0.05	0.2875	90		
chrX	153039615	153039615	A	G	hom	222	PLXNB3			1	1	1	rs1543781 [];										0.4375	0	0.5625	69		
chrX	153041544	153041544	T	C	hom	222	PLXNB3	nonsynonymous SNV	PLXNB3:NM_001163257:exon28:c.T4673C:p.M1558T,PLXNB3:NM_005393:exon27:c.T4604C:p.M1535T,	0.82	0.82	0.82	rs5987155 [];	-1.2370	0.0001	0.5400	0.0000	0.7831					0.6625	0.05	0.2875	116		
chrX	153042419	153042419	G	A	hom	222	PLXNB3	synonymous SNV	PLXNB3:NM_001163257:exon30:c.G4980A:p.R1660R,PLXNB3:NM_005393:exon29:c.G4911A:p.R1637R,	0.47	0.47	0.47	rs34966902 [];	0.4340	0.8374			0.6617					0.575	0.0625	0.3625	97		
chrX	153045202	153045202	A	G	hom	222	PLXNB3			0.84	0.84	0.84	rs762650 [];										0.7	0.05	0.25	71		
chrX	153048648	153048648	T	-	hom	54.7	SRPK3			0.46	0.46	0.46	rs201302475 [];										0.0375	0.0125	0.95	9		
chrX	153052661	153052661	A	G	hom	222	IDH3G			0.95	0.95	0.95	rs2269482 [];										0.425	0	0.575	45		
chrX	153062853	153062853	G	A	hom	156	SSR4			0.03	0.03	0.03	rs41301321 [];					0.0531					0	0	1	3		
chrX	153068677	153068679	GAG	-	hom	214	PDZD4			0.35	0.35	0.35	rs72151348 [];										0.5375	0.075	0.3875	58		
chrX	153071351	153071351	T	C	hom	207	PDZD4			0.53	0.53	0.53	rs3747310 [];										0.2625	0.025	0.7125	29		
chrX	153073752	153073752	T	C	hom	222	PDZD4			0.89	0.89	0.89	rs3761532 [];										0.4	0	0.6	43		
chrX	153129556	153129556	G	A	hom	222	L1CAM			0.86	0.86	0.86	rs2071127 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.4125	0	0.5875	44		
chrX	153134521	153134521	G	C	hom	178	L1CAM			1	1	1	rs78371277 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.4375	0	0.5625	45		
chrX	153149170	153149170	G	C	hom	222	L1CAM;AVPR2		L1CAM:dist=7771;AVPR2:dist=21359	0.1	0.1	0.1	rs142085600 [];	1.0870							308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.0375	0	0.9625	3		
chrX	153149709	153149709	-	C	hom	214	L1CAM;AVPR2		L1CAM:dist=8310;AVPR2:dist=20820	0	0	0	rs66466703 [];								308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.9375	0	0.0625	136		
chrX	153149715	153149715	C	G	hom	222	L1CAM;AVPR2		L1CAM:dist=8316;AVPR2:dist=20814	0	0	0	rs6643650 [];	-2.6770							308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.9375	0	0.0625	135		
chrX	153150791	153150791	C	T	hom	99.3	L1CAM;AVPR2		L1CAM:dist=9392;AVPR2:dist=19738	0.49	0.49	0.49	rs12156710 [];					0.2273			308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.0125	0	0.9875	10		
chrX	153150929	153150929	G	A	hom	222	L1CAM;AVPR2		L1CAM:dist=9530;AVPR2:dist=19600	0.5	0.5	0.5	rs41311376 [];					0.2120			308840 [L1 cell adhesion molecule - Hydrocephalus due to aqueductal stenosis, 307000 (3); MASA syndrome,303350 (3); CRASH syndrome, 303350 (3); Hydrocephalus with Hirschsprung disease, 307000 (3); Hydrocephalus with congenital idiopathic intestinalpseudoobstruction, 307000 (3); Corpus callosum, partial agenesis of, 304100 (3)];		0.0875	0.0125	0.9	10		
chrX	153168407	153168407	G	A	hom	222	L1CAM;AVPR2		L1CAM:dist=27008;AVPR2:dist=2122	0.5	0.5	0.5	rs3761529 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.0875	0.025	0.8875	11		
chrX	153168449	153168449	T	C	hom	208	L1CAM;AVPR2		L1CAM:dist=27050;AVPR2:dist=2080	0.59	0.59	0.59	rs3761528 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.0875	0.025	0.8875	11		
chrX	153170448	153170448	-	C	hom	214	AVPR2			0	0	0	rs67971735 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.975	0	0.025	95		
chrX	153170980	153170980	T	G	hom	158	AVPR2			1	1	1	rs56689668 [];								300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.9125	0	0.0875	169		
chrX	153171993	153171993	A	G	hom	222	AVPR2	synonymous SNV	AVPR2:NM_000054:exon3:c.A927G:p.L309L,	0.6	0.6	0.6	rs5201 [];	0.2580	0.2772	0.0200		0.2999			300538 [Arginine vasopressin receptor-2 - Diabetes insipidus, nephrogenic, 304800 (3); Nephrogenic syndromeof inappropriate antidiuresis, 300539 (3)];		0.275	0.0625	0.6625	80		
chrX	153174820	153174820	-	G	hom	214	ARHGAP4			0	0	0	rs33963388 [];										0.4375	0	0.5625	73		
chrX	153174868	153174868	-	G	hom	214	ARHGAP4			0	0	0	rs34046683 [];										0.4375	0	0.5625	73		
chrX	153175054	153175054	-	C	hom	214	ARHGAP4			0	0	0	rs56015121 [];							211			0.4	0	0.6	38		
chrX	153176254	153176254	A	G	hom	205	ARHGAP4	synonymous SNV	ARHGAP4:NM_001666:exon15:c.T1716C:p.H572H,ARHGAP4:NM_001164741:exon16:c.T1836C:p.H612H,	0.63	0.63	0.63	rs2070097 [];	-2.3230				0.3909					0.325	0.0375	0.6375	60		
chrX	153186413	153186413	-	G	hom	214	ARHGAP4			0	0	0	rs34153599 [];										0.4375	0	0.5625	46		
chrX	153186485	153186485	-	C	hom	184	ARHGAP4			0	0	0	rs11428457 [];										0.4375	0	0.5625	73		
chrX	153210184	153210184	-	G	hom	137	RENBP			0	0	0											0.8625	0	0.1375	82		
chrX	153210196	153210196	-	G	hom	46.6	RENBP			0	0	0											0.8625	0	0.1375	82		
chrX	153215839	153215839	G	A	hom	222	HCFC1	synonymous SNV	HCFC1:NM_005334:exon24:c.C5859T:p.C1953C,	0.29	0.29	0.29	rs3027875 [];	-1.1950				0.6301					0.575	0.0125	0.4125	131		
chrX	153277889	153277889	C	T	hom	135	IRAK1			0.56	0.56	0.56	rs2239673 [];										0.325	0.025	0.65	38		
chrX	153278307	153278307	G	A	hom	222	IRAK1			0.56	0.56	0.56	rs763737 [];										0.3375	0.025	0.6375	38		
chrX	153278829	153278829	G	A	hom	222	IRAK1	nonsynonymous SNV	IRAK1:NM_001569:exon12:c.C1595T:p.S532L,IRAK1:NM_001025243:exon11:c.C1358T:p.S453L,	0.57	0.57	0.57	rs1059703 [];	-0.3780	0.0001	0.3800	0.0000	0.8528					0.7875	0.0375	0.175	133		
chrX	153279822	153279825	TAAA	-	het	65.5	IRAK1			0	0	0								189			0	0.025	0.975	2		
chrX	153279841	153279844	AAAA	-	hom	17.7	IRAK1			0	0	0								701			0.075	0.0125	0.9125	8		
chrX	153284192	153284192	A	G	hom	222	IRAK1	nonsynonymous SNV	IRAK1:NM_001569:exon5:c.T587C:p.F196S,IRAK1:NM_001025243:exon5:c.T587C:p.F196S,IRAK1:NM_001025242:exon5:c.T587C:p.F196S,	0.68	0.68	0.68	rs1059702 [];	0.2350	0.0004	0.4400	0.0010	0.8595					0.8	0.0375	0.1625	126		
chrX	153284483	153284483	G	A	hom	222	IRAK1	synonymous SNV	IRAK1:NM_001569:exon4:c.C483T:p.V161V [1(stomach)]; IRAK1:NM_001025243:exon4:c.C483T:p.V161V [1(stomach)]; IRAK1:NM_001025242:exon4:c.C483T:p.V161V [1(stomach)]; 	0.48	0.48	0.48	rs1059701 [];					0.8039	150839 [1(stomach)]; 				0.7125	0.0375	0.25	114		
chrX	153292180	153292180	T	C	hom	222	MECP2			0.67	0.67	0.67	rs2734647 [];								300005 [Methyl-CpG-binding protein-2 - Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked, Lubs type, 300260 (3)];		0.8125	0.0375	0.15	132		
chrX	153294542	153294542	T	C	hom	222	MECP2			0.99	0.99	0.99	rs2853337 [];							200	300005 [Methyl-CpG-binding protein-2 - Rett syndrome, 312750 (3); Mental retardation, X-linked, syndromic13, 300055 (3); Rett syndrome, preserved speech variant, 312750 (3); Encephalopathy, neonatal severe, 300673 (3); {Autism susceptibility, X-linked3}, 300496 (3); Angelman syndrome, 105830 (3); Mental retardation, X-linked, Lubs type, 300260 (3)];		0.9375	0	0.0625	155		
chrX	153416537	153416537	A	C	hom	181	OPN1LW			0	0	0	rs78751796 [];										0.4375	0	0.5625	46		
chrX	153523604	153523604	G	A	hom	222	TEX28;TKTL1			0.04	0.04	0.04	rs115875344 [];										0.05	0.0375	0.9125	8		
chrX	153629155	153629155	A	G	hom	222	RPL10	nonsynonymous SNV	RPL10:NM_006013:exon7:c.A605G:p.N202S,RPL10:NM_001256577:exon6:c.A442G:p.I148V,RPL10:NM_001256580:exon6:c.A497G:p.N166S,	0.71	0.71	0.71	rs12012747 [];	1.5890	0.2894	0.4200	0.0020				312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.8	0.025	0.175	179		
chrX	153630255	153630255	G	C	hom	222	DNASE1L1;RPL10			0.71	0.71	0.71	rs12877 [];								312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.825	0.025	0.15	136		
chrX	153630293	153630293	C	T	hom	222	DNASE1L1;RPL10			0.71	0.71	0.71	rs12559 [];								312173 [Ribosomal protein L10 - {Autism, susceptibility to, X-linked 5}, 300847 (3)];		0.8	0.025	0.175	133		
chrX	153633359	153633359	G	C	hom	222	DNASE1L1	synonymous SNV	DNASE1L1:NM_001009932:exon5:c.C201G:p.P67P,DNASE1L1:NM_006730:exon3:c.C201G:p.P67P,DNASE1L1:NM_001009934:exon3:c.C201G:p.P67P,DNASE1L1:NM_001009933:exon4:c.C201G:p.P67P,	0.73	0.73	0.73	rs1130929 [];					0.8897					0.8125	0.025	0.1625	133		
chrX	153633533	153633533	G	A	hom	211	DNASE1L1			0.73	0.73	0.73	rs28602900 [];										0.3625	0.0125	0.625	40		
chrX	153633953	153633953	T	C	hom	222	DNASE1L1			0.88	0.88	0.88	rs1050094 [];					0.8921					0.8	0.025	0.175	108		
chrX	153636858	153636858	G	C	hom	222	DNASE1L1			0.73	0.73	0.73	rs4898484 [];										0.3625	0.0125	0.625	40		
chrX	153637305	153637305	T	C	hom	222	DNASE1L1			0.73	0.73	0.73	rs2070807 [];										0.8125	0.025	0.1625	81		
chrX	153640061	153640061	T	-	hom	102	TAZ			0.81	0.81	0.81	rs11388353 [];								300394 [Tafazzin - Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)];		0.5875	0.0125	0.4	66		
chrX	153649813	153649813	G	C	hom	222	TAZ			0.89	0.89	0.89	rs743547 [];								300394 [Tafazzin - Barth syndrome, 302060 (3);Cardiomyopathy, dilated, 3A, 300069 (3); Left ventricular noncompaction, X-linked, 300183 (3)];		0.8125	0.025	0.1625	137		
chrX	153657083	153657083	A	G	hom	202	ATP6AP1	synonymous SNV	ATP6AP1:NM_001183:exon1:c.A45G:p.R15R,	0.91	0.91	0.91	rs28497482 [];					0.9013					0.7875	0.025	0.1875	124		
chrX	153660041	153660041	C	T	hom	222	ATP6AP1			0.83	0.83	0.83	rs11156577 [];										0.3625	0.0125	0.625	39		
chrX	153660070	153660070	T	C	hom	222	ATP6AP1			0.35	0.35	0.35	rs3737557 [];										0.0625	0	0.9375	8		
chrX	153689385	153689385	C	T	hom	222	PLXNA3			0.01	0.01	0.01	rs41301333 [];										0	0	1	0		
chrX	153744044	153744044	C	G	hom	160	FAM3A			0.01	0.01	0.01	rs187461328 [];					0.0106					0	0	1	2		
chrX	153906394	153906394	-	A	het	40.5	GAB3			0	0	0								186			0	0.225	0.775	19		
chrX	153928031	153928031	C	T	hom	222	GAB3			0.54	0.54	0.54	rs884840 [];										0.2875	0.0375	0.675	29		
chrX	153994596	153994596	G	T	hom	222	DKC1	synonymous SNV	DKC1:NM_001142463:exon5:c.G369T:p.T123T,DKC1:NM_001363:exon5:c.G369T:p.T123T,	0.99	0.99	0.99	rs2728532 [];	-2.1510				1.0000			300126 [Dyskerin - Dyskeratosis congenita-1, 305000 (3); Hoyeraal-Hreidarsson syndrome,300240 (3)];		0.975	0	0.025	210		
chrX	154009618	154009618	G	-	hom	73.5	MPP1			0	0	0	rs11318110 [];										0.325	0.0375	0.6375	46		
chrX	154009645	154009645	A	-	hom	52.5	MPP1			0	0	0											0.0125	0	0.9875	2		
chrX	154013484	154013484	-	C	hom	5.79	MPP1			0	0	0	rs59913063 [];										0.275	0.05	0.675	27		
chrX	154020114	154020114	C	A	hom	222	MPP1	synonymous SNV	MPP1:NM_001166460:exon3:c.G204T:p.T68T,MPP1:NM_001166461:exon3:c.G255T:p.T85T,MPP1:NM_001166462:exon4:c.G165T:p.T55T,MPP1:NM_002436:exon3:c.G255T:p.T85T,	0.62	0.62	0.62	rs1126762 [];					0.7225					0.65	0.0375	0.3125	103		
chrX	154045229	154045229	G	A	hom	222	MPP1;SMIM9		MPP1:dist=11427;SMIM9:dist=6394	1	1	1	rs113790313 [];										0.9625	0	0.0375	89		
chrX	154064580	154064580	T	C	hom	222	F8			1	1	1	rs1396947 [];								300841 [Coagulation factor VIII, procoagulant component - Hemophilia A, 306700 (3)];		0.95	0	0.05	153		
chrX	154456747	154456747	A	G	hom	222	VBP1	nonsynonymous SNV	VBP1:NM_003372:exon4:c.A367G:p.M123V,	1	1	1	rs572013 [];	1.0640	0.0000	1.0000	0.0000						0.9625	0	0.0375	144		
chrX	154718933	154718933	C	T	hom	157	TMLHE			0	0	0	rs782335 [];										0.075	0.025	0.9	8		
chrX	154720953	154720953	C	A	het	67	TMLHE			0.52	0.52	0.52	rs188309189 [];										0.175	0.025	0.8	16		
chrX	154721357	154721357	G	C	hom	161	TMLHE-AS1			0.56	0.56	0.56	rs150926226 [];					0.6826					0.3125	0.025	0.6625	34		
chrX	154722396	154722396	-	G	het	44.5	TMLHE-AS1			0	0	0											0.025	0	0.975	2		
chrX	154774707	154774707	C	T	hom	212	TMLHE			0.67	0.67	0.67	rs2305518 [];					0.7650		252			0.3375	0.0375	0.625	55		
chrX	154842666	154842666	C	T	hom	167	TMLHE			0.65	0.65	0.65	rs89278 [];										0.3375	0.0375	0.625	34		
chrMT	212	212	C	T	hom	178	TMLHE			0.65	0.65	0.65	rs89278 [];										0.3375	0.0375	0.625	34		